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vRÉSUMÉ
La maladie d’Alzheimer (MA) est la principale cause de maladies dégénératives et se ca-
ractérise par un début insidieux, une perte de mémoire précoce, des déficits verbaux et
visuo-spatiaux (associés à la destruction des lobes temporal et pariétal), un développement
progressif et une absence de signes neurologiques tôt dans l’apparition de la maladie. Au-
cun traitement n’est disponible en ce moment pour guérir la MA. Les traitements actuels
peuvent souvent ralentir de façon significative la progression de la maladie. La capacité de
diagnostiquer la MA à son stade initial a un impact majeur sur l’intervention clinique et la
planification thérapeutique, réduisant ainsi les coûts associés aux soins de longue durée. La
distinction entre les différents stades de la démence est essentielle afin de ralentir la progres-
sion de la MA.
La différenciation entre les patients ayant la MA, une déficience cognitive légère précoce
(DCLP), une déficience cognitive légère tardive (DCLT) ou un état cognitif normal (CN) est
un domaine de recherche qui a suscité beaucoup d’intérêt durant la dernière décennie. Les
images obtenues par tomographie par émission de positrons (TEP) font partie des meilleures
méthodes accessibles pour faciliter la distinction entre ces différentes classes. Du point de vue
de la neuro-imagerie, les images TEP par fluorodésoxyglucose (FDG) pour le métabolisme
cérébral du glucose et pour les plaques amyloïdes (AV45) sont considérées comme des bio-
marqueurs ayant une puissance diagnostique élevée. Cependant, seules quelques approches
ont étudié l’efficacité de considérer uniquement les zones actives localisées par la TEP à des
fins de classification.
La question de recherche principale de ce travail est de démontrer la capacité des images
TEP à classer les résultats de façon précise et de comparer les résultats de deux méthodes
d’imagerie TEP (FDG et AV45). Afin de déterminer la meilleure façon de classer les sujets
dans les catégories MA, DCLP, DCLT ou CN en utilisant exclusivement les images TEP,
nous proposons une procédure qui utilise les caractéristiques apprises à partir d’images TEP
identifiées sémantiquement. Les machines à vecteurs de support (MVS) sont déjà utilisées
pour faire de nombreuses classifications et font partie des techniques les plus utilisées pour
la classification basée sur la neuro-imagerie, comme pour la MA. Les MVS linéaires et la
fonction de base radiale (FBR)-MVS sont deux noyaux populaires utilisés dans notre clas-
sification. L’analyse en composante principale (ACP) est utilisée pour diminuer la taille des
données suivie par les MVS linéaires qui sont une autre méthode de classification. Les forêts
d’arbres décisionnels (FAD) sont aussi exécutées pour rendre les résultats obtenus par MVS
comparables. L’objectif général de ce travail est de concevoir un ensemble d’outils déjà exis-
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tants pour classer la MA et les différents stades de DCL. Suivant les étapes de normalisation
et de prétraitement, une méthode d’enregistrement TEP-IRM multimodale et déformable est
proposée afin de fusionner l’atlas du MNI au scan TEP de chaque patient et de développer
une méthode simple de segmentation basée sur l’atlas du cerveau dans le but de générer
un volume étiqueté avec 10 régions d’intérêt communes. La procédure a deux approches : la
première utilise l’intensité des voxels des régions d’intérêt, et la seconde, l’intensité des voxels
du cerveau en entier.
La méthode a été testée sur 660 sujets provenant de la base de données de l’(Alzheimer’s
Disease Neuroimaging Initiative) et a été comparée à une approche qui incluait le cerveau
en entier. La précision de la classification entre la MA et les CN a été mesurée à 91,7%
et à 91,2% en utilisant la FBR et les FAD, respectivement, sur des données combinant les
caractéristiques multirégionales des FDG-TEP des examens transversal et de suivi. Une amé-
lioration considérable a été notée pour la précision de classification entre les DCLP et DCLT
avec un taux de 72,5%. La précision de classification entre la MA et les CN en utilisant
AV45-TEP avec les données combinées a été mesurée à 90,8% et à 87,9% pour la FBR et les
FAD, respectivement. Cette procédure démontre le potentiel des caractéristiques multirégio-
nales de la TEP pour améliorer l’évaluation cognitive. Les résultats observés confirment qu’il
est possible de se fier uniquement aux images TEP sans ajout d’autres bio-marqueurs pour
obtenir une précision de classification élevée.
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ABSTRACT
Alzheimer’s disease (AD) is the most general cause of degenerative dementia, characterized
by insidious onset early memory loss, language and visuospatial deficits (associated with
the destruction of the temporal and parietal lobes), a progressive course, and lack of early
neurological signs early in the course of disease. There is currently no absolute cure for AD
but some treatments can slow down the progression of the disease in early stages of AD. The
ability to diagnose AD at an early stage has a great impact on the clinical intervention and
treatment planning, and hence reduces costs associated with long-term care. In addition,
discrimination of different stages of dementia is crucial to slow down the progression of AD.
Distinguishing patients with AD, early mild cognitive impairment (EMCI), late mild cognitive
impairment (LMCI), and normal controls (NC) is an extremely active research area, which
has garnered significant attention in the past decade. Positron emission tomography (PET)
images are one of the best accessible ways to discriminate between different classes. From a
neuroimaging point of view, PET images of fluorodeoxyglucose (FDG) for cerebral glucose
metabolism and amyloid plaque images (AV45) are considered a highly powerful diagnostic
biomarker, but few approaches have investigated the efficacy of focusing on localized PET-
active areas for classification purposes.
The main research question of this work is to show the ability of using PET images to
achieve accurate classification results and to compare the results of two imaging methods of
PET (FDG and AV45). To find the best scenario to classify our subjects into AD, EMCI,
LMCI, and NC using PET images exclusively, we proposed a pipeline using learned features
from semantically labelled PET images to perform group classification using four classifiers.
Support vector machines (SVMs) are already applied in a wide variety of classifications,
and it is one of the most popular techniques in classification based on neuroimaging like
AD. Linear SVMs and radial basis function (RBF) SVMs are two common kernels used
in our classification. Principal component analysis (PCA) is used to reduce the dimension
of our data followed by linear SVMs, which is another method of classification. Random
forest (RF) is also applied to make our SVM results comparable. The general objective
of this work is to design a set of existing tools for classifying AD and different stages of
MCI. Following normalization and pre-processing steps, a multi-modal PET-MRI registration
method is proposed to fuse the Montreal Neurological Institute (MNI) atlas to PET images of
each patient which is registered to its corresponding MRI scan, developing a simple method of
segmentation based on a brain atlas generated from a fully labelled volume with 10 common
regions of interest (ROIs). This pipeline can be used in two ways: (1) using voxel intensities
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from specific regions of interest (multi-region approach), and (2) using voxel intensities from
the entire brain (whole brain approach).
The method was tested on 660 subjects from the Alzheimer’s Disease Neuroimaging Initiative
database and compared to a whole-brain approach. The classification accuracy of AD vs
NC was measured at 91.7 % and 91.2 % when using RBF-SVM and RF, respectively, on
combining both multi-region features from FDG-PET on cross-sectional and follow-up exams.
A considerable improvement compare to the similar works in the EMCI vs LMCI classification
accuracy was achieved at 72.5 %. The classification accuracy of AD versus NC using AV45-
PET on the combined data was measured at 90.8 % and 87.9 % using RBF-SVM and RF,
respectively. The pipeline demonstrates the potential of exploiting longitudinal multi-region
PET features to improve cognitive assessment. We can achieve high accuracy using only
PET images. This suggests that PET images are a rich source of discriminative information
for this task. We note that other methods rely on the combination of multiple sources.
ix
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1CHAPTER 1 INTRODUCTION
Alzheimer’s disease (AD) is one of the most common causes of dementia in the aging popu-
lation and is known as a neurodegenerative disorder. Typically, AD follows certain stages,
which will bring about changes in a person’s life. Mild cognitive impairment (MCI) is the pre-
clinical stage of Alzheimer’s disease (Dessouky and Taha, 2013) and is an intermediate stage
of normal aging dementia between expected age-related dementia and the serious decline of
dementia. MCI is classified into early stage and late stage before converting to AD. The early
stage of MCI (EMCI) refers to any aged person who has mild impairment. Some common
symptoms are recognized in this stage, like forgetfulness, changes in mood and behaviour,
as well as problems with memory, language, thinking, and judgment that are greater than
normal age-related changes. The next stage of MCI is late stage (LMCI), which brings a
greater decline in the person’s cognitive and functional abilities (Mayo Clinic Staff, 2017).
In developed countries, due to good treatment and the high rank of health, people can live
longer. However, their lifestyles and habits influence disease risk. Moreover, some vascular
system problems (hypertension, type 2 diabetes, and obesity) increase the risk of dementia
including AD (Kalaria et al., 2008). As of today, there is still no absolute cure for AD but
some treatments like cholinesterase inhibitors, a type of drug approved for Alzheimer’s disease
given to people with MCI whose main symptom is memory loss (Lee et al., 2011), can slow
down the progression of the disease in the early stages of AD (Salmon, 2008), (Cabral and
Silveira, 2013). Therefore, being able to differentiate and diagnose the different stages of AD
can help improve on time treatment for the early stages. The early detection of AD as well as
finding a successful treatment to slow down the progression of symptoms are still challenges.
In the last few years, the development of automated diagnostic tools has attracted great
attention. Classification between the different stages of AD and normal control (NC) is po-
pular, and different approaches were developed to get better results of classification (Fox
et al., 1996), (Zhang et al., 2011a), (Habeck et al., 2008), (Smailagic et al., 2015). The PET
images are one of the best accessible ways to discriminate between different classes. The-
refore, classification of AD and MCI based on PET images has been the main objective of
several works (Gray et al., 2012), (Rodrigues and Silveira, 2014), (Aidos et al., 2014a). In
this work, PET images are used as the main biomarker to discriminate between the different
stages of MCI and AD versus NC.
21.1 Definition and Basic Concept
Alzheimer’s disease (AD) is a brain disorder that is not part of normal aging, although the
greatest known risk factor is increasing age (Alzheimer’s Association, 2016). Since there is
an abundance of published information about AD, emphasis will be put on basic information
related to the work of this thesis.
Neuroimaging, with its strong ability to produce high-quality images of the brain, has been
a true revolution in medicine. Computerized tomography (CT), magnetic resonance imaging
(MRI), positron emission tomography (PET), and single photon emission computed tomo-
graphy (SPECT) are the most common imaging techniques used to provide detailed and
non-invasive visualization of internal anatomy and physiology. For instance, to help evaluate
organ and tissue functions, PET uses small amounts of radioactive materials called radiotra-
cers, an adapted camera, and a computer. By identifying body changes at the cellular level,
PET may detect the early onset of the disease before it is evident on other imaging tests.
Among the modalities above, PET provides very good and complimentary information for
diagnosis of AD (Bauer, 2014).
There is no definite cure for AD. Likely there is some treatment for early stage of AD and
in case of diagnosing the AD in early stage and recommending the treatment planing we can
reduce the costs associated with the long term care.
The PET exam is usually used after ensuring that patient does not have any other neuro-
logical disorders using clinical tests and CT or MRI scans. When the patient is diagnosed
with any stage of AD, a long-term follow up is arranged along with treatment planning,
when applicable. In this case, using only PET imaging can be a possible solution to track the
patient’s disease progression as well as to diagnose patients who are not able to have a MRI
due to metal parts like a heart battery. Therefore, we used PET images at two time points :
first visit (or baseline) and second visit, which is approximately after 12 months.
There is different way for AD diagnosis, brain imaging (structural, functional or metabolic
examination) can help to get more accurate and robust diagnosis. MRI is already tested by
several publications and it gives high results, but still neurological finding regions which are
more affected by AD is under question. PET is looking at metabolic activity of radioactive
compound inside of the body and specifically in brain to find out the most affected regions
by AD.
Most of the published works on classification between AD and MCI vs NC. However, diffe-
rentiating between the different stages of MCI is more relevant in treatment planning.
31.2 Problem and Research Question
Medical signs, which are limited to the medical observations of the patient, can be measured
accurately and reproducibly (Strimbu and Tavel, 2011). Biomarkers, on their side, refer to
signs measured with medical tools such as clinical exams, blood tests, imaging, and neu-
roimaging. Neuroimaging is focused on early detection among the most promising areas of
research (Alzheimer’s Association, 2016). Recently, standard workup for AD includes struc-
tural imaging with MRI or CT to rule out other conditions that may cause symptoms similar
to Alzheimer’s with different treatment. Structural imaging can reveal tomors, evidence of
small or large strokes, damage from severe head trauma or a buildup of fluid in the brain.
Whereas, PET suggests that those with Alzheimer’s typically have reduced brain cell activity
in certain regions. For example, studies with fluorodeoxyglucose (FDG)-PET indicate that
Alzheimer’s disease is often associated with reduced use of glucose (sugar) in brain areas im-
portant in memory, learning and problem solving. However, as with the shrinkage detected
by structural imaging, there is not yet enough information to translate these general patterns
of reduced activity into diagnostic information about individuals. Accurate and reliable clas-
sification of AD, EMCI, LMCI, and NC requires a targeted combination of biomarker results
for treatment planning and follow up of the patients. To have a more accurate and robust
method for this purpose, many researchers suggested solutions and methods, which have va-
luable results (Pontecorvo and Mintun, 2011), (Jack et al., 2004),(Carbonell et al., 2015).
Nevertheless, among all these researchers and publications, few considered PET images as
the only biomarker. In addition, PET images are categorized by their radiotracers, which
are β-Amyloid (AV45) and fluorodeoxyglucose (FDG). Specifically, AV45-PET images are
still not a frequently used biomarker for AD diagnosis, despite giving good information for
discrimination between different stages.
Therefore, focusing on longitudinal PET images with two radiotracers (FDG and AV45) only
for classification without any other biomarkers is still a relevant topic to investigate the high
accuracy of classification. Using PET images is one step of the diagnosis of AD for patients
who are referred to the medical team. Without PET images, there is a lack of non-invasive
information to discriminate between the different stages of MCI and AD. Therefore, the hy-
pothesis in this project is to use only PET images to investigate : 1) the regions of interest
(ROIs), which are the most affected by AD and the different stages of MCI, compared to
the whole brain, 2) the best classifier(s) using different methods to achieve the best possible
accuracy, 3) the best method for classification of longitudinal data using a combination time
points. In brief, our research question is to achieve the most accurate and robust classification
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1.2.1 Motivation
In diagnostic imaging, Positron Emitted Tomography (PET) is one of the most effective
imaging modalities for assessing neurological disorders. For Alzheimer’s disease (AD), PET
imaging was shown to be able to detect the onset of neurological disorders with increased
levels of amyloid accumulation (Serrano-Pozo et al., 2011). Early detection provides patients
with access to therapies that are more effective in the early stages of the disease. Distin-
guishing between the different stages of cognitive impairment currently depends on clinical
history and some neuropsychological, biological, and molecular genetic examination. PET
shows different patterns of hypometabolism in this disorder that might aid differential diag-
nosis (Morin et al., 2012). Imaging by different modalities such as CT and MRI provides rich
anatomical information. Nevertheless, in the case of AD, PET images may also provide evi-
dence of disease progression. In additional, PET images include complementary information
to the best-established structural brain imaging measurements of disease progression (i.e.,
MRI measurements of hippocampal volume) (Weiner and Khachaturian, 2005). PET ima-
ging with fludeoxyglucose (FDG) radio tracer can highlight different levels of pathology in
dementia disorders, which may aid diagnosis. Therefore, FDG-PET provides slightly better
discrimination than MRI (Mosconi et al., 2006) (Kawachi et al., 2006) (De Santi et al., 2001)
(Matsunari et al., 2007) (Ishii et al., 2007) (Barrack, 2013).
Different anatomical regions used in previous works with multi-region approach to classify the
subjects. However, integrated spesific anatomical regions detected by previous works could
obtain better accuracy which attracted our attention to focus on certain offered ROIs in
literature which are not tested together.
This project focused on the diagnostic value of PET imaging alone, particularly on two radio-
tracers of PET, namely FDG and AV45. FDG-PET has been used to study neurodegenerative
diseases for over two decades. Indeed, a particular application for FDG-PET is recognizing
AD because of the sharp contrast in their pattern of glucose hypometabolism. Therefore,
FDG-PET is a valuable technique for diagnosing AD (Silverman et al., 2001) and for eva-
luating the efficacy of drugs that aim at modifying the progression of AD (Alexander et al.,
2002). Decreased FDG-PET uptake reflects metabolic deficits due to synaptic dysfunction
and possibly tau-mediated neuronal injury (Vemuri and Jack, 2010). Since the researchers
could have complementary information of glucose metabolism from PET images could dis-
criminate between AD and different stages of MCI versus NC, adding more biomarkers and
using PET imaging in combination with MRI may improve discrimination performance over
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nical information available, the present work focused on having a better understanding of the
diagnostic accuracy of AV45 or FDG-PET imaging in AD, independently of other available
modalities, cognitive examinations, and neuropsychological testing correlation. Future work
could combine additional information.
1.2.2 Contribution
The contribution of this work is in validating the direct use of voxel intensity to discriminate
between four classes (AD, LMCI, EMCI,NC) which is not used as a feature in the literature :
(Aidos et al., 2014a)(Gray et al., 2012) (Rodrigues and Silveira, 2014) (Cabral and Silveira,
2013) (Carbonell et al., 2015). We extracted the anatomical structure of the brain by labelling
116 regions, which were extracted by applying the Automated Anatomical Labelling atlas
(based on the MNI152 atlas) in PET images after registering them to their corresponding
MRI scans. This differs from other works which performed segmentation using the watershed
algorithm on FDG-PET images (Aidos et al., 2014a), multi-atlas propagation with enhanced
registration (Gray et al., 2012), automated atlas-based segmentation developed by Desikan
et al. (Rodrigues and Silveira, 2014) and by a ratio of voxel intensities (Cabral and Silveira,
2013), (Carbonell et al., 2015). Specifically, the majority of prior methods used, as ROIs the
frontal, superior parietal, lateral temporal, lateral occipital, medial temporal, anterior cingu-
late and posterior cingulate cortex regions. Our method uses features extracted from ROIs
using a single atlas-based segmentation, which enabled us to create the 2D matrices of the
voxels in the multi-region approach to compare the images together. Our work employs two
different classification approaches (multi-region, whole-brain) for two time points (baseline
and second visit) and combination of the two time points for FDG-PET and AV45-PET
images. We obtained the highest classification accuracy by combining the two time points,
which is in line with published studies (Gray et al., 2012) (Cabral and Silveira, 2013) (Aidos
et al., 2014a). An important consideration of the described multi-regional approach is that
it requires MR imaging data. Structural imaging, which helped us to localize the anatomical
regions, is routinely used to identify brain lesions. To clarify that we only used MRI to find
the anatomical regions in the brain and the data for classification obtained from PET images
only. MR imaging data also provides regional volumes and volume changes, which may be
beneficial in combination with PET images. We additionally attempt the less commonly re-
ported classification task of separating EMCI from LMCI patients. Our accuracy of 72% is
encouraging compared with the most directly comparable studies based on PET imaging
data and similar methodologies.
61.3 Research Objectives
In this work, we proposed a pipeline using the available image processing tools for each step
(such as registration and segmentation) to classify our subjects into four different classes
(AD, EMCI, LMCI, and NC). The main biomarker to do this classification is brain PET
images (FDG-PET and AV45-PET). Our objectives are the following :
— To collect and analyze our cohort data downloaded from a pre-processed Alzheimer’s
Disease Neuroimaging Initiative (ADNI) database, which encompasses patients with
both PET images (FDG & AV45) and structural MRI for two time points (baseline
exam and after 12 months approximately) ;
— To register PET images by their corresponding MRI to find the brain anatomical
structures and to segment the images into different regions including our ROIs ;
— To classify our subjects into four classes using different classifiers ; and
— To evaluate the results of classifiers and to compare the results of the two approaches
(multi-regions and whole-brain).
1.4 Thesis Structure
This thesis is composed of eight chapters. Following the introduction, Chapter 2 provides
background information and describes some useful terms for understanding this thesis. Chap-
ter 3 presents a critical literature review of works with their methods, which are compared
or applied to the current work. The included methods and their results of classification ac-
curacies are state of the art. Chapter 4 explains our methodology and our proposed pipeline,
particularly the two important steps of registration and segmentation. Chapter 5 presents our
manuscript entitled “Identification of AD/LMCI/EMCI Patients from Semantically Parcel-
led AV45 and FDG-PET Images ”submitted to the IEEE Journal of Biomedical and Health
Informatics (March, 2017). This paper details the method of classification of our subjects
and compares the results of different approaches using AV45 and FDG-PET. Chapter 6 then
presents additional results of all our experiments, including our validation results, tuning pa-
rameters for classifiers, and classification results of different test methods. Chapter 7 discusses
our method and results and Chapter 8 is the conclusion of this work.
7CHAPTER 2 LITERATURE REVIEW
2.1 Human Brain
The human brain is one of the most complex organs in the body and is responsible for
reasoning, memory, and coordination of bodily functions (MILLER et al., 2005). Each of the
brain’s parts perform a different function. We have different classifications of brain parts ;
from the anatomical view, we can divide our brain into different parts.
The brain stem is deep in the centre of the brain between the spinal cord and the rest
of the brain. The brain stem is an extremely important part of the brain as it serves to
control motor and sensory systems, which controls many basic functions, such as breathing
and sleeping, as well as the heart rate and blood pressure. It is also the seat of our most
fundamental emotions like happiness, sadness, fear, love, or hate ; they all seem to reside in
the brainstem (Watson et al., 2010). The basal ganglia on top of the brainstem coordinate
messages between multiple other brain areas. In other words, it acts as a gateway to the
higher cortical regions. All sensory information from our body passes through the thalamus
and is directed to the correct regions of the cortex for further processing. The hippocampus,
surrounding the thalamus, is a crucial part of the brain and the seat of our special working
memory. It allows us to remember where we put those keys or how to get back home from
work or school. At the base and the back of the brain, the two lobes of the cerebellum are
responsible for coordination and balance of movement, allowing us to move multiple sets of
muscles in a coordinated fashion so that we can walk and talk, take things up, and set things
down (Hoffman, 2014). Therefore, the major parts of the brain are the cerebellum, cerebrum
(cerebral hemisphere), diencephalon (hypothalamus), and brain stem, as shown in Figure
2.1.
The outermost layer of brain cells are called the cerebral cortex. The cerebral hemispheres
are divided into four lobes, as shown in Figure 2.2. The different lobes perform very different
functions. The occipital lobe contains the brain’s visual processing system. The parietal
lobe is concerned with processing sensory information and integrating it with the visual
information from the occipital lobe ; it also manages handwriting and body position. The
temporal lobe is the centre for memory and learning that contains the hippocampus and
a number of other regions that are required to recognize different objects, faces, sounds,
and environments. The frontal lobe is an important part of the brain and is responsible for
problem solving, judgement, and motor function. It is associated with personality, language
and social behaviour. It is the decision-making centre and contains the motor cortex, which
8Figure 2.1 The major parts of human brain (http ://www.edoctoronline.com, 2016)
controls the movement.
2.1.1 Brain Structure
A human bain contains about 86 billion neurons (Pelvig et al., 2008). These cells are very
specialized with long extensions through which they communicate with each other and form
a large and complex network. These networks are the basis of how the brain works. The pro-
cesses comprise two basic types ; dendrites receive incoming information from other neurons,
and signals pass through the cell body of the soma to the other neurons. Figure 2.3 displays
the structure of the neuron (Dayan and Abbott, 2001).
2.1.2 Neuronal Communication
Neurons usually use electrical signals to communicate ; however, the act of passing the signal
from one neuron to another is a chemical process (Dayan and Abbott, 2001). Neurons are
connected to each other via synapses. This is formed by the terminal of the axon of neuron A
and the small membranous protrusion from a dendrite for neuron B, which is called a spine.
Electrical signals from the axon pass through the dendrite, firing a chemical message called
a neurotransmitter. Neurotransmitters are stored in small vesicles inside the axon terminal
9Figure 2.2 Four lobes of each hemisphere of the cerebral cortex ( frontal, parietal, temporal,
and occipital)(CaliSun, 2013).
(also called the synaptic bouton). When a signal arrives down the axon, one or more of these
vesicles join with the outer membrane of the bouton and release its contents into a small gap
between the axon and dendrite ; this is the synaptic cleft. On the other side of the synaptic
cleft, the receptor molecules bind with the transmitter in much the same way as a key fits into
a lock. There are actor molecules, actor poles through the outer membrane of the dendritic
spine allowing charged atoms or ions to cross, this entry of charged ions into the spine re-
creates the signal that was sent from the previous neuron. Consequently, information is passed
from one neuron to the next and around the neuronal network. Although we described the
synapse between two neurons, in reality, each neuron communicates with many others, over
thousands of spines. In this way, an extraordinary complex system can be built that allows us
to see, hear, and experience the world around us (Jahn, 2016). Figure 2.4 illustrates chemical
synapse.
2.1.3 Neurodegenerative Disease
Degenerative nerve disease or neurodegenerative disease is a general term for several disorders
and abnormalities that primarily affect the neurons in the human brain (Przedborski et al.,
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Figure 2.3 Structure of neuron (adapted from (Kirwan, 2016)).
2003). Consequently, it affects many of our body’s activities, such as balancing, moving,
talking, breathing, and heart functioning. Neurons are normally not replaceable, and they
cannot reproduce themselves (Gage, 2004), so when they degenerate, they can not be replaced
by new neurons. Additionally, as we know, neurons are the building blocks of the nervous
system, which includes the brain and spinal cord. Neurodegenerative diseases are mostly
incurable, and debilitating conditions result in progressive degeneration and or the death
of nerve cells. This causes problems with movement or mental functioning. Dementias are
responsible for the greatest proportion of such disease, with AD representing approximately
70 % of cases (Neurodegenerative Diseases Research, 2014).
The most popular neurodegenerative diseases are :
— Alzheimer’s disease (AD) and other dementias,
— Parkinson’s disease and related disorders,
— Prion disease,
— Motor neuron diseases,
— Huntington’s disease,
— Spine cerebellar ataxia, and
— Spinal muscular atrophy.
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Figure 2.4 A chemical synapse (Lodish et al., 2000).
Alzheimer’s disease
Alzheimer’s disease (AD) was described for the first time in 1907 by the German psychiatrist
Alois Alzheimer. In performing a histopathologic study on the brain of his patient, Auguste
D., suffering from dementia, he brought to light the presence of two types of lesions in the
brain : senile plaques and neurofibrillary tangles. Thus, he reached the conclusion that a
distinct disease of the cerebral cortex exists. A hundred years later, due to current scientific
techniques, research has made a great leap in understanding the disease. We know that
the brain is made of neurons and that these are interconnected in a vast network. These
connections (nano synapses) can transmit the information from one neuron to another. In
Alzheimer’s disease, 10 to 15 years before the development of apparent symptoms, two main
lesions form in the brain, one is senile plaque composed of β-amyloid (Aβ) protein, and the
other one comprises neurofibrillary tangles composed of τ protein (Budson and Kowall, 2011).
Senile plaque formation
There is a large protein on the surface of the neuron called the amyloid precursor protein
(APP). Normally, APP is sectioned by an enzyme on the surface of the neurons and it releases
the protein called Aβ. Then, the Aβ protein is cleared in the body. In the case of AD, there
is an accumulation of Aβ since the clearing rate of the amyloid is decreased substantially,
leading to the formation of plaques. The protein assembles to form indiscernible fibrosis and
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creates senile plaque (Crews and Masliah, 2010).
Neurofibrillary tangle formation
When a neuron communicates with another neuron, the signal passes through the skeleton of
the neuron composed of microtubules. These microtubules are stabilized by normal τprotein.
In AD, τprotein becomes defective and gets detached from the microtubules. Thus, the
skeleton of the neuron dissociates, as it is no longer maintained. Defective τprotein then
assemble to form filaments in the neuron without the skeleton. The neuron degenerates,
and connection between the neurons is lost. The abnormal accumulation of τ filaments and
neurons creates neurofibrillary tangles and eventually causes the death of the neurons (Crews
and Masliah, 2010).
Lesions spread out in the brain
Neurofibrillary tangles and senile plaque do not follow the same pathway in the brain over
time. Neurofibrillary tangles first develop in the hippocampus, which is essential to memory
and learning and then reach the whole brain following a centrifugal movement. The process
causes brain atrophy, which engenders global dysfunction. The progression of the lesions
corresponds with symptoms of the disease, which begins with memory problems, followed
by problems of language, recognition, and inability to form gestures. Senile plaques develop
differently. They are initially observed in the cortex, next in the hippocampus, and then the
senile plaques reach the whole brain following a centripetal movement. Their progression does
not correspond to the symptoms of the disease (Budson and Kowall, 2011).
Figure 2.5 illustrates different key players in the pathogenesis of AD. In brief, the aggregation
and accumulation of Aβ in the brain may result from increased neuronal production of Aβ,
decreased activity of Aβ degrading enzymes, or alterations in transport processes that shut-
tle Aβ across the blood-brain barrier. The Aβ oligomers impair synaptic functions, whereas
fibrillar amyloid plaques displace and distort neuronal processes. The Aβ oligomers interact
with cell surface membranes and receptors, altering signal-transduction cascades, changing
neuronal activities, and triggering the release of neurotoxic mediators by microglia (resident
immune cells). The lipid carrier protein apoE4 increases Aβ production and impairs Aβ clea-
rance. When produced within stressed neurons, apoE4 is cleaved into neurotoxic fragments
that destabilize the cytoskeleton and, like intra-cellular Aβ, impair mitochondrial functions.
The τprotein and a synuclein can also self-assemble into pathogenic oligomers and can form
larger intra-neuronal aggregates, displacing vital intra-cellular organelles (Ott et al., 2011).
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Figure 2.5 Example of key players in the pathogenesis of Alzheimer’s disease (Roberson and
Mucke, 2013).
2.1.4 Diagnosis of Alzheimer’s Disease
Diagnosing AD with 100 percent accuracy is possible by post-mortem microscopic examina-
tion of the brain (Love, 2005). In terms of in vivo diagnosing, some neuropsychological tests,
checking the familial history of the patient, and neuroimaging can help discover whether
the patient’s brain is inflicted by AD and recognize its progress and level. Moreover, AD
should be differentiated from other neurodegenerative dementia like frontotemporal demen-
tia, Lewy-Body dementia, and Creutzfeldt-Jakob disease. In neuroimaging like MRI, PET,
and SPECT, we have more detailed information of the brain and some regions that are more
relevant to investigate. Then, it is necessary to look for some regions of interest (ROIs), which
are involved in learning and memory as well as decreased glucose metabolism and uptake of
radioligands, which detect some proteins that are not normal. The CSF is another biomarker
that may show abnormalities like low levels of Aβ protein. In AD versus Normal control the
levels of τ and phospho-τ are higher (Ott et al., 2011). In addition, AD has different stages
from the beginning of the illness to its merciful end. Some experts believe in following a
simple three-phase model, such as early, moderate, and end stage, whereas others have found
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a breakdown to be a more useful tool to understand the progression of the illness.
Dr. Barry Reisberg of New York University breaks the progression of AD into seven stages.
In each stage, the patient has different symptoms and less ability, progressing as far as losing
the ability to swallow (Reisberg, 2016). Here is a summary of the seven stages of AD based
on the ideas of Dr. Reisberg. In the first stage, there is no impairment ; the patient does not
have memory problems, and no symptoms are seen. The second stage is a very mild decline
in which minor memory problems start, such as losing things around the house. In this situa-
tion, the patients still do well on memory tests, and the disease can easily be distinguished
as normal age-related memory loss. In the third stage, there is a mild decline and the friends
and family members of the individual may begin to notice memory and cognitive problems.
In addition, cognitive tests are affected in this stage, and there is some difficulty in finding the
right word during conversations and remembering names of new acquaintances. In stage four
(moderate decline), clear-cut symptoms of AD are apparent. Patients have difficulty with
simple arithmetic, may forget details about their life histories, have poor short-term memory
or inability to manage finances and pay bills. During the fifth stage (moderately severe de-
cline), patients need help with many daily activities. They have significant confusion ; they
are unable to recall simple details about themselves, such as their own phone number. Ad-
ditionally, dressing appropriately is difficult for them, but they typically can still bathe and
use the toilet independently. They still know their family members and some details about
their personal histories. In the next stage, severe decline occurs in which patients at this level
need constant supervision and frequently require professional care. Some symptoms, such as
confusion or unawareness of the environment and surroundings or major personality changes
and potential behaviour problems, are significant. They need assistance with activities of
daily life, such as toileting and bathing. In the final stage (very severe decline), patients are
nearing death because AD is a terminal illness. They lose the ability to respond to their
environment or communicate. While they may still be able to utter words and phrases, they
have no insight into their condition and need assistance with all activities of daily life. At
the end of the illness, patients may lose their ability to swallow (Reisberg, 2016).
2.1.5 Risk Factor of Alzheimer’s Disease
Scientists have identified factors that increase the risk of AD. The most important risk
factors are age, genetics, family history, heredity, and environmental or infectious mechanisms
(Brayne, 1993). Some studies have also shown the number of years of education (Katzman,
1993), history of head injury (Heyman et al., 1984) are associated with a greater risk of AD.
Advancing age is the greatest known risk factor for AD (Tyas et al., 2001). Another strong risk
factor is family history. Those who have a parent, brother, sister, or child with AD are more
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likely to develop the disease. The risk increases if more than one family member has the illness.
When diseases tend to run in families, either heredity (genetics) or environmental factors or
both may play a role. Scientists identified several risk genes implicated in AD. However,
there are three genes in which mutations with the strongest influence are involved, resulting
in early onset autosomal dominant familial AD. These are the APP or apolipoprotein E-e4
(APOE-e4), presenilin-1 (PS-1) and presenilin-2 (Tilley et al., 1998). Scientists estimate that
APOE-e4 is the main genetic determinant of AD (Chalovich and Eisenberg, 2005).
2.2 Neuroimaging Modalities
Generally, for any evaluation of dementia, routine structural imaging studies are recommen-
ded to facilitate the diagnosis of dementia. The most popular structural imaging is MRI
scans (or CT if MRI is not available), which should be performed at least once in the
diagnostic examination of patients (Silverman, 2009). To distinguish vascular lesions and
neurodegenerative dementia, structural imaging is strongly recommended. To differentiate
between various forms of dementing disorders, such as neoplastic infiltration in lymphomas
or Creutzfeldt-Jakob disease, neuroimaging can indicate reliable pathological processes in the
brain. From the other point of view, functional imaging with PET using isotopes, such as
18F-2-fluoro-deoxy-D-glucose (FDG) or other radio tracers, has become the test of choice for
the differential diagnosis of neurodegenerative disorders (Román and Pascual, 2012). In this
section, we present a short introduction of routine imaging.
2.2.1 Magnetic Resonance Imaging (MRI)
Magnetic resonance imaging (MRI) is a test that uses a magnetic field and pulses of radio wave
energy to make pictures of organs and structures inside the body. To produce detailed pictures
of organs, MRI uses a powerful magnetic field, radio frequency pulses, and a computer. Figure
2.6 illustrates one MRI scanner with different main parts. The images produced by MRI have
details of soft tissues, bone, and virtually all other internal body structures. Furthermore,
MRI is able to detect brain abnormalities. The brain imaging has complimentary information
of some diseases associated with MCI and can be used to predict which patients with MCI may
eventually develop AD. The MRI allows for accurate measurement of the three-dimensional
(3D) volume of brain structures, especially the size of the hippocampus and related regions
and therefore can be used as the primary choice of neuroimaging examination for AD (Van
de Pol et al., 2007). An MRI scan of the brain may be normal in the early stages of AD, but
in later stages, MRI may show a decrease in the size of different areas of the brain (Weiner
and Khachaturian, 2005).
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Figure 2.6 MRI scanner structure (Orthopaedics, 2017)
The American Academy of Neurology (AAN) suggests that neuroimaging may be most useful
in patients with dementia characterized by an early onset or an unusual course (Petersen
et al., 2001). Longitudinal MRI scans can provide brain volume change, which Fox et al.
(1996) used with an automated technique to subtract MRI scans obtained at an average
of one year apart. They observed that there was a significant difference between the rate of
change in patients with AD and the rate in the control subjects. The disease usually begins in
the medial temporal lobe, particularly the entorhinal cortex and hippocampus. Later, when
subjects are in the MCI stage, the disease spreads to the basal temporal lobe and paralimbic
cortical areas, such as the posterior cingulate gyrus and precuneus (Vemuri and Jack, 2010).
Figure 2.7 illustrates the typical MRI scans in normal subjects and in patients with MCI
or AD. As seen in the figure, there is increasing medial temporal atrophy (specifically, the
hippocampus and ventricular enlargement) in MCI and AD when compared with NC.
The MRI scans have two separated targets to acquire the images. The first is recognizing
several brain anatomical structures, which are called structural MRI (sMRI) and second is
to detect changes in blood oxygenation and flow, which is called functional MRI (fMRI).
2.2.2 Positron Emission Tomography (PET)
The PET scan is a nuclear medicine imaging technique that not only provides 3D images but
also enables in vivo examination of brain functions. It allows for non-invasive quantification
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Figure 2.7 Progressive atrophy (medial temporal lobes) in an aged normal subject (NC), MCI
subject (MCI) and an AD subject (Vemuri and Jack, 2010).
of cerebral blood flow, metabolism, and receptor binding. The most common basic imaging
methods currently use metabolic imaging (PET and SPECT) in the diagnosis of dementia
(Silveira and Marques, 2010). The PET scan produces the 3D images using radioactive tra-
cers, which are usually administered to a patient through intravenous injection. The tracers
are made up of carrier molecules that are tightly bonded to a radioactive atom, called an
isotope. The carrier molecule can interact with or bind to specific proteins or sugars in the
body. The carrier molecule that will be used depends on what is being investigated. If looking
for AD or the progression of early stage of AD, FDG, a modified form of glucose, which gets
absorbed by tissues, may be used. When tissues do not absorb glucose, it may indicate a
low rate of metabolism in the brain. Table 2.1 displays three common isotopes, which are
usually used for scanning to diagnose AD (Román and Pascual, 2012).
Table 2.1 Physical properties of some common isotopes used in PET scanning
Isotopes Name Half-life (min) Energy range (Kev)
11C Carbon-11 (20.4) 960
15O Oxygen-15 (2.1) 1720
18F Flourine-18 (109.8) 640
The radiation from the tracers poses little danger to the patient since they quickly pass it
out of the body. The isotope produces small particles called positrons, which interact with
surrounding electrons. This interaction results in the complete annihilation of both particles,
releasing two photons that speed off in opposite directions. The detectors in the PET scanner
measure these photons and use this information to create an image of the distribution of the
tracer in the body. Figure 2.8 displays how the PET modality works.
Among different radiotracers, FDG-PET has been used extensively to study AD, and it is
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Figure 2.8 Schema of a PET acquisition process (Maus, 2003)
evolving into an effective tool for early diagnosis and differentiation of AD from other types
of dementia. The FDG-PET has been used to detect persons at risk for AD, even before
the onset of symptoms (Silverman et al., 2001). The carrier molecules 18F 2-fluorodeoxyD-
glucose (FDG, a modified form of glucose) are absorbed by normal neurons, which means
they are not degenerated (Silverman, 2009). The PET scanners provide clear benefits, such
as the following :
— Earlier tissue tumour detection ;
— Improved accuracy of therapies based on tumour evolution and tracking ;
— Lower radiation exposure for patients compared to PET-CT (Kim et al., 2016)
— Better brain imaging when combined with MRI.
A sugared radionuclide tracer is introduced in the human body, typically in the blood circu-
lation. Figure 2.9 displays a brain scan using PET with the isotope marker 18fluoro-deoxy-
glucose (FDG-PET) on the left and amyloid plaques (AV45-PET) on the right side. In the
FDG-PET image, red areas indicate good utilization of glucose by the brain in contrast with
the yellow to blue areas in the posterior parietal regions characteristic of AD. In the AV45-
PET image, the red areas indicate accumulation of amyloid plaque, which is more significant
19
in the AD image, while in the NC image, amyloid is negative.
Figure 2.9 FDG-PET images showing reduced glucose metabolism in temporal and parietal
regions in patients with MCI and Alzheimer’s disease (left) . PET scans revealing amyloid
plaques, (warm colours, ie. red and orange)(right). Person with no symptoms of cognitive
problems, but with evident levels of amyloid plaque in the brain (middle scan) (Baker, 2010).
2.2.3 Quantification of PET Imaging
The PET scan is one of the main functional neuroimaging techniques used in AD. The FDG-
PET provides measurements of regional glucose metabolism, which, in AD, is indicated by
the presence of a temporal parietal decline in glucose metabolism. In brief, the diagnostic
accuracy of PET is similar to the accuracy of a pathologically confirmed clinical diagnosis of
AD (Román and Pascual, 2012). A few years before the onset of symptoms, the concentration
of Aβ starts to decrease in the CSF (Bateman et al., 2012). Atrophy of the grey matter
(GM) in AD can be quantified with automated methods to measure cortical thickness. In
AD, loss of cortical neurons is accompanied by atrophy of white matter (WM) due to axonal
disconnection and loss of anisotropy of affected axonal bundles.
2.3 Classification
Classification means naming and categorizing things based on physical or non-physical at-
tributes to two or more individual groups. One of the most common data mining techniques
is classification. A classification process yields a discrete value representing the probability
that a case belongs to a particular group. Classification will be executed in accordance with
some knowledge about the data, such as density, texture etc. (Japan Association of Remote
Sensing., 1996), (Joshi et al., 2010). Hence, a training set is used to identify specific pa-
rameters. Training data requires sample input data, domain expertise, and a classification
assignment to the data. A classification problem occurs when an object needs to be assigned
into a predefined group or class based on a number of observed attributes related to that
object. In this chapter, we review some classification methods, which are used in different
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related research. After that, we note some methods that are common to use and have very
good results, especially in the field of image processing.
2.3.1 Support Vector Machines (SVMs)
Support vector machines (SVMs) are already applied in a wide variety of classifications, and
it is one of the most popular techniques in classifications based on neuroimaging like AD.
Linear and nonlinear algorithms are already developed, and they are available as functions
in different programming, like MATLAB, Python, C++, etc.
Linear SVM
The goal of SVM is to find the optimal separating hyperplane between binary classes. To
achieve this goal, maximized margin criteria should be followed (Cortes and Vapnik, 1995).
To explain more, we assume training data as vectors Xi ∈ Rd, i = 1, 2, ..., l in two classes, and
the label vector y ∈ {1,−1}l , SVM requires to solve the following optimization problem :
W∈H,b∈R,ξi∈RMin(
1
2W
T .W + C
l∑
i=1
ξi) (2.1)
Subject to
yi(W Tϕ(Xi) + b) ≥ 1− ξi, ξi ≥ 0, i = 1, 2, ..., l (2.2)
where W ∈ Rd is the weight vector, C ∈ R+ is the constant regularization, the mapping
function ϕ projects the training data into a suitable feature space, and H is to allow the non-
linear decision to surface (Cortes and Vapnik, 1995). Following the SVM problem definition
in brief, we have the following :
f(x) = W Tx+ b (2.3)
Formulated as solving an optimization problem over w, we have :
w∈RdMin(‖W‖2 + C
N∑
i
max(0, 1− yif(xi)) (2.4)
The SVM can be formulated to learn a linear classifier :
f(x) =
N∑
i
αiyi(xTi x) + b (2.5)
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by solving an optimization problem over αi (Bishop, 2006). More details about derivations of
the algorithm can be found in the work by Cortes and Vapnik (1995) and Guo (2014) (Cortes
and Vapnik, 1995) (Guo, 2014).
Radial Basis Function (RBF)
Support vector machines (SVMs) with the Gaussian (RBF) kernel have been also widely
applied in many classification problems in different fields (Howlett and Jain, 2001). Model
selection in this class of SVMs involves two hyper parameters : the penalty parameter C and
σ the kernel width σ.
Usually, the decision is on the use of a linear or an RBF (aka Gaussian) kernel. Typically,
the best possible predictive performance is better for a nonlinear kernel (or at least as good
as the linear one), as it has been shown that the linear kernel is a degenerate version of RBF.
Hence, the linear kernel is never more accurate than a properly tuned RBF kernel (Keerthi
and Lin, 2003). Based on the SVM equation, we can reformulate it for the RBF kernel as
shown below :
f(x) =
N∑
i
αiyi exp(
−‖x− xi‖2
2σ2 ) + b (2.6)
Then RBF kernel is defined as :
KRBF (x, xi) = exp(−γ‖x− xi‖2) (2.7)
Where γ is a parameter that sets the spread of the kernel.
2.3.2 Principal Component Analysis (PCA)
Principal component analysis (PCA) is a method to reduce the number of features used to
represent data. This dimensionality reduction can provide a simpler representation of the
data, specifically on a 3D matrix of voxel intensity of each image. Moreover, reduction in
memory and faster classification are some advantages of using PCA (Pedersen et al., 1993).
Given data points. x1, x2, ..., xn with each vector xi being p-dimensional. We want to trans-
form that into λ1, λ2, ..., λn with each vector λi q-dimensional. q < p. The dimensionality
of the data is reduced. In example, we are trying to reduce two-dimensional data to one
dimension. Each 2D data point can be projected onto a subspace which is a line. We can find
the sum of squared distance (i.e. reconstruction error) from the data to its projection on the
subspace. So,
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f(λ) = µ+ vqλ (2.8)
In this rank q model, the mean is µ is a p-dimensional vector vector which represents the offset
in p-space. vq is a p×q covariance matrix with q orthogonal unit vectors. Its q vectors are the
principal components of the data. Finally, λ is the q vector. Creating a good low-dimensional
representation of the data requires a careful selection of µ , vq and λ. One possible way to
do this is to minimize the reconstruction errors given by,
min
µ,λ1...N,vq
N∑
n=1
(‖xn − µ− vqλn‖)2 (2.9)
In Equation 2.9, µ is the interception of the lower space in the higher space. Next, λ1...N
is the q_dimensional coordination of x , or where x lies on the line in Figure 2.10. The
p_dimensional plane, using vq and µ is defined. Lastly, the quantity inside the sum is the
distance between the original data and the low-dimensional representation reconstructed in
the original space.
Figure 2.10 Projecting R3 data to R2 (Pop, 1993).
Singular Value Decomposition (SVD) is a widely used implementation of PCA. It is based
on variance and principal components (PCs), which are determined by the dataset matrix
(Pedersen et al., 1993). Using the reshaped matrix of the voxel of each subject to the vector,
the dataset matrix is produced. The data matrix contains one volume dataset per column
for all subjects. Consider the following :
X = UDV T (2.10)
Where
— X is a N × p matrix.
— U is an N × p orthogonal matrix, and the columns are linearly independent.
— D is a positive p× p diagonal matrix with d11 ≥ d22 ≥ ... ≥ dpp .
— V T is a p× p orthogonal matrix.
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We represent each data point as linear combinations (Pedersen et al., 1993).
x1 = u11d1v´1 + u12d2v´2 + ...+ u1pdpv´p
x2 = u21d2v´1 + u22d2v´2 + ...+ u2pdpv´p
...
After applying PCA on the dataset, the PC coefficients are returned as a p × p matrix.
Each column of coefficients contains coefficients for one PC. The columns are in the order of
descending component variance.
2.3.3 Random Forest (RF)
Random forests (RF) (Breiman, 2001) are an improvement of classification and regression
trees method (Breiman et al., 1984). The RF algorithm works as a large collection of corre-
lated decision trees. Decision trees are compact tree-like representations of conditions that
specify when decisions should be taken together with the actions/decisions. Decision trees
consist of intermediate nodes and leaf nodes. The outgoing edges from intermediate nodes
are labeled by conditions. The leaf nodes are labeled by decisions or actions. Decision trees
are used by starting at the root and then navigating down on true conditions until a leaf is
reached. The action or decision in the leaf is then taken. Decision tree classifiers are decision
trees used for classification, which were first introduced by Breiman (Breiman et al., 1984).
In other words, RF is the result of the combination of bagging (Breiman, 1996) and the
random selection of features (Dietterich, 2000). The algorithm for inducing an RF was de-
veloped by Leo Breiman and Adele Cutler, and “Random Forests” is their trademark (Liaw
and Wiener, 2002). Every tree is built using a deterministic algorithm in two stages. First,
at each node, a good split is chosen from a random subset of the predictors rather than
all of them. Second, every tree is built using a bootstrap sample of the observations. The
combination of learning models increases the classification accuracy. When we use different
learning models, we can increase the accuracy of classification, which is the main idea of the
bagging technique. Bagging averages noisy and low bias models to create another model with
a lower variance, in terms of classification. The RF definition by Breiman is a classifier with
a collection of tree-structured classifiers {h(x, θk), k = 1, ...} where the {θk} independently
identically distributed random vectors, and each tree casts a vote for the predicted class for
input x (Breiman, 2001). The RF algorithm uses the decision trees to make a classification,
which is why it is based on the bagging technique. The random forests classification and
regression algorithm draws ntree bootstrap samples from the original data. For each of them,
it grows an unpruned classification or regression tree with modification. If the tree is too big,
the lower branches are modeling noise in the data, called over-fitting ; it then becomes ne-
cessary to prune back unnecessary splits ; pruning methods use some form of cross-validation
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and it may need to tune amount of pruning. At each node, rather than choosing the best
split among all predictors, randomly sample mtry of the predictors and choose the best split
from among those variables. (Bagging can be thought of as the special case of random forests
obtained when mtry = p, the number of predictors) Splitting criteria for regression is residual
sum of squares :
RSS =
∑
left
(yi − YL)2 +
∑
right
(yi − YR)2 (2.11)
Where
YL = Mean y - value for left node
YR = Mean y - value for right node
and for classification is gini criterion :
Gini = ηL
∑
k=1,...,K
pkL(1− pkL) + ηR
∑
k=1,...,K
pkR(1− pkR) (2.12)
Where
pkL = proportion of class k in left node
pkR = proportion of class k in right node
At the end, it predicts new data by aggregating the predictions of the ntree trees (i.e., majority
votes for classification, average for regression).
A part of the RF algorithm is estimating the prediction error on the training data. To obtain
this prediction first, we need to predict the data at each bootstrap iteration and not in the
bootstrap sample (what Breiman calls “out-of-bag”, or OOB, data) using the tree grown with
the bootstrap sample. Next, it needs to aggregate the OOB predictions (the out-of-bag OOB
data, approximately one-third of the observations, are then used to estimate the prediction
accuracy). We then calculate the error rate, and call it the OOB estimate of error rate.
Our experience has been that the OOB estimate of error rate is quite accurate, given that
enough trees have been grown (otherwise the OOB error estimate can be biased upward ;
more details in (Bylander, 2002)). Parameter Tuning : Random Forest effectively has only
one tuning parameter, mtry. This parameter is the number of descriptors randomly sampled
as candidates for splitting at each node during tree induction. It can range from 1 to p,
the total number of descriptors available. The latter case is equivalent to bagging. In our
Random Forest classification experiments we used Breiman’s algorithm (Breiman, 2001) as
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implemented in MatLab with 60 trees and 2 features to split each node, based on results
suggesting that performance was highly insensitive to this parameter.
RF function
For better understanding of how the RF classification works, we start with an example. Here,
we have a matrix S, which is a matrix of training samples that we will submit to the algorithm
to create a classification model.
S =

fA1 fB1 fC1 C1
. . . .
. . . .
. . . .
fAN fBN fCN CN

In this case fA1, fB1, fC1 are a set of extracted features ; for example, fA1 is feature A of the
first sample, and we continue in all the samples up to N, so that fCN is feature C of the Nth
sample, and in the last column, the C1...CN are labels for the rows. Therefore, the aim is to
create a RF to classify this sample set. From sample set S, we can create many subsets with
random value as shown below :
S1 =

fA12 fB12 fC12 C12
fA15 fB15 fC15 C15
. . . .
. . . .
. . . .
fA42 fB42 fC42 C42

S2 =

fA2 fB2 fC2 C2
fA6 fB6 fC6 C6
. . . .
. . . .
. . . .
fA20 fB20 fC20 C20

SM =

fA4 fB4 fC4 C4
fA9 fB9 fC9 C9
. . . .
. . . .
. . . .
fA12 fB12 fC12 C12

S1, S2, ..., SM are randomly selected samples which may belong to multiple subsets and are
used to create the decision trees. In the first subset S1, we used the line number 12, 15, and
35 with some other random elements. Thus, we get a subset from the main sample set S,
and from this element, we create a decision tree number 1, then we make another random
subset S2 with different values, and we can see that we have the sample number 2, 6, and 20
and many others. With these values, we can create a decision tree number 2. From the SM
subset, we can create the decision tree number M. After we create these decision trees, we
will repeat it using different samples from each of the sample sets. We created a subset with
random samples. Then, with all these decision trees, we have different variations of the main
classification. We will then use all these decision trees to create a ranking of classifiers.
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In Figure 2.11 we showed five different patterns of class prediction, only to see how the class
prediction will work. In this case, we have five decision trees, and our forest is composed of
five trees.
If we have a new element to classify, then we need to check five trees for their prediction.
The first tree responded that the classification of this sample is class 1. Then, we checked the
second decision tree, and its answer is class number 3. The answer of the third and fourth
trees are class number 1, and the last tree responded as class number 2. Thus, we have five
independent decision trees, which were created using sub-samples of the entire sample set,
and we can now count the number of votes for each class. It is obvious that we have three
votes for class 1 and one vote for class 3 and one vote for class 2, so the result will be class
1. This RF classified all the elements, and class 1 was the selected for this classification.
The difficulty for this technique is to create many decision trees and use them for a fast and
accurate method of classification.
Figure 2.11 Five different pattern of class prediction (Mitchell, 2014)
2.3.4 Artificial Neural Networks (ANN)
Traditional statistical classification patterns, such as discriminant analysis, based on the
Bayesian decision theory (Duda et al., 2001) are often used. The accuracy of these patterns
depends on the various assumptions or conditions, which are selected by users who have a
knowledge of both data properties and model capabilities before the models can be success-
fully applied. However, recently, researchers are motivated to use neural classification as an
alternative to various conventional classification methods. This alternative solution has some
benefits : first, artificial neural networks (ANNs) are data-driven self-adaptive methods in the
sense that they can adjust themselves to the data without any explicit specification of func-
tional or distributional form for the underlying model. Second, they are universal functional
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approximators in the sense that neural networks may be particularly useful to approximate
functions with varying levels of accuracy. Third, deep nonlinear neural networks are flexible
in modelling real-world complex relationships. Finally, ANNs can estimate posterior proba-
bilities, which provide the basis for establishing classification rules and performing statistical
analysis (Richard and Lippmann, 1991)(Cybenko, 1989)(Hornik, 1991)(Hornik et al., 1989).
Recently, different techniques for neural classification of AD are available. We review the
ANN, which is used for the first time to discriminate AD vs NC.
Artificial Neural network function
Some computer scientists had the idea that we could make a computer that is modelled after
the system of neuron connections (Furber and Temple, 2007). The idea behind the artificial
neural networks (ANN) is that we have nodes and connections between those nodes. This
is similar to the neurons in the brain and their synapses. A typical neural network has few
dozen to hundreds, thousands, or even millions of artificial neurons called nodes arranged in
a series of layers, each of which connects to the layers on either side. Since we are used to the
computer model of computation, well-defined input and output nodes are preferred. Input
nodes, are designed to receive various forms of information from the outside. Other nodes
sit on the opposite side of the network and signal how it responds to the information it has
learned ; those are known as output nodes. In between the input and output nodes are one or
more layers of hidden nodes. Information is fed into the network via the input nodes, which
trigger the layers of hidden nodes, and these in turn arrive at the output nodes. This common
design is called a feedforward network. We also prefer to have directed connections, so that
we know which way information is going. Moreover, we want connections to have different
values ; thus, some connections should be more important than others. Here, the connection
values are called weights. The purpose of having different connection weights is to allow our
nodes to behave individually. In neurons, when one node is stimulated by two different nodes,
it can decide which one is more important by the connection weights ; for example, as seen
in Figure 2.12, if we have nodes A and B, which are giving the values green and orange to
node C, since the connection weights between B and C are much larger than those in the
connection between A and C, node C decides B is more important and takes its value. In some
cases, we would like to be able to decide for several nodes, whether they want to accept their
choice. Thus, to decide which input to accept, each node is given what is called a transfer
function. The transfer function is a mathematical equation. After a node decides, it sets its
value and then takes it to the next item with the same value. Choosing whether to accept the
trade in value is most useful for the output nodes since these are the nodes that produce the
results that are actually required. Usually, though, the transfer function will return a value
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that is a combination of the node’s current value and true value. Thus, using the connection
weight and transfer functions, the ANN takes the inputs and produces outputs. This is the
same task that the computer would do, but it is done in a way that is similar to the way that
neurons work. Since the input and output nodes are the ones that matter to us, we consider
the nodes in the middle to be hidden nodes. They do most of the work but get the least credit.
Hidden Units OutputInputs
Bias Bias
A 
B
C
Figure 2.12 Example of neural network.
Now, as we know the basics, one of the more important questions is how the connection
weights are determined. It turns out that the ANN can learn them, but ANN are extre-
mely demanding in terms of training time. Their learning is through a process called back-
propagation. Back-propagation networks require extensive computational resources, needing
possibly thousands of iterations to learn. We start with random connection weights. Then,
for a given set of inputs, we determine the set of desired outputs. In terms of using ran-
dom weights, we first let the network calculate the outputs. Then, we compare the outputs
calculated by ANN with the desired outputs that we defined. Since we gave the network
random weights, we obviously cannot expect them to be equal, so we find their difference.
We call this difference the error in the network. Now, we have their error, and we need to
adjust the connection weights to try to produce the smallest errors. This is the where the
back-propagation comes in. The output nodes tell the hidden nodes about the error, and
together they decide how to adjust the connection weights between them. The new weights
are calculated using an equation based on the old weight, the node’s input value, the error,
and the learning rate.
∆wij(t+ 1) = (1− α)ηδjoi + α∆wij(t) (2.13)
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where :
∆wij(t + 1) is the change in weight wij(t + 1) in the connection of node i to node j at time
(t+ 1),
η a learning rate ( η < 0), δj the error signal of node j and oi the output of node i, which is
also an input of the current node (node j),
α the influence of the inertial term ∆wij(t) (in [0, 1]). This corresponds to the weight change
at the previous point in time.
With the weights adjusted, the hidden nodes calculate their own errors using a similar formula
as before. Then, these nodes with their newer calculated errors push the errors back through
the hidden nodes and adjust the weights behind them. This goes on until all the weights have
been adjusted, and all the nodes have been assigned an error. The idea is to determine which
nodes are most to blame for the error in the output and to try to adjust their weights the
most. Now, that all the paths are updated, the network tries out the original inputs again
and tries to calculate some outputs, the calculated outputs should be closer to the desired
outputs than before. However, there are still some errors ; thus, the whole process should be
repeated again and again. As stated, ANN takes a lot of time to train. This is because the
ANN must repeat the process above for each different input set, and there are usually many
inputs to achieve a better training. To try to produce the desired output more quickly, we
could try adjusting the learning rate and change the number of nodes, but it would still take
millions of attempts for the ANN to get the desired output for even a simple problem (Rojas,
1996).
In standard back-propagation, too low a learning rate makes the network learn very slowly ; in
contrast, too high a learning rate makes the weights and objective function diverge, meaning
there is no learning at all. If the objective function is quadratic, as in linear models, good
learning rates can be computed from the Hessian matrix (Bertsekas and Tsitsiklis, 1996).
In machine learning, ANNs are a family of models inspired by biological ANNs and are
used to estimate functions that can depend on many inputs and are generally unknown.
Therefore ANN training is strictly a “supervised learning” process. The learning is essentially
by example, with no guidance from the user as to the criteria to employ (Kippenhan et al.,
1992). An ANN is an interconnected group of nodes, namely, input, hidden, and output
nodes. The structure of an ANN suitable for the classification task is shown in Figure 2.12
The three-layer feedforward network has four input units.
30
2.4 Registration
Image registration, as a crucial step for image analysis (Kiebel et al., 1997), also known as
image fusion, matching, or warping, can be defined as the process of putting two images of
the same thing into spatial alignment. In other words, a process of transforming or aligning
different sets of data into one coordinate system is image registration. In general, we can
divide its applications into four main groups, in which valuable information is conveyed in
more than one image, like images acquired at different times, from distinct viewpoints, or
by different sensors and scenes. For medical purposes, the data are the medical images from
different digital modalities. Registration, alignment, geometrical correspondence, matching,
and motion estimation are some crucial steps in registration between two images (Oliveira
and Tavares, 2014).
Generally, we can classify the registration methodology into physical categories : rigid and
non-rigid registration or mathematical categories, linear and nonlinear registration or com-
plexity categories, and parametric and non-parametric registration categories (Chumchob
and Chen, 2009). Nevertheless, the majority of the registration methods consist of feature
detection, feature matching, transform model estimation, and image resampling and transfor-
mation (Zitová and Flusser, 2003). Registration based on these four steps starts determining
what kinds of features are appropriate for the given task. The features should be easily detec-
table and frequently spread over the images with enough common elements, even in the case
in which the images do not cover the same scene. In the feature matching step, we establish
the correspondence between the features detected in the sensed image and those detected in
the reference. Then, we need to estimate the type and parameters of the mapping functions,
aligning the sensed image with the reference image. Finally, the sensed image is transformed
by means of the mapping functions. Image values in non-integer coordinates are computed
by the appropriate interpolation technique. In addition, there is four simple transformations :
translating, rotating, scaling, and shearing for aligning datasets.
In the case that images are acquired in the same scene with different sensors (modalities),
we need to integrate the images from different sources to obtain more detailed scene re-
presentation. The goal of registration in medical images for MRI with sensors monitoring
metabolic body activities in PET is to find the anatomical body structure (Zitová and Flus-
ser, 2003). Therefore, inter-modality registration to find anatomical information in some
functional images like PET is necessary (Friston et al., 1995). Medical image registration has
been developed for almost all anatomic parts or organs of the human body like the brain
(Ashburner, 2007). Hence, registration of functional PET and T1-weighted MR images is
recommended for image processing in this area.
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2.5 Segmentation
Segmentation partitions an image into distinct regions containing each pixels with similar
attributes. This attributes can be simply established by sets of semantically meaningful, ho-
mogeneous, and no overlapping regions of similar attributes or descriptors on the objects
represented in the images. The attributes include intensity, depth, colour, texture, points,
edges, lines, contours, surfaces, areas, volumes, medial axes, etc. Additionally, the descrip-
tors can be included by distances, lengths, angles, moments, or shape signatures. In some
cases, descriptors involve even more complex structures containing information about the
objects, such as graphs, skeletons, or diagrams in the images. The segmentation result is
either an image of labels identifying each homogeneous region or a set of contours, which
describe the region boundaries (Oliveira and Tavares, 2014).
In the last few decades, non-invasive brain imaging technologies have rapidly improved, and
this has caused dynamism in analyzing and studying the brain anatomy and function (Des-
potovic et al.). Functional and structural brain imaging is one of the most important steps in
neuroscience and experimental medicine (Heckemann et al., 2006). In the same way, image
segmentation is playing an expanding role in medical image analysis, since its quality affects
the accuracy of the subsequent analysis (Kalini, 2004). Specifically, the anatomical structure
of the brain is one of the popular uses of image segmentation, and in this case, the MR image
is one of the first main materials to be used for brain segmentation (Fischl et al., 2002a).
Recently, there has been a number of automated segmentation methods (Fischl et al., 2002a),
(Fischl et al., 2002b), (Pham et al., 2000) as well as manual segmentation used by clinicians
who must manually extract their ROIs. However, manual segmentation is time-consuming
and prone to errors due to various inter or intra operator variability studies. All these diffi-
culties in MRI image segmentation, especially when the subject is the brain, drive us to use
automated methods for segmenting each structure precisely and quickly.
The most common segmentation method of brain MRI can be classified into two groups :
basic tissue classification and anatomical segmentation procedures (Heckemann et al., 2006).
In basic tissue classification, typically, the image of the brain is divided into three main tissue
types : WM, GM, and CSF (Despotovic et al.). This classification assigns a label, such as a
tissue class, to each element in the image, where the classes are defined in advance. There
are some automated methods for tissue classification, such as BET and FAST, from the FSL
library (Smith et al., 2004), Exbrain (Lemieux et al., 2003). The brain structures have no
border or boundaries to be distinguished from other structures ; therefore, anatomical seg-
mentation is comparatively difficult to use for tissue classification. Most procedures involving
labelling the brain structures offer the interactive input of human knowledge for each case
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individually (Hammers et al., 2003). The diversity of shapes and the numerous various ap-
pearances of anatomical structures make this segmentation one of the most challenging and
essential topics in medical image processing (Elnakib et al., 2015). Lewandowski et al. (2015)
categorized image segmentation methods into :
— Rule-Based Segmentation ;
— Segmentation by Optimal Statistical Inference ;
— Atlas-Based Segmentation ;
— Segmentation with Deformable Models.
In atlas-based segmentation approaches, anatomical atlases are used as reference images.
The first step after choosing the atlas is nonlinear registration to the target image. Next,
labels are transferred from the atlas to the image using the same geometric mapping as
the registration. Finally, the target regions are obtained from the labelled map. Obviously,
segmentation accuracy depends on the accuracy of registration (Morin et al., 2012), (El-Baz
et al., 2015). Wachinger and colleagues (2015) proposed a method to increase the efficiency of
the atlas-based segmentation using sparse correspondences between keypoints that represent
automatically identified distinctive image locations in the test and training images. This
method consists of three steps : (i) keypoint matching, (ii) voting-based keypoint labeling,
and (iii) keypoint-based probabilistic transfer of organ label maps (Wachinger et al., 2015).
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CHAPTER 3 CRITICAL LITERATURE REVIEW OF ALZHEIMER’S
CLASSIFICATION METHODS
In this chapter, we have an overview of various publications in the field, and we introduce
their methods and present their results. However, before that, we need to review the previous
classification techniques using brain images. Therefore, this chapter comprises sections based
on using two modalities that produce the 3D images of brain, including complementary
information to discriminate between different stages of AD and NC.
3.1 Magnetic Resonance Imaging (MRI)
3.1.1 Structural MRI
In this part of the review, we discussed the roles and limitations of sMRI for AD. The two
most pathological dementia features are cortical atrophy and vascular changes (Chetsadaporn
et al., 2015). As we mentioned in the previous chapter, MRI is recommended for distingui-
shing vascular lesions and neurodegenerative dementia. As mentioned previously, MRI images
present rich anatomical information, and it is useful to extract some features which can be
identified as a saliency criterion of the image (Toews et al., 2010) Structural MRI has the
ability to visualize specific atrophy patterns in the brain ; hence, it is important for the dif-
ferential diagnosis of AD (Wattjes, 2011). From the sMRI point of view, brain atrophy and
neuronal loss, as common MRI biomarkers in some special parts of the brain, are key criteria
for the diagnosis of AD. Atrophy starts from the entorhinal area and continues in the hip-
pocampus, amygdala, and parahippocampus along with disease progression (Johnson et al.,
2012), (Vemuri and Jack, 2010).Other brain regions, such as the posterior temporal, parietal
cortex, and mesial temporal lobe, are affected by progress of AD (Chetsadaporn et al., 2015).
When changes in different individual brain regions occur, it is possible to assess the degree
of atrophy visually. Volumetry is the most common quantitative metric used in AD (Ve-
muri and Jack, 2010). Voxel-based morphometry (VBM) is a validated method to assess
atrophy over the entire 3D sMRI scan (Ashburner and Friston, 2000). Moreover, VBM has
an alternative, which is manual segmentation of ROIs instead of the voxel-based approach.
Toews and colleagues (2010) proposed a fully data- driven technique to find the anatomical
structural patterns in 3D images by using feature-based morphometry (FBM). To classify
the subjects based on their image, FBM can promote an image model which is more rela-
ted to the most probable class. The authors used this technique to obtain high accuracy of
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classification between AD and NC (Toews et al., 2010). Multivariate analysis and machine
learning-based algorithms recently attracted the investigator’s (Chupin et al., 2009),(Suk and
Shen, 2013) attention to compare brain volume changes by forming a disease model against
which individual subjects may be compared. In addition, there are several techniques based
on sMRI, which are used to discriminate healthy controls from subjects with AD and to pre-
dict conversion from MCI to AD. Comparing the shape of the hippocampus, evaluating the
power of hippocampal volume, and measuring cortical thickness, tensor-based morphome-
try, and manifold-based learning are some examples of methods used with sMRI scans (Wolz
et al., 2011). Local image texture features is used for characterizing Alzheimer’s disease (AD)
in brain MRI. One of the most discriminative techniques regarding subject groups (AD vs
NC) is using computed texture features from local sub-volumes of MR images (Chaddad
et al., 2016). Finding well-known ROIs for most studies on the automated detection and
characterization of AD from MRI data is the important step of their methodology (Maani
et al., 2015). In another work (Chaddad et al., 2016) using multitextural information like
3D Gray-Level Co-Occurrence Matrix, the Laplacian of Gaussian filter and the 3D discrete
wavelet transform determine discriminative brain regions in a data-driven manner, without
having to segment specific ROIs. Table 3.1 presents some studies that used sMRI with dif-
ferent techniques to distinguish AD or its progression from the early onset stage.
In (Desikan et al., 2009), volume and mean thickness of 34 neuroanatomic ROIs were in-
vestigated on MRI images. To better discriminate MCI, in addition to the cortex thickness,
hippocampal volume and supramarginal gyrus thickness were used which yielded over than
91% of accuracy in their results. In other work (Klöppel et al., 2008), following segmentation
of grey matter, normalization and combining images of different groups were implemented.
Then they tested several method of classification, especially linear kernel of SVM. With this
method the authors could differentiate AD- patients versus controls with 95% accuracy. Jaco-
bian determinants method was used for scaled grey-level intensity in some ROIs, specifically
medial temporal lobe, to separate the probable AD and age-matched normal controls with
92% accuracy in one work of Duchesne et al. (2008). As well as last work SVM classifier ob-
tained the best results of this method (Duchesne et al., 2008). The work of (Liu et al., 2016)
investigated on some ROIs based on AAL to find the classification features. Their method
proposed using hierarchial network to extract the ROIs. The parcellated whole brain into 90
regions based on AAL in first layer of network and some regions merged to obtain 54 region
in next layer. In next layer 14 regions found after merging between two previous layers’ ROIs
and the last layer containing one ROI that was whole brain. They computed the connectivity
between each pair of regions in terms of Pearsons correlation coefficient. In their method
Features selected based on Feature ranking approach. The results of their work obtained by
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multiple kernel boosting, which is about 95 % accuracy of classification between AD and
NC, and about 72 % between MCI convertable and MCI non convertable. Ben Ahmad et
al. (2014) presented an automatic classification framework for AD recognition in structural
MRI. Hippocampal area is the ROI in this work. Their proposed method extract the visual
information from MRI using the approximation of image signal by Circular Harmonic Func-
tions. Where the probabilistic outputs of classifies on both local features and the amount of
CSF were fused, a late fusion scheme could perform the final classification of the MRI scans.
The experimental results of their work show 87% of classification accuracy on AD versus NC
and 78 % and 72 % for MCI versus NC and MCI versus AD respectively on ADNI database
(Ben Ahmed et al., 2014). Rao et al. (2011) applied Sparse Logistic Regression (SLR) to
classify 69 AD and 60 NC subjects based on voxel-wise grey matter volumes derived from
structural MRI. Penalized Logistic Regression (PLR) and Spatially Regularized Sparse Lo-
gistic Regression (SPSLR) are two different formulations of SLR which applied to solve the
problem of having large number of voxels in comparison to the number of training subjects.
The input features in the classifiers for this work were the standardized grey matter voxel
intensities. Their results present about 85 % of overal classification accuracy for AD and
NC (Rao et al., 2011). (Vemuri et al., 2010) compared the annual change in MRI and CSF
biomarkers for their subjects based on intergroup discrimination, correlation with concur-
rent cognitive or functional changes and some other biomarkers. This paper didn’t use some
common feature from imaging to discriminate between different classes of ADNI subjects.
Whereas, it compared the Annual change in CSF and MRI biomarkers across clinical groups
for the pairwise discrimination between groups. The importance of reviewing this work is to
investigate clinically about the ADNI subjects consisting of AD, MCI and NC cohorts with
both baseline and 12-month follow-up. There results of this work presents that the annual
change did not differ by clinical group in pairwise comparisons. From the findings, it’s possible
to indicate that Aβ deposition itself is not directly responsible for clinical symptoms, but
rather initiates a pathologic cascade that later results in clinical symptoms. Another work
(Walhovd et al., 2010) combined MRI, FDG-PET and CSF biomarkers in diagnostic classifi-
cation to examine : 1) most sensitive measures to diagnostic status, 2) the effects of providing
unique information in diagnostic classification 3) most predictive measures of clinical decline.
Their ROIs included by hippocampus, entorhinal, parahippocampal, retrosplenial, precuneus,
inferior parietal, supramarginal, middle temporal, lateral and medial orbitofrontal cortices.
They performed regression analyses to determine measures’ sensitivity to diagnostic status
and some clinical measures. The results of this work indicated that each of the biomarkers
have potential to inform diagnosis and enrich clinical trials. Moreover, hippocampal volume
was the most sensitive to diagnostic group. Quantitative MRI morphometry and regional
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metabolism by co-registered FDG-PET data, both together provided better prediction of cli-
nical decline than CSF biomarkers. As conclusion of this work, MRI scans are often routinely
required as part of the diagnostic work-up.
Table 3.1 Summary of studies using MRI in Alzheimer’s disease
Author(s) Year Subjects Diagnostic measures Associations
Chaddad et al. 2016 62 AD, 62 NC more than 70% AD/NC Texture features are computed from
(Chaddad et al., 2016) local sub-volumes on T1-MRI scans
Liu et al. 2016 200 AD, 120 MCIc, 94.65% AD/NC, 89.63% AD/MCI In the hierarchical network, using ROIs and are also used
(Liu et al., 2016) 160 MCInc, and 230 NC 85.79% MCI/NC 72.08% cMCI/ncMCI the spatial-correlations for the better classification accuracy
Ben Ahmed et al. 2014 35 AD, 111 MCI, 72 NC 87% AD/NC, 78% MCI/NC late fusion of classification results on two
(Ben Ahmed et al., 2014) biomarkers : hippocampus and CSF obtained high accuracy
Rao et al. 2011 69 AD, 60 NC 85% AD/NC overal classification accuracies for SLR and SRSLR
(Rao et al., 2011) with both performing better than PLR and MLDA
Toews et al. 2010 100 AD, 98 NC 80% AD/NC Feature-based morphometry, a group-related
(Toews et al., 2010) equal error classification rate anatomical structure in volumetric imagery
Vemuri et al. 2010 71 AD, 149 MCI, 92 NC Sample size required to detect Longitudinal annual changes were observed only in MRI and not
(Vemuri et al., 2010) treatment effects in AD in CSF. Change in MRI was associated with
MRI : 100 ; CSF >10 change in cognitive measures.
Walhovd et al. 2010 38 AD, 73 MCI, 42 NC AD/NC : MRI : 85% In MCIs, only baseline MRI and FDG were correlated to (or
(Walhovd et al., 2010) CSF :81.2%, CSF+MRI :88.8% predictive of) future clinical decline during 2 years
In assessing degenerative dementia as a result of AD, early stages using sMRI may not be
as specific as advanced and quantitative PET imaging. Richard et al. (2013) assessed the
efficacy of adding sMRI scans to a memory test to predict the progression of MCI to AD
and found no significant increases in the accuracy of the diagnosis. Therefore, sMRI does
not provide adequate diagnostic insight into the progression of MCI to AD (Richard et al.,
2013).
In summary, sMRI is an appropriate biomarker to reflect the disease stage and intensity,
which is extremely useful. It must be noted that it is an independent non-invasive measure of
neuronal loss and thus provides a supplementary measure based only on anatomy. Numerous
publications show that sMRI is a stable biomarker of AD progression.
3.1.2 Functional MRI (fMRI)
Functional MRI (fMRI) is one of the forms of neuroimaging for measuring brain activity. It
detects the changes in blood oxygenation and flow. When a brain area is more active, the re-
lated neurons consume more oxygen, and consequently, in response to the increased demand,
blood flow increases to the active area. Then, fMRI produces activation maps showing which
parts of the brain are involved in a particular mental process. In AD field, fMRI researchers
used memory tests and focused on an activation pattern of fMRI. In fMRI maps, there are
some brain regions that have higher activation than others. Some studies focused on similar
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ROIs, which are affected by AD in sMRI, and did not have satisfactory results. Accordingly,
frontal and mesial temporal lobes have lower activation, and the ventral lateral prefrontal
cortex has higher activation (Lenzi et al., 2011). Likewise, the hippocampus is still an ROI
(Miller et al., 2009).
There are some advantages in assessing AD using fMRI. It is non-invasive and does not
involve radiation ; hence, fMRI can be done multiple times during the disease. It also has
excellent spatial and good temporal resolution, although sometimes imaging quality can be
affected by any degree of head motion. This matter can be more intense for patients with
more advanced dementia who cannot perform the task in an adequate manner. It is easy for
the experimenter to use and interpret the fMRI scans (Chetsadaporn et al., 2015).
3.2 Positron Emission Tomography (PET)
From a neuroimaging point of view, the PET image is another main biomarker for AD diag-
nosis (Román and Pascual, 2012). The PET images are acquired for two methods, which are
popular and include PET imaging using amyloid plaque ligands (AV45-PET) and FDG-PET.
The FDG-PET images are the most common tracers for understanding which region of the
brain has a higher accumulation of glucose. The reason we do not have more publications
about classification of AD and MCI using AV45-PET compared to FDG-PET is that AV45-
PET images were used by researchers and were not clinically approved for AD diagnosis.
On January 20, 2011, there was a recommendation to use the AV45-PET scan technique to
diagnose AD, which was approved by the Food and Drug Administration (FDA). Whereas
Fludeoxyglucose 18F Injection ([18F ]FDG) have been approved by the FDA as a new drug
application on August 5, 2004 (Food and Drug Administration, 2014).
In many studies by various researchers (Aidos et al., 2014a), (Gray et al., 2012), (Rodrigues
and Silveira, 2014), (Cabral and Silveira, 2013), FDG-PET is used as the main biomarker for
classification of AD. Recently published AD and MCI criteria showed that AV45-PET tends
to have an increased weight in the diagnosis of some special regions of the brain (McKhann
et al., 2011), (Albert et al., 2011). Therefore, some researchers (Saint-Aubert et al., 2013),
(Pontecorvo and Mintun, 2011), (Vlassenko et al., 2012) have used AV45-PET to differen-
tiate between AD, MCI, and NC. However, there is less research that has used FDG-PET and
AV45-PET to compare results. The PET images should be registered to the subject’s corres-
ponding brain extracted sMRI results. Generally, this registration is used as a first step of
pre-processing on PET images to represent the structure of the brain. A six-parameter rigid
body transformation and affine transformation are the most common methods in this part
(Kiebel et al., 1997). In the work by Rodrigues and Silveira (2014), registration between MRI
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and PET needs to extract the brain tissue in all MR images (skull-stripping) and segment all
MR images to GM and WM . Then, they used SPM8 as the registration tool for 223 subjects
(Rodrigues and Silveira, 2014). Pre-processed FDG-PET images were co-registered with the
corresponding pre-processed MR images with IRTK tools using rigid and affine registration
(Gray et al., 2012) for 221 subjects. In some research with different methods (Stühler and
Merhof, 2012), the registration PET and brain atlas were used to prepare the PET images
for extracting the features.
A feature indicates a distinctive attribute or aspect of something and in computer vision, and
image processing is the relevant data to find the computational attribute for the subjects.
Depending on the field of work, features may vary, such as points, edges, or objects from the
image structure point of view or a general neighbourhood operation or feature detection ap-
plied to the image (Guyon and Elisseeff, 2006). In image processing, features can discriminate
between different images that are basically acquired in the same way. Here, in this section
of literature, we focused on medical images that are acquired by PET and MRI to differen-
tiate between NC and other diagnosed stages of AD. For analyzing MRI images, there are
some feature extraction methods : rates of change in several structural measures, including
whole-brain (Fox), entorhinal cortex (Frisoni et al., 2010), hippocampus (Thompson et al.,
2004) and temporal lobe volumes (Hua et al.) as well as ventricular enlargement (Hua et al.),
(Jack et al., 2004) that correlate closely with changes in cognitive performance, supporting
their validity as markers of disease progression. In addition, PET images have very good in-
formation to be extracted, such as the ratio of voxel intensities (Fox et al., 1996), (Smailagic
et al., 2015) and mean voxel intensity (VI) in each ROI (Smailagic et al., 2015). There are
several studies that used VI as feature and that published acceptable results (Gray et al.,
2013), (Aidos et al., 2014a), (Habeck et al., 2008), (Román and Pascual, 2012), (Zhang et al.,
2011a) or combination of some of these features.
We can classify things into different groups. Image classification is used to assign correspon-
ding classes based on image features and its homogeneous characteristics (Japan Association
of Remote Sensing., 1996). As mentioned in previous chapters, using PET scans as an ob-
jective diagnostic tool for dementia can give us a metabolic pattern of the brain in vivo,
which facilitates classifying different stages of dementia. To discriminate normal and abnor-
mal FDG-PET scans, we can use different methods of classification. The performance of each
method is dependent on the number of features that are obtained from all patient information
and their images.
After extracting the features from the images and before applying the methods for classifi-
cation, in different works, they have different ways to prepare their information. In different
works, there is specific technique to extract the features from the images and to prepare
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the data for training the classifiers. For this purpose, Aidos et al. (2014) used whole-brain
and some regions of FDG-PET images. To extract the features, they used two approaches
(manual and automated). Using VI, they reduced the number of voxels by giving some values
to each region, and they trained the classifiers SVM, K nearest neighbour, and naïve Bayes.
The results were 85% accuracy for AD vs NC, 65% and 79% depending on the classifier
and approach for MCI vs NC. Their results indicated that their automated approach and
using a small number of features can discriminate subjects with AD from MCI (Aidos et al.,
2014a).Aidos et al. (2014) also proposed the method started by segmentation of each 3D
image, followed by construction of a probability matrix indicating the degree of belonging of
each voxel to a region found by segmentation. Then, they used a feature extraction method,
with SVM. The results had an accuracy rate of 89% in AD vs NC problem. In the case
of AD vs MCI, the worst results were approximately 64% when the best result was higher
than 76% between MCI subjects and NC subjects (Aidos et al., 2014b). Gray et al. (2012)
proposed a method using longitudinal MRI and FDG-PET images to extract the features
from 83 anatomically defined regions to train the SVM classifier in three individual catego-
ries (baseline, 12-months, and combined). This work also investigated differentiating between
progressive and stable MCI, which had the best results with 65% accuracy. Furthermore, they
reported 88% accuracy for AD/NC and 81% for MCI/NC with the combined approach (Gray
et al., 2012). Another work used FDG-PET images in two time points (baseline and after
12 months) as well. The features were extracted from the difference rates of VI between two
time points, and they sorted the number of features using tuned RBF-SVM as a classifier,
giving the overall results of 92.6% for NC/AD and 70.2% for NC/MCI for their best method
of combining the longitudinal and cross-sectional data (Rodrigues and Silveira, 2014).
Table 3.2 presents some studies that used PET images to distinguish different stages of AD
from NC.
Table 3.2 Summary of studies using PET in Alzheimer’s disease
Author(s) Year Subjects Diagnostic measures Associations
Carbonell et al. 2015 23 AD, 125 LMCI, 73% AD/NC, 94% EMCI/LMCI determination of an optimal target ROI
(Carbonell et al., 2015) 151 EMCI, 155 NC on AV45-PET images
Rodrigues & Silveira 2014 48 AD, 109 MCI, 66 NC 93% AD/NC, 67% MCI/NC the best classification results were achieved by
(Rodrigues and Silveira, 2014) combining cross- sectional and longitudinal information
Aidos et al. 2014 59 AD, 59 MCI, 59 NC 85% AD/NC, 65% MCI/NC to identify ROIs by segmenting 3-D FDG-PET and extracting features
(Aidos et al., 2014a) 79% MCI/NC (other classifier) proposed methodology outperforms using VI despite a small number of features
Gray et al. 2012 50 AD, 53 sMCI, 88% AD/NC, 65% MCI/NC our combined method shows considerably better performance
(Gray et al., 2012) 64 pMCI, 54 NC compared to the case of using an individual modality of biomarkers
Salas-Gonzalez et al. 2010 53 AD, 114 MCI, 52 NC 95% AD/NC, 88% MCI/NC selection of voxels of interest using the t-test and a posterior reduction
(Salas-Gonzalez et al., 2010) 86% AD/MCI/NC achieves better compared to the voxel-as-features and a PCA- based approach
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Cabral and Silveira (2013) used FDG-PET images and VI of each brain scan as the classifi-
cation features. To select the subset of features, they ranked the features according to their
mutual information with the class label, selecting the highest-ranking features. They used
two classifiers (SVM and RF) and one proposed method to combine the outputs of seve-
ral classifiers and to increase performance by exploring the diversity of the base classifiers
in terms of random features. They achieved, based the classifiers across all tested features,
66.55% and 64.63% averaged for ensembles of SVM and RF (Cabral and Silveira, 2013).
Establishing relationships between multiple features facilitates finding a good classification
between some datasets, but people are often prone to making mistakes during analysis, and it
makes it difficult to find solutions for certain problems. Machine learning can help to decrease
the number of mistakes and improve the efficiency of systems (Kotsiantis, 2007).
One model for the classification of AD focuses on the selection of the most influential risk
factors using various attribute evaluation schemes, for instance, the ranker search method. It
was found that some specific genetic factors, diabetes, age, and smoking were the strongest
risk factors attributing to AD (Joshi et al., 2010). A detailed study on the various risk factors
for AD has been proposed by many researchers (Luchsinger et al., 2001). It is often useful to
apply different supervised machine learning methods for classification, such as the decision
tree (Pushpa et al., 2006), bagging, RF tree, RBF networks, and multilayer perceptron. Mo-
reover, ANN is another method of AD classification which is also used (Joshi et al., 2010).
There was one work that focused on EMCI and LMCI, which used AV45-PET images to
classify their subjects (Carbonell et al., 2015). Carbonell et al. (2015) developed a statisti-
cal approach using amyloid-PET images to optimize the selection of regions of interest and
corresponding standardized uptake value ratio cut-off for the automated classification of sub-
jects into amyloid-low and amyloid-high. Amyloid-high or amyloid-positive in PET is almost
always associated with low CSF amyloid-β42 in individuals with symptomatic Alzheimer’s
disease. There are individuals (typically cognitively normal) with similarly low levels of CSF
amyloid-β42 but who are amyloid-low or amyloid-negative by PET. The authors used ADNI
subjects with different diagnosis, and grouped the subjects into different levels of cognitive
impairment : cohort 1 included EMCI and LMCI subjects and cohort 2 a combination of NC
and AD subjects. In order to achieve segmented MRI images into gray matter, white matter,
cerebrospinal and partial volume estimation, they used a 9-parameter affine transformation
on MRI images and mapped them on MNI reference. Projection of segmented mid-cortical
surface on PET images after correction and registration to the subject MRI image gave
them voxel wise SUVR corresponding to each ROI. For each subject mean SUVR across the
whole cerebral cortex was calculated. Regularized Discriminant Analysis (RDA) served to
determine the optimal threshold in order to separate subjects based on whole cortex SUVR
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(SUVR_WC) measurements. Additional statistical testing including cognitive performance
measures (MMSE, Alzheimer’s disease assessment scale-cognitive subscale (ADAS-Cog), CSF
(Aβ1− 42), gender, clinical classification and APOE genotype were considered to obtain the
results of discrimination between AβH and AβL for each cohort (classification between EMCI
and LMCI (cohort 1), also for AD vs. NC (cohort 2)).
In the subject characteristic results, which is not completely relevant to our work, the au-
thors did not find significant association between clinical classification and APOE, similarly
to gender. In contrast there was a statistically significant age difference between EMCI and
LMCI subjects, also the initial SUVR_WC measurements, cognitive measures and CSF bio-
markers. Statistically significant association between clinical classification (NC vs. AD) and
APOE was reported, but not for gender. SUVR_WC and cognitive measurements, also CSF
biomarkers were significant for cohort 2. The results of anatomical target ROI, which is more
relevant part of this publication and our work, the performance of the proposed approach
on target ROI compared to the results of subject classification based on SUVR value. For
cohort 1, the accuracy of 0.942 with the cut-off value of 1.10 and 0.985 with 1.24 cut-off value
reported. In addition accuracy of 0.966 with cutoff of 1.10 for cohort 2 is reported. Conclu-
sion : Based on this paper, the authors did not investigate the classification between different
stages of AD among their subjects directly, however their results displayed that several ite-
rations of the discriminant analysis improved the classification of subjects into amyloid-low
and amyloid-high groups. Determination of the cut-off value for classification of the subjects
based on the optimal target ROI SUVR measurement is their main key of their statistical
approach.
Among all previous works, Carbonell et al. (2015), achieved 94% classification accuracy to
discriminate between low and high amyloid accumulation with the cohort of EMCI vs LMCI
(cohort1), which is different to the classification of cognitive class, and reported 73% for AD
vs NC using amyloid PET images, which is lower than most of the state-of-the-art methods.
3.3 Multi-modality
Recent studies have demonstrated that multiple neuroimaging contains complementary in-
formation for diagnosis of AD and its classification into different stages with high accuracy.
However, to obtain more reliable classification results, these multiple biomarkers need to be
combined to provide an accurate diagnosis. In previous sections, we reviewed some modalities,
such as sMRI, fMRI, FDG-PET, and AV45-PET, which yielded satisfactory results (Chet-
sadaporn et al., 2015). In this section, we studied some research that used multi-modality
to achieve higher results. Some of the publications above had extra experiments to show the
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results of combining two multi-modal images or combining more clinical and biological bio-
markers. Different biomarkers can expose different aspects of pathological changes associated
with AD. Some biological biomarkers have been developed for diagnosis of AD. Three CSF
biomarkers are common in state of the art : total τ (T-τ), hyper-phosphorylated τ (P-τ) and
the 42 amino acid isoforms of Aβ (Aβ42) (Tong et al., 2017).
Table 3.3 presents some studies that used multi-modal images to obtain higher accuracy.
Table 3.3 Summary of studies using multi-modal images in Alzheimer’s disease
Author(s) Year Subjects Diagnostic measures Associations
Tong et al. 2017 37 AD, 75 MCI, 35 NC 98.1% AD/NC, 82.4% for MCI/NC significantly better using multi-modality
(Tong et al., 2017) and 77.9% for AD/MCI/NC biomarkers (PET, MRI and CSF)
Lele Xu et al. 2015 113 AD, 110 MCI, 117 NC 94.8% AD/NC, 74.5% for MCI/NC classification with multi-modality
(Xu et al., 2015) and 77.8% for pMCI/sMCI data were helpful
Saint-Aubert et al. 2014 22 AD, 17 NC well discriminated using PET template-based quantification
(Saint-Aubert et al., 2014) Florbetapir (AV-45) with the MRI-based cortical quantification method
Richard et al. 2013 181 MCI More than 95% accuracy unlike PET MRI or CSF do not substantially affect
(Richard et al., 2013) diagnostic accuracy for predicting progression to AD with MCI
Zhang et al. 2011 51 AD, 99 MCI, 52 NC 86.5% AD/NC, 76.4% for MCI/NC our combined method shows considerably better performance
(Zhang et al., 2011a) 93.2% AD/NC (3 biomarkers) compared to the case of using an individual modality of biomarkers
3.4 Summary
In this section, we reviewed the publications in similar domains, and we selected some relevant
research to present here. In these studies, different approaches were applied to prepare the
images, to extract the features, to select the classifiers, and to use some extra biomarkers.
The results were obtained in several manners, which are studied. Among all studied work,
there are a few studies that pointed to the different stages of MCI (EMCI and LMCI). The
studies that used MRI images only gave us a good historical review on methods for finding
ROIs and different classifiers. In addition, it led to more understanding of the advantages
and disadvantages of MRI compared to PET modality. The studies using FDG-PET images
mostly focused on VI in multiple regions.
PET images provide a wealth of diagnostic functional information in various sites, particularly
in the brain. A large number of prior work investigated different topics on PET images,
including differentiating between brain disorders and health controls (AD vs NC) or other
disordering by inferring sites of pathology based on characteristic signs and symptoms (AD vs
FTD). FDG-PET provides a separate, simpler, more objective and quantitative way to make
this same judgement. Good reliability and diagnostic accuracy was observed with traditional
images. There are also many potential ways to analyze FDG-PET data. Thus, the most
43
accurate classification method via the PET images was necessary to be able to obtain the
best result of classification for FDG-PET and AV45-PET images.
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CHAPTER 4 GENERAL METHODOLOGY
This chapter comprises sections along with our proposed pipeline steps, which are formed by
a set of tools. The pipeline schema is divided into two parts to present more details. Figure 4.1
presents the first part of our pipeline to select the features from extracted ROIs. Each step of
this flowchart includes a tool chosen after validation and tests. The tool selection was done
among several available ones, according to our needs and their advantages.
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Figure 4.1 Pipeline of proposed method, Part I : Image processing.
Following a summary of data collection and image pre-processing, selection of the registration
tool will be explained. It is followed by segmentation and extracting the features from regis-
tered images. Selecting the ROIs to prepare data for classifier training is the next section.
Then, the second part of our pipeline presents the different classifiers, which are applied and
mentioned in Chapter 2.
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4.1 Data Collection and Image Pre-processing
First, the images were downloaded from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database. The ADNI has three databases : ADNI1, ADNI2, and ADNI GO. Pre-
processed PET and MRI images were selected from all three ADNI databases. The most
available subjects that had complete information (such as clinical test (MMSE), FDG-PET,
AV45-PET images, and T1 weighted MRI scans) were downloaded, which comprised 1088
subjects.
Subject images were pre-processed by ADNI. Pre-processing on PET images included four
steps : 1) co-registration between extracted frames of PET scans to the first extracted frame
of the raw image file to reduce the effect of patient motion, 2) averaging of the six 5-minute
frames of the co-registered dynamic image set, 3) reorientation of the output images into a
standard space (160× 160× 96 voxel in 1.5mm3) and 4) obtaining a uniform image isotropic
resolution of 8 mm full width at half maximum (FWHM). The MRI images also were correc-
ted using three steps : 1) Gradwarp, a system-specific correction of image geometry distortion
due to gradient non-linearity, 2) non-uniformity correction, calibration, and correction of the
image intensity non-uniformity, and 3) reduction of the intensity of non-uniformity and re-
duction of the residual intensity non-uniformity (ADNI, 2014).
Next, the ADNI cohort were analyzed to select the sample set with PET and MRI and clas-
sification evaluation (diagnostics results by ADNI). In this step, 428 subjects were excluded
because some of the subjects did not have the corresponding MRI in a close enough time
to the PET acquisition, or the AV45-PET for those subjects was not available. Finally, 660
subjects were selected for this work.
4.2 Registration
Registration is one of the most important parts of our proposed method, and we aimed to
choose the most convenient tool for this step, which includes two separate registration steps.
The first step parcels the native MRI of patient by performing a non-rigid registration with
the MNI152 atlas. This allows to the segment the patient’s image by anatomical regions of
interest and extract the specifics region that will be analyzed with PET. The second step
registers the parcelled MRI with the patient’s PET scan.. Based on our literature, affine
registration is one of the commonly used parametric models (Chumchob and Chen, 2009).
An affine transformation corrects some global distortions in the images to be registered.
Moreover, the rigid body method is accurate because there are only six rigid body parameters
46
required to map between the structural and functional images.
Many software solutions have been presented for medical image registration. For this work,
we investigated and tried some of free open-source software packages, such as :
— Automated Image Registration (AIR) (Woods et al., 1998) – source code in C ;
— ITK (Ibanez et al., 2005) – source code in C++ ;
— FLIRT (Jenkinson and Smith, 2001) – source code in C++ ;
— Elastix (Klein et al., 2010) – source code in C++
— Statistical Parametric Mapping (SPM) (Ashburner and Friston, 1999) designed for
the analysis of brain imaging data sequences.
We looked for an accurate and fast method to execute this step of our pipeline in appropriate
time with less errors. We considered to find a solution that was 1) suitable for registration
between PET and T1-MRI, 2) programmable and compatible with the rest of the pipeline,
and 3) accurate for standard atlas and MRI with less cost function. Among all algorithms
for registration after validation, we used affine geometric transformations and rigid body (six
parameters) with several transformations and cost functions that have been published in
functional brain imaging studies.
The Functional Magnetic Resonance Imaging of the Brain (FMRIB) Software Library (ab-
breviated FSL) is a known software library of analysis tools for different imaging data and
specifically for fMRI, MRI, and diffusion tensor imaging. The FMRIB Analysis Group from
Oxford University made a series of analysis and statistical tools for functional, structural,
and diffusion MRI brain imaging data. The latest stable version in 2012 for Linux and Mac
OS X was released. Several functional and structural functions for MR images are included
using FSL tools. In addition, FMRIB’s linear image registration tool (FLIRT) is the linear
inter-modal and intra-modal registration tool.
Statistical parametric mapping (SPM) is another tool, which is recommended for PET
images. Below, we compare two final chosen tools to select one, considering their cost func-
tions and different transformations. We applied them for the real data to find the best solution
for our pipeline.
The FSL has a few well-defined, easy-to-use programs with a small number of input parame-
ters. The SPM works quite well, but due to its file format conventions, it is best if SPM is not
mixed into a pathway with other packages. One should only consider using SPM if prepared
to rigorously validate the left/right orientation for the data. The SPM is more GUI-oriented
than FSL, which uses the NIFTI file format to make it easy to integrate into processing pi-
pelines (brainimaging, 2017). Among all registration tools, such as AIR (Woods et al., 1998),
FLIRT, SPM, and so many automatic and non-automatic tools, based on our state of the
art, we chose FLIRT and SPM to test. In Chapter 6, we presented the results of our cross
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validation for choosing FLIRT as our registration tool.
4.3 Segmentation
In this work, a more relevant method for our pipeline is using atlas-based segmentation.
Because we need our images to be comparable and uniform to each others and to select
the spesific regions as ROIs. For this purpose we used single atlas-based segmentation using
MNI152 to segment the brain into 116 anatomical structures. As we mentioned in the last
chapter, the accuracy of segmentation based on an atlas is dependent on the registration
between the input image and atlas. This is another reason for scrutinizing to choose the
best method of registration. When compared to other methods for image segmentation, the
atlas-based segmentation has the ability to segment the image with no well-defined relation
between regions and pixel intensities (Kalini, 2004).
The use of anatomical atlases as reference images to guide segmentation of new images is very
popular in different medical applications. The atlas typically helps to localize the anatomical
structures. All the known atlas-based methods can be classified into single and multi atlas-
based segmentation. In this work, we used the single atlas method, and the way we applied
the labels for each brain region is different from the regular method of atlas-based segmenta-
tion. Therefore, we proposed a simple anatomical segmentation based on the MNI152 atlas
and AAL pattern of 116 labels. In general, the accuracy of the atlas-based segmentation de-
pends on the accuracy of the atlas-to-target registration (Oliveira and Tavares, 2014) ; thus,
we can rely on our method, as we validated the method of registration.
The next step of segmentation after registration between the subjects and atlas is extracting
the regions that are ROIs by subtracting to the mask of ROIs individually. This is done by
implementing a function using the NIFTI toolbox in MATLAB (version : NIFTI_20100413).
After verification of the effect of each region on the classification accuracy (results in Chap-
ter 6), we combined all regions and made a mask in the atlas space. Figure 4.2 illustrates
the steps of creating a mask for all ROIs. To create our mask, we performed five steps : I)
The PET image is registered into the MNI atlas, and the AAL was applied on the image.
II) Each ROI was extracted from the whole labelled image (in different slices, different ROIs
are seen). III) All 10 ROIs were added together (logically there is no overlap) and a mask
is created for each subject individually. IV) the PET image registered with MNI was used
to replace the raw voxel intensities. V) The mask is applied on the PET image, and it is
available to create matrix X.
We use voxel intensity (VI) as a feature and after ROI selection we used the VI of those regions
to train the classifiers. ROIs have different size in different images, then all ROIs resized to
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(I)         (II)             (III)
(IV)                (V)
Figure 4.2 Steps of creating mask using individual ROIs.
maximum number of voxel. To find this number, we counted the maximum number of voxels
among all subjects for each ROI. Based on the maximum identified values, we calculated the
maximum length of the overall vector (reshaped 3D image voxels to 2D vector). Each subject
ROI which did not reach the maximum value were zero-padded. Using this approach, we
created the matrix X with vector of the subjects as rows and a maximum number of valued
voxels ascolumns. Creating the matrix X for two approaches is explained in detail in Chapter
5. Therefore, the last step is classification and evaluation of the results, which is in the next
section.
4.4 Classification
Our data for training the classifiers from the previous step were collected in matrix X, which
had two versions for both approaches. Figure 4.3 shows the second part of our pipeline,
which is training and testing the classifiers and cross validation. As mentioned previously,
four different classifiers were selected for classification. Two matrices had 660 rows of data
and depending on the approaches, the number of columns varied. To train all four classifiers,
we chose 80% of the data randomly, and to test, we used the rest (20%) of the data. For each
iteration, the sample sets changed, and we had at least five iterations per each classifier to
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train and test. The results, which are presented in the result section, were obtained as an
average of all iterations. All classifiers were implemented on MATLAB (2015) software and
the results were stored on a spreadsheet for future data analysis.
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Figure 4.3 Pipeline of proposed method, Part II : Classification.
Linear SVM For linear kernels in SVM, we analyzed the C parameter. To find the optimal
value for C, we used a 10-fold cross-validation on training data which is 80% of the total data.
We selected the value for C using a grid search, followed by a refined search. The maximum
in-sample validation accuracy were found at Copt = 10. We used the same optimal parameter
for linear SVM and PCA-SVM. To clarify the persentage of each subsets, we used 80% of total
data as training set and the remained 20% as test set. We executed 10-fold cross-validation on
training set which splited to 10 subsets. Of the 10 subsets, a single subset was retained as the
validation data for testing the model, and the remaining 9 subsets were used as training data.
The cross-validation process was then repeated 10 times, with each of the 10 subsets used
exactly once as the validation data. The advantage of this method is that all observations
are used for both training and validation, and each observation is used for validation exactly
once.
PCA-SVM We derive the Principal Components (PCs) from the raw dataset while preser-
ving 91% of the group variance. This implies that there is only a slight loss of discriminative
information. Even when we were preserving 91% of the group variance, we could reduce the
feature matrix from 6012 to 20 columns, thereby significantly reducing the computational
time.
In our 50 iterations we removed the PCs and computed the average squared of the rest
components in off-diagonal to find the minimum value and in rest of iterations we obtained
ignorable change in minimum number. Therefore, in the first iteration, we first removed PC
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from the correlation matrix and then the average squared of components in off-diagonal was
computed. In the next iteration we removed the first two PCs and the same process repeated,
and so forth. After twenty iterations, the first twenty PCs were removed from the correlation
matrix and the above-mentioned processes repeated again. Obtained minimum of squared
average value was a factor for selecting optimum PCs and implementing this method. We
chose the optimum number of principal components such that the variance retained was 91%
(Velicer, 1976). In MATLAB, the PCA function is predefined, we achieved PC = 20, and the
results of the PCA were used to train the linear-SVM function to achieve the final results.
RBF-SVM The RBF-SVM classifier needs to be adjusted ; therefore, we used a 10-fold
cross validation approach to test the method. To do this, we chose randomly 10 subsets out
of 660 subjects, of which 9 were used for training the SVM classifier and the remaining subset
is used for test. The process is successively repeated 1000 times to avoid any possibility of
bias. After all the optimum parameters, achieved :
Coptimum = 1.0, γoptimum = 0.100000001, Score = 0.917 (4.1)
Random forest To train the TreeBagger function in MATLAB, one of the crucial para-
meters is the number of trees (ntree). Based on the literature, this number should be greater
than 50. To adjust the number of trees, a selected sub-sample was classified and evaluated
10 times. Each time the ntree was numbered in the range of [20 : 120 : 20], and the best
accuracy of 91.2% was obtained when the ntree was equal to 60.
4.4.1 Classification Accuracy Calculation
To calculate the accuracy of each classifier, we present a common method. After applying
the classifiers and all iterations of training and testing of the classifiers, the result data were
saved. Table 4.1 shows an example of the data yielded by the linear SVM.
Table 4.1 Example of result data yielded by linear SVM on FDG-PET images.
True False
Positive 19 0
Negative 30 11
Accuracy (ACC), sensitivity (SEN), and specificity (SPE) are used to quantify the perfor-
mance of the classifiers based on the results. The ACC, SEN, and SPE were calculated using
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the following formulas :
ACC = TP + TN
TP + TN + FP + FN (4.2)
SEN = TP
TP + FN (4.3)
SPE = TN
TN + FP (4.4)
where TP, FP, TN, and FN are the numbers of true positives, false positives, true negatives,
and false negatives, respectively. Therefore, the ACC of our example in Table 4.1 is equal to
81.67%. In the case of presenting significant results, the p value was obtained by the t-test
function of the spreadsheet (LibreOffice, version : 4.3.3.2).
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CHAPTER 5 ARTICLE 1 : IDENTIFICATION OF AD/LMCI/EMCI
PATIENTS FROM SEMANTICALLY PARCELLED AV45 AND FDG-PET
IMAGES
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Remarks : This paper presents a proposed pipeline of classification between AD and dif-
ferent sages of MCI, using PET images in two time points (baseline and second visit). The
proposed method includes two approaches : first, multi-region approach using the region of
ineterest in PET images to select the features for training the classifiers. Second, whole-brain
approach using whole voxels of brain image to compare the results. Experiments revealed
that the combination of two time points together obtain better results than single time point
individually.
Identification of AD/LMCI/EMCI Patients from Semantically
Parcelled AV45 and FDG-PET Images
Seyed Hossein Nozadi, Samuel Kadoury
for the Alzheimer’s disease Neuroimaging Initiative 1
Dept. of Computer and Software Engineering,
Ecole Polytechnique Montréal, Montreal, Canada
5.1 Abstract
Distinguishing patients with Alzheimer’s disease (AD), Late mild cognitive impairment (LMCI),
Early Mild Cognitive Impairment (EMCI) and normal controls (NC) is an extremely active
research area, which has garnered significant attention in the past decade. Discrimination of
different stages of dementia is crucial to slow down the progression of AD. Positron Emission
Tomography (PET) is considered a highly powerful diagnostic biomarker, but few approaches
1. Data used in preparation of this article were obtained from the Alzheimer’s disease Neuroimaging
Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to
the design and implementation of ADNI and/or provided data but did not participate in analysis or writing
of this report. A complete listing of ADNI investigators can be found at : http ://adni.loni.usc.edu/wp-
content/uploads/how_to_apply/ADNI_Acknowled gement_List.pdf
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investigated the efficacy of focusing on localized PET-active areas for classification purposes.
In this work, we propose a pipeline using learned features from semantically labelled PET
images to perform group classification using Radial Basis Function (RBF) SVMs and Random
Forests (RF). Following normalization and pre-processing steps, a deformable multi-modal
PET-MRI registration method is proposed to fuse the MNI atlas to each patient-specific PET
scan, generating a fully labelled volume from which 10 common regions of interest used for
AD diagnosis are extracted. The method was tested on 660 subjects from the Alzheimer’s
Disease Neuroimaging Initiative database and compared to a whole brain approach. The
classification accuracy of AD vs NC was measured at 91.2% when using RF combining both
multi-region features from a cross-sectional and follow-up exam. A considerable improvement
in the EMCI vs LMCI classification accuracy was achieved with a 72.5 % rate. The pipeline
demonstrates the potential of exploiting longitudinal multi-region PET features to improve
cognitive assessment.
IEEEkeywords Alzheimer’s disease, Mild cognitive impairment, Classification, Longitudi-
nal analysis, [18F ] fluorodeoxyglucose, Positron emission tomography, Semantic segmentation
5.2 Introduction
Alzheimer’s disease (AD) is one of the most common types of neurodegenerative disorders in
the aging population (Liu et al., 2010). A recent research by the Alzheimer’s association re-
ports that AD is the sixth-leading cause of death in the United States and is rising every year
considering its proportion in the causes of death (Alzheimer’s Association, 2016). A typical
AD starts with forgetfullness and progresses by affecting language, visuo-spatial and frontal
lobe functions (Westman et al., 2011). Therefore the onset of forgetfullness is an important
marker in the diagnosis of early stage AD, which is known as mild cognitive impairment
(MCI) (Mucke, 2009). However, it could be due to age-related memory decline. Still, clinical
and neuroimaging studies have demonstrated differences between MCI and normal control
(NC) (Román and Pascual, 2012), (Silverman, 2009). The cognitive screening is a routine
clinical method to detect, diagnose and classify dementia but the accuracy of classification is
hindered due to the overlapping nature of the cognitive impairment. Different types of demen-
tia are diagnosed by cognitive screening such as Mini–Mental State Examination (MMSE),
which is usually sensitive to significant cognitive impairments, and in some patients can also
detect MCI. Therefore, an integrated approach is needed to diagnose MCI in a more accurate
manner.
MCI is divided into two stages such as early MCI (EMCI) and late MCI (LMCI) ; these
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stages can either progress to the next stage (convertable MCI) or not (non-convertable MCI).
Current treatments are effective for early MCI which is an active research area, whereas, there
is still no complete cure for AD. This implies a great urgency to develop sensitive markers
to detect and monitor early brain changes. The ability to diagnose and classify AD at an
early stage helps in making a more informed decision at later stages for clinical intervention
and treatment planning, thus having a great impact on reducing the cost of longtime care
(Stoeckel and Fung, 2007). From a neuroimaging perspective, positron emission tomography
(PET) of fluorodeoxyglucose (FDG) for cerebral glucose metabolism and β amyloid (also
known as AV45 or florbetapir) can provide complementary information for the diagnosis of
AD (Gray et al., 2012; Saint-Aubert et al., 2013; Bauer, 2014).
The classification of patients who are candidates under AD at its early stage versus NC is a
topic looked by many studies conducted with PET imaging. To be able to classify patients,
brain features of interest need to be extracted from the PET images. Features can discriminate
between NC and other diagnosed stages of AD. By selecting the best features, we can make
a better use of classifiers and subsequently, improve accuracy of the results. Feature-based
methods can use brain volume (Cabral and Silveira, 2013), ratio of voxel intensities (Fox et al.,
1996), (Smailagic et al., 2015), mean voxel intensity (VI) (Hinrichs et al., 2009) in each regions
of interest (ROIs) and combinations of some of these features. Voxel intensity is one of the
most important method in feature extraction (Zhang et al., 2011a), (Habeck et al., 2008). For
instance, Smailagic et al. used VI to reduce the number of voxels by excluding lower intensity
values from the PET images and simplify the classification process (Smailagic et al., 2015).
Gray et al. differentiated AD and NC with an accuracy of 88%, whereas non-convertable MCI
and NC yielded a 65% accuracy (Gray et al., 2012). The authors used FDG-PET images from
the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Their method proposed to classify
AD versus non-convertable MCI and convertable MCI to test regional feature sets based on
signal intensities. In a work by Rodrigues and Silveira using the same longitudinal database,
the best classification accuracy was obtained by combining two time points (baseline and
after 12 months) (93% for NC vs AD) (Rodrigues and Silveira, 2014). In another study,
Aidos et al. used VI in some ROIs which were manually selected by experts (Aidos et al.,
2014a). By using an automated feature selection method to classify the subjects, they applied
ROIs and mutual information to rank the features and identify the highest values to reduce
the number of features. The best accurate classification rates among support vector machine
(SVM), k-nearest neighbor (KNN) and naive Bayes were obtained by using ROIs with SVM
or KNN for MCI, with rates ranging between 65% and 79%. An accuracy of 85% for AD vs
NC was also obtained using the proposed method.
In this work, we concentrate solely on the diagnostic potential of PET images without using
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additional biomarkers. In the first approach (hereafter called multi-region approach), we
developed a method to segment the ROIs and extract the features while in the second, we
used a similar method but for the entire brain (hereafter called whole-brain approach). Due to
it’s challenging nature, EMCI and LMCI is not frequently tested for classification. Generally,
most studies compared AD, MCI and NC (Gray et al., 2012), (Cabral and Silveira, 2013),
(Zhang et al., 2011a), (Zhang and Shen, 2012). However it must be noted that Carbonell
et al. achieved 94% classification accuracy to discriminate between low and high amyloid
accumulation in PET images from automatically identify ROIs, rather than LMCI vs EMCI,
and they reported 73% for AD vs NC the same method, which is lower than most of the
state-of-the-art methods.
Here we propose a fully automated pipeline to extract specific regions known for amyloid
accumulation in order to classify the cognitive class. Therefore, we decided to group our data
into four classes (AD, EMCI, LMCI, NC) using PET images only. Each subject had two
PET scans at two time points (baseline and after approximately 12 months), FDG-PET and
AV45-PET images. We believe longitudinal PET images provide additional information to
acheive a high level of discrimination between EMCI vs NC, LMCI vs NC and EMCI vs
LMCI. The main objective is to develop a method to select the best features using PET
images only to classify AD, EMCI, LMCI and NC. To our knowledge, this work is unique
because of the large sample size compared to those of previous works which used less than
250 subjects (Gray et al., 2012; Rodrigues and Silveira, 2014; Aidos et al., 2014a).
We propose to classify the subjects by using their PET images both at baseline and after
approximately 212 months (hereafter called second visit). First, using the baseline images, a
primary registration between magnetic resonance images (MRI) and PET images was perfor-
med to facilitate uniform measurements between the varying image resolutions and generating
a gross alignment of the anatomical brain structure between all subjects. After registration
between the PET and MRI images using FMRIB’s Linear Image Registration Tool (FLIRT)
(Jenkinson and Smith, 2001; Jenkinson et al., 2002), the resulting images were registered to
the Montreal Neurological Institute (MNI) atlas (MNI152) in order to compare voxels among
the subjects’ image. Label assignment was performed with the automated anatomical labeling
(AAL) atlas, yielding 116 different areas in the brain used for the multi-region approach. To
extract features from each area, we used this AAL labeling method and selected 10 ROIs in
each subject. The second visit images underwent the same process to extract the features and
combined to the baseline for the multi-region approach for AV45-PET and FDG-PET images
individually. The whole-brain approach used voxel-wise features from the entire volume for
2. The second scan of ADNI subjects was acquired between 6 to 18 months after baseline ; this period of
time is not the same for all subjects which gives an approximate 12-month period.
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Figure 5.1 Pipeline of proposed method.
the same images and time points. For classification, we used as basis of comparison both
linear and RBF SVMs, PCA and Random Forests (RF). The paper is structured as follows.
Section II presents the materials and the methodology for the classification pipeline. Section
III presents the experimental results, followed by a discussion. Section IV concludes the paper.
5.3 Materials and Methods
We propose a pipeline including PET and MRI registration, atlas registration, anatomical
segmentation, feature selection and classification as shown in Figure 5.1. The following
sections describe each component of the pipeline.
5.3.1 Data selection
The data used in this work was from the ADNI database (www.loni.ucla.edu/ADNI). ADNI
is an ongoing effort launched in 2003, longitudinal, multicenter study designed to deve-
lop clinical, imaging, genetic, and biochemical biomarkers for the early detection and tra-
cking of AD. It includes approximately 1800 subjects recruited from over 50 sites across
the US and Canada in three database (ADNI, ADNI GO and ADNI 2) (Jagust, 2010),
(http ://adni.loni.usc.edu/). Among all subjects which are available for download, this study
used resting-state FDG-PET brain volumes acquired at two time points : baseline and second
visit. The total number of subjects was 1046 patients, 386 patients were excluded because
they did not have the complete PET series and/or corresponding MRI images at the same
time. A final set of 660 subjects with PET and MRI images was selected, which amounted to
99 AD, 164 EMCI, 189 LMCI and 208 NC, and MMSE scores in both time points. Table 5.1
presents the characteristics of the patient cohorts.
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Table 5.1 Characteristic of sample
Characteristics AD EMCI LMCI NC
n 99 164 189 208
Mean age 75.7±8.2 74.3±8.1 72.8±7.0 76.3±8.4
Gender (M/F) 57/42 94/70 101/88 119/88+1(undefined)
MMSE
Baseline 22.9±2.2 28.5±1.4 27.6±1.8 29.1±1.2
second visit 20.4±4.1 27.7±2.7 24.4±4.9 28.3±2.3
5.3.2 PET & MRI datasets
PET protocol
Anatomical brain imaging (ex. MRI) and metabolic imaging (ex. PET) are two commonly
used imaging modalities used in the diagnosis of dementia (Román and Pascual, 2012). PET
creates three-dimensional (3D) metabolic images of the brain by using radioactive tracers,
which are usually administered to patients through intravenous injection. This technique
creates 3D images of the brain by detecting the emitted radiation of the intra-venously
injected radiation tracers. The carrier molecules in the tracers binds to specific receptors.
The routinely used PET tracer is FDG (a modified glucose) that binds to normal functioning
cells, i.e., neurons in the brain. The radio-active past of the tracer emits positrons, which
interacts with surrounding electrons resulting in 2 photons of 144 Kv. The principle of PET
imaging is to localize the tracers from the detected photons, creating tomographic images.
However, the distribution of the tracers depends on the functioning (metabolism) of the tissue
thereby creating a functional imaging (Silverman, 2009).
PET is a functional neuroimaging technique used in AD, which produces a distribution map
of glucose uptake. The absence of uptake in the temporal parietal lobe is an indication of AD
(Román and Pascual, 2012). Importantly, the diagnostic accuracy of PET correlates with
the histopathology confirming diagnosis of AD. Foster et al. demonstrated that FDG-PET
improves the accuracy of differentiating AD from fronto-temporal dementia, especially when
the symptoms and clinical tests are equivocal (Foster et al., 2007).
PET images were preprocessed in four steps. Scans were further processed to provide increa-
singly uniform datasets. The four steps were : 1) co-registration step to reduce the effect
of patient motion and converted file into DICOM format ; 2) averaging of the 6 five-minute
frames of the "co-registered dynamic" image set ; 3) reorientation of the output images into a
standard space with 160×160×96 voxel image grid of 1.5 mm cubic voxels ; and 4) acquiring
a uniform image with isotropic resolution of 8 mm full width at half maximum (Jagust, 2010),
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(http ://adni.loni.usc.edu/).
MRI protocol
The MR images were acquired on Phillips, GE and Siemens systems. Since the protocols for
each scanner were different, a correction was provided by ADNI. These image corrections
for each MPRAGE image were linked with related image files which have undergone specific
image preprocessing correction steps. Corrections included geometry distortion, calibration
and reduction of intensity of non-uniformity. More detailed information is available on the
ADNI website (http ://adni.loni.usc.edu/). We used T1-weighted images which were selected
and reviewed for quality and correction in terms of data format and/or alignment. MR
images were used only to find the sub-cortical anatomical structures to increase the labelling
accuracy of the ROIs. Finally, the MRI with 176× 256× 256 resolution with 1 mm spacing
were collected with the purpose of increasing the accuracy of registration and labelling.
5.3.3 Mask Extraction
PET - MRI registration
Accuracy of inter-modality registration between PET and MRI is a crucial step as it dictates
the reliability of PET segmentation and subsequently provides better results for ROIs. The
first step was to register the PET and its corresponding T1-w MRI. For this, we used FLIRT
which is a robust, accurate and fully automated registration tool for brain images (Jenkinson
and Smith, 2001), (Jenkinson et al., 2002). In our pipeline, skull stripping was not needed,
so by reducing the total processing steps from the original images, we tried to keep as much
detailed information of signal intensities as possible. We tested rigid body (6 parameters) and
affine (12 parameters) transformation (mutual information and correlation ratio cost function
done for each transformation). We used an affine transformation with correlation ratio for all
660 subjects in two time points as it provided the best inter-modality registration accuracy.
Atlas registration
The MNI152 atlas was created as a response to increasing demand for 3D standard templates
to examine, validate and measure the accuracy of different image analysis procedures in a
standardized space (Collins et al., 1998). This atlas is based on a brain phantom, which is
made up of ten volumetric datasets in different tissues. This atlas is often considered as a gold
standard to test brain analysis algorithms (Collins et al., 1998). Thus registration between
the MNI152 atlas and the patient MRI facilitates the localization of the analyzed regions.
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Figure 5.2 Regions of interest in AD diagnosis by using PET image.
Afterwards, AAL is used for labelling each region on the brain atlas. This labelling technique
provides 116 cortical and subcortical labels, which are accurate and are perfectly compatible
with the MNI152 atlas (Tzourio-Mazoyer et al., 2002). Registration with AAL enables to
segment the whole brain structure and choose the ROIs. In order to perform voxel-wise
analysis, all images were registered to the uniform size of the MNI template. Therefore, after
PET and MRI registration, the resulting images were registered once more with MNI152 atlas
(2 mm). Thus, we obtained all images with 91×109×91 resolution, with 2mm isotropic voxel
size. FDG-PET images in dementia show some regions presenting patterns of abnormality
due to atrophy caused by the disease, namely in each brain hemisphere : 1) Anterior cingulum
(right and left), 2) Posterior cingulum (right and left), 3) Inferior frontal gyrus/orbitofrontal
(right and left), 4) Precuneus (right and left), 5) Lateral temporal (right and left). These
patterns appear in multiple neurological disorders, including Alzheimer’s disease. The main
reason to draw the ROIs is to extract functional data from specific structural areas within
the dataset. These ROIs were previously identified in the literature (Alexander and Moeller,
1994), (Markiewicz et al., 2009), (Apostolova and Thompson, 2008) and in the neuroscience
field. The ten selected regions were extracted by selecting the specific labels after the AAL
registration technique, and regional extraction in the original image volume space ( Figure
5.2).
60
Extraction of ROIs
Regions in the 3D MRI of the brain can be labeled manually by experts, but segmenting
and labeling these structures for large cohorts would require an extensive amount of time.
Using an anatomical correspondence estimation relating the atlas to the target image space
increases the accuracy of the resulting target labeling (Heckemann et al., 2006). The current
literature on classification of AD did not use the previously mentioned regions which are
more likely to be affected by AD (Lancaster et al., 1997a), (Fischl et al., 2002a). In order to
accurately find the ROIs, we propose a method based on the MNI152 and AAL atlases. For
the purpose of anatomical segmentation to extract the ROIs, we used registration by AAL
(2 mm). From the 116 regions of the brain identified using our registration technique, five
regions in each hemisphere were studied for the accumulation of glucose in each area.
Creating the masks based on ROIs was the next step in our pipeline before applying it on the
processed images. Each voxel from the labelled ROIs obtained from segmentation were used
in this process. In this step, we had 10 different patterns which had a labeled ROI. To create
a single mask including all ROIs, we combined the 10 separate masks together. The mask
represented a single pattern of all regions which had more probability of being affected by AD
and specifically had less accumulation of glucose. After applying the mask, we then replaced
the mask ROIs labels by the voxel values from the raw data for each subject. Following that,
the data and images were ready for feature extraction.
5.3.4 Feature Selection
Preprocessed subject images each had 902629 voxels with corresponding intensity values.
The training of the classifiers requires a reduced amount of labelled voxels for a cost-effective
approach. Therefore, after replacing the ROI labels, we excluded the zero-valued voxels from
the matrix. From the remaining values, assuming that the number of voxels differed for each
region ki, each subject dataset S, which included 10 ROIs, can be defined as follows :
S = {k1, k2, k3, ..., k10} (5.1)
As we had 660 subjects and needed to have a vector of voxels for each subject, we reshaped
the 3D matrix for all subjects, ROI’s and voxels/per ROI, to a single feature vector. However,∑10
i=1 ki for subject S1 would be different from S2 and other subjects. To solve this, we counted
the maximum number of voxels among all subjects for each ROI. Based on the maximum
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Figure 5.3 Creating matrix X from the reduced dimension dataset.
identified values, we calculated the maximum length of the overall vector such that :
10∑
i=1
N∑
j=1
max(kij), N = 660 (5.2)
X = {S1 = {k1, k2, k3, ...,k10}, ...,
S660 = {k1, k2, k3, ..., k10}} (5.3)
Each subject ROI which didn’t reach the maximum value were zero-padded. Using this ap-
proach, we created the matrix X with vector of the subjects as rows and a maximum number
of valued voxels (kmax) as columns( Figure 5.3).
In the proposed multi-region approach, we used matrix X which had a dimensionality of
22229×660 in order to train the classifiers. Whereas in the whole-brain approach, the size of
the feature matrix was 902629× 660. The objective was to learn the features from the VI in
order to discriminate classes. The main difference between the two approaches was the total
number of voxels used.
5.3.5 Classification
Once the voxel intensity extraction and feature selection steps were performed, the feature
vector containing mean-centered voxel intensities was created for each of the 10 ROIs and
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assembled for all cases. Supervised classification was performed using four different two-
class methods, which included : a linear SVM, an RBF kernel SVM, a principal component
analysis (PCA) model which reduced the feature space dimensionality, as well as a Random
Forests classifier. Hyper-parameters of the RBF kernel were obtained using an exhaustive
search grid (described in Section III), where the parameters were selected based on the
maximum in-sample validation accuracy which outperformed polynomial kernels. The tuned
hyper-parameters were then used to predict the out-of-sample accuracy values on the test
set.
5.4 Results and Discussion
5.4.1 Parameter selection
We first present the methodology to determine the parameter settings of the classifiers. In
order to train the RBF-SVM classifiers, two hyper parameters need to be determined : the
penalty parameter C and the kernel width γ. Considering the number of features and data
for training and testing, a properly tuned RBF kernel was shown in preliminary testing to be
superior in terms of accuracy to linear kernels, even though they are simpler to use (Keerthi
and Lin, 2003).
Cross-validation was used for tuning the RBF kernel. To evaluate the performance of different
classification methods, and to find the best hyperparameters for SVM classifiers, we used a 10-
fold cross-validation strategy in each iteration. To do so, we performed 1000 iterations using
10 randomly selected subjects each time. The range of values for C and γ were analyzed
with a coarse search grid, followed by a refined search to find the optimal hyper-parameters.
The maximum in-sample validation accuracy were found at Copt = 1 and γopt = 0.1. The
tuned hyperparameters were then used to predict the out-of-sample accuracy values on the
test set. As for the PCA approach, principal components were calculated such that 95% of
the group variance was retained. Finally, the number of trees grown in each forest (t) and
the number of features (f) randomly selected at each tree node had to be determined. Based
on out-of-bag classification errors to measure stability of training, we found that t = 60 and
that f =
√
D for all the experiments, where D is the initial dimensionality of the vectors,
based on the findings of Liaw and Wiener (2002).
5.4.2 Results
We begin by presenting the results of the multi-region approach, followed by the whole-brain
approach, both using FDG-PET images. This is followed by a more detailed analysis of the
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Figure 5.4 Classification accuracies using the multi-region approach for the four clinical group pairs
based on the proposed classifiers (SVM, PCA, RBF, RF), using both baseline and longitudinal data.
longitudinal classification experiments, with the combination of two time points (baseline and
12-months). Finally, we present the comparative results between FDG-PET and AV45-PET.
In this work, we report the results of classification between six different paired classes of
cognitive states using four classifiers in two approaches (multi-region and whole-brain). The
results of four paired classes (AD vs NC, AD vs EMCI, AD vs LMCI, EMCI vs LMCI) of
cognitive states are presented in 5.4 and Figure 5.5. Considering the whole set of classifica-
tions we produced, the tables with all accuracies and additional results are presented in the
appendix.
Multi-region classification
We first used the proposed method to segment and classify the baseline based on regional
signal intensities (ROIs). As showed in the boxplots in Figure 5.4 (a) and (b), RF and RBF-
SVM demonstrated higher accuracies (over 80%). In Figure 5.4 (c) and (d), although values
were globally lower, these classifiers still had the highest accuracies (over 65%), with the
exception of the SVM classifier which has 70 % accuracy in the second visit (Figure 5.4(d)).
64
 
Figure 5.5 Classification accuracies using the whole-brain approach for the four clinical group pairs
based on the proposed classifiers (SVM, PCA, RBF, RF), using both baseline and longitudinal data.
Whole-brain classification
In comparison to the region-based approach, the whole-brain technique does not perform as
well for AD vs NC, and for AD vs EMCI as showed in Figure 5.5 (a) and (b). On the other
hand, the RF classifier for the whole-brain approach demonstrated the highest accuracies for
AD vs LMCI and EMCI vs LMCI (81.7% and 72.5% respectively) compared to the other
classifiers which were between 55% and 68.2%. These results also outperform the region-based
approach using the baseline scan for these last two pairs.
Combination of longitudinal data
The classification results using the combination of two time points in the multi-region ap-
proach were obtained by combining the second visit data to the baseline data. Based on the
literature and the previous mentioned results, we applied RBF-SVM and RF on the combined
data. The highest classification accuracy was obtained for AD vs NC based on FDG-PET
images using RBF-SVM (91.7 %) and RF (91.2 %) methods. These results are shown in
Table 5.2 and are higher than baseline and second visit results taken individually ( Figure
5.4).
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Figure 5.6 (a) shows the Receiver Operating Characteristic (ROC) curves, for the results
based on Table 5.2. Classification accuracies of AD vs NC for FDG-PET in RBF-SVM and
RF were similar but still significantly different based on student-t tests (P=0.01).
Table 5.2 Comparison in classification accuracy between FDG-PET and AV45-PET using
combination of baseline and second visit time points for all diagnostic pairs.
FDG-PET Results AV45-PET Results
RBF-SVM Random Forest P-value RBF-SVM Random Forest P-value
AD vs NC 91.7% 91.2% 0.010 90.8% 87.9% 0.024
AD vs EMCI 85.7% 85.7% 0.015 80.0% 88.0% 0.024
AD vs LMCI 87.5% 79.2% 0.016 88.9% 81.5% 0.027
EMCI vs NC 63.3% 56.7% n.a. 57.7% 59.7% n.a.
LMCI vs NC 63.5% 65.4% n.a. 61.2% 55.7% n.a.
EMCI vs LMCI 53.9% 64.1% n.a. 52.2% 56.5% n.a.
AV45-PET vs. FDG-PET
Finally, we compared the diagnostic accuracy between AV45-PET and FDG-PET images.
Table 5.2 presents the results of the multi-region approach using combined data for AV45-
PET images (right columns) compared to the results of FDG-PET images (left columns).
These results demonstrate the high accuracy of RBF-SVM and RF classifiers for AD vs NC
(90.8% vs 87.9%), AD vs EMCI (80.0% vs 88.0%) and AD vs LMCI (88.9% vs 81.5%). As for
previously mentioned for the FDG-PET results, higher accuracies were achieved when using
the combination of the two time points compared to individual time point results.
Figure 5.6 (b) illustrates the ROC curves for the classification results based on 5.2. Classi-
fication accuracies of AD vs NC for AV45-PET in RBF-SVM and RF were similar but still
significantly different (P=0.02).
5.4.3 Discussion
To the best of our knowledge, this is one of the first studies to propose a PET classification
method for stage identification in AD, comparing learned features from both AV45-PET and
FDG-PET images, while using a multi-regional approach. The objective was to assess how
a feature-learning approach focused on pre-defined sub-cortical regions with known decline
in uptake for AD patients can help achieve better accuracy and minimize the errors of an
automated classification of different stages of Alzheimer’s, especially in the early stages of
the disease. The classification results in this work are comparable and, in some cases, better
than the performances reported in the literature (Gray et al., 2012), (Zhang et al., 2011a).
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Figure 5.6 Receiver Operating Characteristic (ROC ; sensitivity vs specificity) curves for classifi-
cation between AD vs NC using longitudinal data for (a) FDG-PET images and (b) AV45-PET
images (b).
Generally, classification accuracy between AD and NC is a common banchmark to compare
different methodology performances. Classification between the different stages of MCI, na-
mely EMCI and LMCI, is a more challenging issue in this field. In fact, most publications
discriminate the MCI and AD, with fewer attempts on EMCI or LMCI (Cabral and Silveira,
2013), (Zhang et al., 2011a), (Rodrigues and Silveira, 2014). Considering the importance of
having the results of early and late stages of MCI versus NC, we conducted additional ex-
periments to demonstrate that the models can indeed discriminate between early and late
stages of MCI.
We demonstrated that AV45-PET images as well as FDG-PET images offer relevant infor-
mation to yield classification results, which are comparable to models using imaging and
non-imaging data (Zhang et al., 2011a), (Hinrichs et al., 2009). Results were slightly better
with FDG-PET due to increased spatial resolution in the image, which helps to delineate the
localized structures affected by AD.
Regarding the atlas registration step, it was crucial to choose an atlas offering all segments
of the brain anatomy which would be included in our predefined ROIs. To achieve this
purpose, we explored a number of different atlases such as the Harvard-oxford cortical and
subcortical structural atlas (Gorgolewski et al., 2016), the Talairach atlas (Lancaster et al.,
2000) (Lancaster et al., 1997b), the MNI152 structural atlas (Collins et al., 1998) and the
automated anatomical labelling (AAL) atlas (Tzourio-Mazoyer et al., 2002). Among all four
atlases, only MNI152 includes all 10 ROIs of interest which are labelled by AAL, which
segments the brain image into 116 cortical and subcortical regions. Therefore, the MNI152
atlas combined with AAL was selected for the purposes of our pipeline.
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The results obtained in this study using the ADNI-PET images were similar to previous works
(Gray et al., 2012), (Aidos et al., 2014a), which also used VI as features. This confirms the
high diagnostic power of uptake values in discriminating between different cognitive stages,
particularly by integrating a progression component using time series features to the analysis.
To achieve these results, multi-modal registration played another key role to properly align
both PET and MRI. The FLIRT tool is able to register intra and inter-modal brain images
without extracting or segmenting the whole volume of the brain, which is convenient for pro-
cessing large cohorts of patients with the proposed pipeline, by using automated registration
for all subjects. Table 5.1 displays the MMSE for both groups of AD and NC for the two
time points. It confirms a significant progression of the disease from baseline to second visit
exam as observed in the results of the two approaches.
Results using PCA-SVM sees little changes in most diagnostic pairs between baseline and
second visit, compared to RBF-SVM or RF classifiers. This indicates that the additional PET
features provided in the longitudinal scans are non-linear features better detected by kernel-
or learning-based methods. From these results, we can also interpret that combining second
visit data provides additional information to discriminate between the classes compared to
the baseline data. Finally, when comparing both the ROIs and whole-brain approaches, re-
sults at each time point individually were better with the ROIs method, except when using
the linear SVM classifier. The combination between cross-sectional and longitudinal infor-
mation achieved very good accuracy for AD compared with other classes but as presented in
Table 5.2 for EMCI vs NC, LMCI vs NC and EMCI vs LMCI, it is not as adequate as with
longitudinal data alone.
5.5 Conclusion
In this work, we compared both whole-brain and multi-region approaches to identify stages
of AD using FDG-PET and AV45-PET. We observed that the classification accuracy of
AD vs NC was improved using longitudinal images, as well as to other pairs of cognitive
classes. Either FDG-PET or AV45-PET enabled to discriminate early and late MCI from
AD, as well as to NC. The methodologies used in this work can contribute to improving the
classification accuracy between different stages of AD by using the combination of two time
points. Our results confirm that we can rely on PET images only, without the addition of
other biomarkers to achieve high accuracy classification. Results were shown to be favorable
or better compared to previous studies, especially for the more challenging classification
problems such as NC vs. EMCI, AD vs. LMCI or EMCI vs. LMCI. Future work will involve
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combining additional biomarkers such as cortical thickness data, volume, voxel-wise tissue
probability and density of gray matter, in comparison with deep classifiers and other state-
of-the-art AD classification approaches. In the context of Alzheimer’s disease, the method
can improve for the early detection of the disease with promising classification rates based
on ground-truth knowledge.
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CHAPTER 6 ADDITIONAL RESULTS
This chapter presents additional results on our experiments, which were achieved and were
not presented in our submitted paper. Additional results include cross validation results
of registration methods, different resolutions of our subject images, classification results of
individual ROIs, effects of calculating mean VI for each ROI on final accuracy, and trial
classification on PET images without registration by MRI.
6.1 Cross validation results of registration
Inter-modality registration was a crucial step of our pipeline. Therefore, choosing a registra-
tion tool for this step has been particularly important. As mentioned in Chapter 4, FLIRT
was the tool used for this step. This tool is validated by the authors and is published (Jenkin-
son and Smith, 2001), (Jenkinson et al., 2002). However, the results of registration between
PET and MRI, using the SPM tool and FSL tool (FLIRT) were compared to the measured
errors. To compare the errors, we used the same method that Kiebel et al. (1997) applied
on AIR and SPM tools. The cross validation was executed on six subjects with FDG-PET
and MRI from the ADNI database, including three AD and three NC images. Registration
between PET and MRI using two tools (SPM and FLIRT) in four different configurations
of cost function and mode is presented in Table 6.1 . Each iteration obtained a registration
transformation matrix (RTM) ; in total, we had 24 RTMs for each tool. Figure 6.1 shows an
example of the resulting registration between PET and MRI using FLIRT, and Figure 6.2
shows an example using SPM12. There is no common gold standard for registration between
PET and MRI. Thus, to compare with the gold standard, we used the same method as similar
works, using PET simulated based on corresponding MRI (Kiebel et al., 1997), (Grova et al.,
2001).
The simulated PET images were generated by the method proposed by Kiebel et al. (1997).
The sequences of this method are scalp editing and segmenting the MRI images into GM,
WM, and CSF, which is done using the Seg3D tool version 1.10.0 (1993-2008 Scientific Com-
puting and Imaging Institute, University of Utah). After that, we modified the GM, WM,
and CSF intensities. Next, a rigid body or affine transformation and resampling to the PET
voxel size was applied, and RTM was saved for further comparisons. At the end, 8 mm
FWHM Gaussian filter was used to make the image smooth and to remove the noise. The
only difference between our repeating the Kiebel method was doing 16 iterations for each
image. For more details on the method, refer to the work by Kiebel et al. (1997). To choose
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the best configuration (method and cost function) we compared the error of transformation
matrices for 4 configurations in 16 iterations on 6 different subjects. The results are 96×4
matrices. For each subject we have 4 configurations which obtained 24 registration transfor-
mation matrices to compare the minimum landmark error. Table below present the min error
of differentiation between the registration results and gold standard for each configuration.
We obtained the same trend of the results for different iterations.
Table 6.1 Configuration of cost function and model of registration
Iteration Cost function model of registration Results
1 mutual information affine (12 parameters) -0.89 0.05 0.03 167.72
-0.04 -0.85 -0.26 229.43
0.01 -0.19 0.87 -22.22
2 correlation ratio rigid body (6 parameters) 0.84 -0.01
0.02 0.85
-0.03 -0.10
3 mutual information rigid body (6 parameters) 0.96 -0.03
0.02 0.87
-0.04 -0.19
4 correlation ratio affine (12 parameters) 0.85 -0.03 0.02 -0.52
0.02 0.79 0.23 -24.58
-0.03 -0.17 0.83 -25.92
Figure 6.1 Example of result registration between PET and MRI using FLIRT.
To achieve the total error of registration, we compared nine members of RTM (translation,
rotation, and scaling) to the transformation matrix, which was obtained by simulated PET.
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Figure 6.2 Example of result registration between PET and MRI using SPM12.
First, we chose the best configuration of registration, which gave a smaller error of transforma-
tion. Registration with affine with the correlation ratio cost function was chosen in both tools.
Table 6.2 Comparison registration error (SPM and FLIRT)
tool Mean error of SPM Mean error of FLIRT
Registration 1.15 0.05 -0.06 0.98 0.04 -0.02
Transformation -0.06 1.13 -0.26 -0.05 0.95 -0.25
Matrices 0.05 0.27 1.18 0.01 0.26 0.94
We then evaluated the results between registration tools (SPM and FLIRT). Table 6.2
illustrates the errors of registration. Finally, based on these results, we chose the FSL tool
for our pipeline.
6.2 Classification Results
6.2.1 PET Images (1 mm)
We designed our pipeline independent of the resolution of images. We downloaded all images
from ADNI in two resolutions (1 mm and 2 mm) for PET and MRI images. After obtaining
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Table 6.3 Classification accuracy of FDG-PET images with 1 mm resolution using four clas-
sifiers.
AD vs. NC AD vs. EMCI AD vs. LMCI
Approache I II I II I II
Linear-SVM 75.05 83.33 66.67 80.05 65.10 60.09 †/ † /†
PCA-SVM 66.67 75.12 61.67 61.67 53.33 61.01 †/ † /†
RBF-SVM 78.33 76.66 70.19 75.01 66.07 65.67 n.a.
RF 86.35 82.33 82.36 80.39 73.21 68.33 †/ † /†
EMCI vs. NC LMCI vs. NC EMCI vs. LMCI
Approache I II I II I II
Linear-SVM 63.33 60.56 58.33 56.67 65.02 50.62 †/ † /†
PCA-SVM 55.01 64.52 50.25 51.67 65.02 53.52 †/ † /†
RBF-SVM 61.64 65.01 62.56 63.33 53.62 51.67 n.a.
RF 66.67 63.10 65.22 65.38 65.22 72.46 †/ † /†
our results, the results of the 2-mm images had higher accuracy. Nevertheless, the results of
images with 1-mm resolution had acceptable accuracy in some classes. Table 6.3 details the
summary of all results of 1-mm images. In this Table, † stands for p<0.001, approach I is
multi-region and approach II represent whole brian method.
6.2.2 Individual Region of Interest
In this section, we display the classification results of linear SVM for 1-mm FDG-PET to test
the effects of each ROI individually. We should mention that the results in Table 6.4 are not
significant and only compare the effects of each region. The best result with 68% accuracy
was for the lateral temporal lobe between AD and NC. Most of the regions obtained close to
chance, indicating they are not reliable to classify the subjects individually
Table 6.4 Classification accuracy of each region of interest by linear SVM individually on
FDG-PET image.
AD vs. NC AD vs. EMCI AD vs. LMCI EMCI vs. NC LMCI vs. NC EMCI vs. LMCI
Cingulum_Ant 63.27 62.00 45.71 52.64 50.98 52.27
Cingulum_Post 59.18 52.00 48.57 45.14 57.00 51.19
Frontal_Mid_Orb 53.06 53.37 51.67 55.56 55.10 49.52
Precuneus 63.33 48.33 50.00 56.15 51.28 42.00
Temporal_Mid 68.00 50.98 56.00 52.00 59.42 46.00
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6.2.3 Mean Voxel Intensity
To test the other features studied in literature, the mean VI was tested for three classifiers
(linear SVM, RBF-SVM, and RF). Table 6.5 presents the classification results of 2-mm
FDG-PET images. These results were obtained using only the multi-region approach, and
the mean VI were calculated by each region. As it shows, RF yielded the best accuracy ;
however, RBF-SVM also was close to high accuracy.
Table 6.5 Classification accuracy of mean voxel intensity for the multi-region approach on
FDG-PET images.
AD vs. NC AD vs. EMCI AD vs. LMCI EMCI vs. NC LMCI vs. NC EMCI vs. LMCI
Linear SVM 55.00 60.00 60.00 48.33 58.33 51.67
RBF-SVM 68.33 62.74 66.07 52.05 51.28 56.52
RF 75.00 72.55 60.71 58.90 58.97 60.87
6.2.4 PET Images without Registration by MRI
Registration between PET and MRI had a very important role in obtaining high accuracy
because of helping to segment different brain anatomies precisely. To understand the im-
portance of the MRI role, we executed the same pipeline on 2-mm PET images without
registering to MRI. The results were relevant but not comparable with the MRI registered
pipeline. The results classified by linear SVM are shown in Table 6.6
Table 6.6 Classification accuracy of non MRI registration using Linear SVM.
AD vs. NC AD vs. EMCI AD vs. LMCI EMCI vs. NC LMCI vs. NC EMCI vs. LMCI
Linear SVM 80.00 75.00 63.33 56.67 53.33 53.33
The average accuracy of all classes was 63.61%, which was lower than the average of 65.83%
when we used MRI images to recognize the brain anatomies in the multi-region approach.
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CHAPTER 7 GENERAL DISCUSSION
7.1 Evaluation of the Result Using ADNI Images
The results obtained in this study using the ADNI-PET images were similar to previous
work (Gray et al., 2012), (Aidos et al., 2014a). We demonstrated that AV45-PET images as
well as FDG-PET images had relevant information to obtain classification results that are
comparable to the imaging and non-imaging classification of data. This important result was
achieved using the ADNI database, which has been used in previous studies (Zhang et al.,
2011a), (Hinrichs et al., 2009), and our results are close and in some cases better than the
state-of-the-art technology. Based on our literature, there is no proposed method of classi-
fication for both AV45-PET and FDG-PET images with the same method that has yielded
comparable results. In addition, the result of the combination of two time points demonstra-
ted better performance in line with our state-of-the-art method.
The additional results of our experiments that were presented in Chapter 6 are much more
than what we displayed in our submitted paper. As shown, two different resolutions were
examined in all steps of our pipeline, which means our subjects were downloaded in 1-mm
and 2-mm resolutions from the ADNI database. The PET and MRI images in 1 mm, despite
including more voxels (7221032 voxels), did not obtain results better than the 2-mm images.
It could be due to our method in the registration and segmentation that made the images
uniform, specifically for atlas registration to have all images comparable in the atlas space.
Interpretation of our results was done using the diagnostic list of the ADNI database. Overall,
660 subjects had definitive diagnoses, including the MMSE score for each subject. We consi-
dered the conversion for all sample sets ; no conversion was reported among our data sample.
Comparing the disease progression to the longitudinal MMSE score made us sure about the
overall results of the classification accuracy. Higher accuracy in the second visit, especially
for distinguishing between AD and NC, was completely logical because brain changes, such
as atrophy and neuron loss, in patients with AD after approximately 12 months made a
clear difference in the NC subjects, whereas these brain changes for discriminating between
EMCI and LMCI were more intense than the baseline. However, the overall results of the
combination of two time points were better than the single time point.
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7.2 Effect of Data Processing on the Results
Data processing in our pipeline included registration and segmentation, which, based on our
experiments, were crucial steps for obtaining higher accuracies. To choose the best scenario
for obtaining the best results, we applied another version of our pipeline for PET images
without MRI registration, and the results were not more accurate than when we registered
PET images with the corresponding MRI (results presented in Chapter 6). Moreover, for
the feature extraction step, we used the mean VI in each ROI individually, and it gave us a
very simple matrix of 660 × 10, which was not a good representation of each class to train
the classifiers. Finding the most relevant ROIs was a very effective step in the classification
results. There are some studies that tested different brain regions to discover whether we
can rely on those ROIs for classifying the PET images (Gray et al., 2012), (Carbonell et al.,
2015). In this work, we selected our ROIs based on our literature and after testing, which
gave us comparable results. In a comprehensive workshop of PET, which was held in McGill
University (2016), we confirmed these ROIs for AV45-PET and FDG-PET by personal com-
munication with Dr. Peter Herscovitch, chief of the PET Department at the NIH Clinical
Center. As presented in Chapter 6, the individual effects of each region were not satisfactory.
However, there were some regions that had more effects on the results. Therefore, after some
testing, we decided to create a whole-brain mask including all ROIs.
We demonstrated the results of cross validation between the two tools of registration in
Chapter 6. To achieve the more accurate results, multi-modal registration played a key role
to properly align both the PET and MRI. The FLIRT tool can register intra- and inter-
modal brain images without extracting or segmenting the whole volume of the brain, which
is convenient for processing large cohorts of patients with the proposed pipeline using auto-
mated registration for all subjects.
In the atlas registration step, we were looking for an atlas with segments of brain images,
which was included in our predefined ROIs. To achieve this purpose, we explored different
available atlases, such as the Harvard-Oxford cortical and subcortical structural atlases, the
Talairach atlas, the MNI152 structural atlas, and the automated anatomical labelling atlas.
Among all four atlases, only the MNI152 atlas includes all 10 ROIs, which are labelled by the
AAL atlas that segments the brain image into 116 cortical and subcortical regions. Therefore,
the MNI152 atlas combined with AAL was selected for the purposes of our pipeline.
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7.3 Comparison of Existing Classification Methods
Classification between AD and NC is relatively simple, while EMCI vs LMCI is the most
difficult and has received relatively little attention in the previous studies. In fact, most pu-
blications discriminate the MCI and AD, with fewer attempts on EMCI or LMCI (Cabral
and Silveira, 2013), (Zhang et al., 2011a), (Zhang et al., 2011b), (Rodrigues and Silveira,
2014). However, to obtain more relevant results, we conducted additional experiments to
demonstrate that the models can indeed discriminate between early and late stages of MCI
applied by four classifiers.
As we mentioned in our literature, different classification methods, primarily in the domain
of AD using PET images used VI as a feature. There are several techniques to use VI ; some
publications (like our proposed method) directly used the value of VI compared to other
subjects’ voxels (Habeck et al., 2008), (Zhang et al., 2011a). Previous studies showed, despite
the passage of time and the improvement of imaging techniques, not only have the effects
of using VI in classification not decreased, but VI has become one of the main features of
PET images (Gray et al., 2013), (Aidos et al., 2014a), (Román and Pascual, 2012). This
confirms the high diagnostic power of uptake values in discriminating between different cog-
nitive stages, particularly by integrating a progression component using time series features
to the analysis.
It is prevalent to apply more than one classifier, such as different kernels of SVMs or RF
in many studies, regardless of using different material (PET or MRI images) (Cabral and
Silveira, 2013), (Dolph et al., 2014), (Tong et al., 2017), whereas some studies were satisfied
using only one, like SVM (Gray et al., 2012), (Liu et al., 2016). This is despite the fact that
we used two classifiers in four methods (linear SVM, PCA-SVM, RBF-SVM, and RF), and
they were tuned up by 10-fold cross validation.
We used PCA to reduce the dimension of our matrix for two approaches. In the first ap-
proach (multi-region approach), we selected 10 ROIs ; consequently, we had less voxels for
each subject. To give an example, after excluding the non-ROIs voxels using our method,
which is explained in Chapter 6, the matrix dimension is 660 × 179625. However, in the
whole-brain approach, despite using a large volume of memory, the matrix has dimensions of
660× 7221032, which are not suitable to train the classifiers. To solve this problem, we used
PCA to reduce the dimensions. With different iterations, we found the optimum number of
PCs, which was about the first 20 PCs. Then, we trained the linear SVM by the matrix of
PCA reduced (660× 20, 20 PCs for each subject). Except for some occasional cases, our re-
sults of PCA-SVM were not higher than other classifiers. We should mention that PCA-SVM
was tested for the multi-region approach too, and its results are displayed in Chapter 5.
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Our work proposed the pipeline for processing images, extracting the features and classifying
the subjects based on FDG-PET images. In addition, our pipeline applied to AV45-PET
images as well, which obtained comparable accuracy without changing on our methodology.
In contrast, the work of Carbonell et al. (2015) used amyloid-PET images and more statistical
information (MMSE, ADAS-Cog, CSF, gender, clinical classification and APOE genotype).
The purpose of the classification approach in our work was discriminating between 6 dif-
ferent cognitive pair classes, whereas, the work of Carbonell et al. (2015) compared 2 pair
classes, concentrating on high versus low level of amyloid. Carbonell and colleagues used the
mean standard uptake value ratio (SUVr) as a feature. The authors tested different cut off
values on mean SUVr for each region and composite of regions to find the optimal threshold.
Nevertheless, in our work voxel intensity was used as a direct feature, which enabled us to
discriminate between different classes by combining the 10 ROIs together as a target segment
of whole image. In addition, our extracted ROIs from PET images based on our pipeline is
automated by choosing the interest labels (according to the list of cortical brain structures),
segmented regions will be available individual or combined. Regarding the methodology, we
compared our work with similar works having used the same method of classification and ex-
tracting the features. Despite the fact that the paper of Carbonell et al (2015) reported high
accuracy, they are not applying similar classifier (RDA classifier used), and there is no more
details of the test and training data. In addition, they used different segmentation in order to
extracting CSF and did not use structural segmentation for finding ROI, their target ROIs
were instead segmented on whole cortical SUVr. They did not mention the performance me-
trics (only EMCI vs LMCI and AD vs NC) and how they calculated the accuracy of results.
However, we can use RDA classifier in future work as it may give high accuracies.
7.4 Limitations and Future Work
Several limitations exist in this study. First, there are many other biomarkers and data
sources that are useful for AD or MCI distinction, such as cortical thickness data, volume,
voxel-wise tissue probability, density of GM, CSF, and APOE. As our hypothesis was using
only PET images, the current study was limited to two modalities of MRI, PET (FDG and
AV45). Second, the proposed method was only designed to compare the results of FDG-PET
and AV45-PET, whereas the Pittsburgh compound B PET images have a great deal of in-
formation to discriminate between AD and NC (Fu et al., 2014), (Zhang et al., 2014). Third,
we used VI as a feature, which was not appropriate for either the whole-brain approach or
for 1-mm resolution images. Other feature selection methods, such as taking samples of sub-
regions in each ROI, need further investigation. Fourth, we did not have the chance to use
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anatomical segmentation methods in the subject space (in this work, we use atlas space) ; if
so, we could achieve more precise regions without deforming the primary images.
Future work will involve covering the limitations as much as possible, mainly combining addi-
tional biomarkers in comparison with deep classifiers and other state-of-the-art AD classifica-
tion approaches. The MRI scan has a cortical and subcortical variety information ; therefore,
using multi-modal methods could have an accuracy-increasing benefit. In the context of AD,
the method can improve the early detection of the disease with promising classification rates
based on ground-truth knowledge.
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CHAPTER 8 CONCLUSION AND RECOMMENDATIONS
In this work, we have introduced a new pipeline for classifying different stages of MCI and
AD vs NC using PET images. Two common tracers, FDG-PET and AV45-PET, were under
investigation and obtained the good results using the same pipeline. Our method included
two approaches (multi-region and whole-brain) in two time points (baseline and second visit).
Our results showed that we answered our research question. We extracted and selected some
features from PET images to classify our subjects accurately. The methods used are valid
and common ; however, it enabled us to obtain accurate results.
Because of the large number of voxels in the whole-brain approach, we were not able to com-
bine the data of the two time points to be able to compare the results of the two approaches.
Preprocessing the data plays an important role in achieving correct efficient classification.
Thus, using more robust tools for co-registration between PET and MRI, such as ANT or
SPM12 instead of FLIRT, despite having a large number of subjects and taking more time to
register, may give more accurate results. In the same way, for segmentation based on atlas, we
recommend using multi-atlas instead of single atlas methods, provided that different atlases
include all ROIs.
As stated in some studies, the ANN has shown success in a variety of classification tasks, in-
cluding PET. Therefore, in future work, we can try to use the ANN classifier to compare with
our current results. Having the ability to classify different stages of MCI and differentiate
AD vs NC, it seems possible to predict the progression of AD in subjects using longitudinal
PET images.
80
REFERENCES
ADNI, “Alzheimer’s Disease Neuroimaging Initiative.” 2014. En ligne : http:
//adni.loni.usc.edu/.
H. Aidos, J. Duarte, et A. Fred, “Identifying regions of interest
for discriminating Alzheimer’s disease from mild cognitive impairment.”
2014 IEEE International Conference on Image Processing, ICIP 2014,
pp. 21–25, 2014. En ligne : http://camoes.lx.it.pt/pia/GroupPapers/
Alzheimer/IdentifyingregionsofinterestfordiscriminatingAlzheimer’
sdiseasefrommildcognitiveimpairment.pdf
H. Aidos, A. L. N. Fred, H. Aidos, et A. Fred, “Finding Coherent Regions in PET
Images for the Diagnosis of Alzheimer’s Disease.” Proceedings of the International
Conference on Bioimaging, no. January 2015, pp. 12–18, 2014. En ligne : http:
//www.scitepress.org/DigitalLibrary/Link.aspx?doi=10.5220/0004802200120018
M. S. Albert, S. T. DeKosky, D. Dickson, B. Dubois, H. H. Feldman, N. C.
Fox, A. Gamst, D. M. Holtzman, W. J. Jagust, R. C. Petersen, P. J. Snyder,
M. C. Carrillo, B. Thies, et C. H. Phelps, “The diagnosis of mild cognitive
impairment due to Alzheimer’s disease : Recommendations from the National Institute
on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s
disease.” Alzheimer’s and Dementia, vol. 7, no. 3, pp. 270–279, 2011. En ligne :
http://dx.doi.org/10.1016/j.jalz.2011.03.008
G. E. Alexander et J. R. Moeller, “Application of the scaled subprofile model to functional
imaging in neuropsychiatric disorders : A principal component approach to modeling brain
function in disease.” Human Brain Mapping, vol. 2, no. 1-2, pp. 79–94, 1994.
G. E. Alexander, K. Chen, P. Pietrini, S. I. Rapoport, et E. M. Reiman, “Longitudinal
PET evaluation of cerebral metabolic decline in dementia : A potential outcome measure
in Alzheimer’s disease treatment studies”, American Journal of Psychiatry, vol. 159, no. 5,
pp. 738–745, 2002.
A. Alzheimer’s Association, “2016 Alzheimer’s Disease Facts and Figures,Report.”
2016. En ligne : https://www.alz.org/documents_custom/2016\T1\textendashfacts\
81
T1\textendashand\T1\textendashfigures.pdf
L. G. Apostolova et P. M. Thompson, “Mapping progressive brain structural changes in
early Alzheimer’s disease and mild cognitive impairment.” Neuropsychologia, vol. 46, no. 6,
pp. 1597–1612, 2008.
J. Ashburner, “A fast diffeomorphic image registration algorithm.” NeuroImage, vol. 38,
no. 1, pp. 95–113, 2007.
J. Ashburner et K. J. Friston, “Nonlinear spatial normalization using basis functions.” Hu-
man Brain Mapping, vol. 7, no. 4, pp. 254–266, 1999.
——, “Voxel-Based Morphometry—The Methods.” NeuroImage, vol. 11, no. 6, pp. 805–821,
2000. En ligne : http://linkinghub.elsevier.com/retrieve/pii/S1053811900905822
J. W. . L. S. Baker, S., “FDG-PET and memory tests best predict Alzheimer’s.
Retrieved from aunt minnie.” auntminnie, On line, vol. 6, 2010. En ligne :
http://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=91172
S. Barrack, Neuroimaging biomarkers in Alzheimer’s disease., 1er éd. iMedPub, 2013.
R. J. Bateman, C. Xiong, T. L. S. Benzinger, A. M. Fagan, A. Goate, N. C. Fox, D. S.
Marcus, N. J. Cairns, X. Xie, T. M. Blazey, D. M. Holtzman, A. Santacruz, V. Buckles,
A. Oliver, K. Moulder, P. S. Aisen, B. Ghetti, W. E. Klunk, E. McDade, R. N. Martins,
C. L. Masters, R. Mayeux, J. M. Ringman, M. N. Rossor, P. R. Schofield, R. A. Sperling,
S. Salloway, et J. C. Morris, “Clinical and biomarker changes in dominantly inherited
Alzheimer’s disease.” The New England journal of medicine, vol. 367, no. 9, pp. 795–804,
2012. En ligne : http://dx.doi.org/10.1056/NEJMoa1202753
C. M. Bauer, “Multimodal analysis in normal aging, mild cognitive impairment, and
Alzheimer’s disease : Group differentiation, baseline cognition, and prediction of future
cognitive decline.” Dissertation Abstracts International : Section B : The Sciences and
Engineering, vol. 75, no. 2-B(E), pp. No–Specified, 2014. En ligne : http://gateway.
proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:
dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:35753075Cnhttp://ovidsp.
ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=psyc11&NEWS=N&AN=2014-99160-291
O. Ben Ahmed, J. Benois-Pineau, M. Allard, C. Ben Amar, et G. Catheline, “Classification
of Alzheimer’s disease subjects from MRI using hippocampal visual features.” Multimedia
Tools and Applications, vol. 74, no. 4, pp. 1249–1266, 2014.
82
D. P. Bertsekas et J. N. Tsitsiklis, Neuro-Dynamic Programming, 1er éd. Athena Scientific,
1996.
C. M. Bishop, Pattern Recognition and Machine Learning (Information Science and Statis-
tics). New York, : Springer-Verlag, 2006.
brainimaging, “Feature extraction.” 2017. En ligne : http://brainimaging.waisman.
wisc.edu/~oakes/teaching/coreg_software_comparison.html
C. Brayne, “Research and Alzheimer’s disease : an epidemiological perspective [editorial].”
Psychol.Med., vol. 23, no. 2, pp. 287–296, 1993.
L. Breiman, “Bagging Predictors.” Machine Learning, vol. 24, no. 421, pp. 123–140, 1996.
——, “Random forests.” Machine Learning, vol. 45, no. 1, pp. 5–32, 2001.
L. Breiman, J. Friedman, C. J. Stone, et R. Olshen, Classification and Regression Trees.
Mathematics, 1984.
A. E. Budson et N. W. Kowall, The Handbook of Alzheimer’s Disease and Other Dementias.
Oxford, UK, : Wiley-Blackwell, 2011, ch. 1. Alzheimer’s Disease., pp. 1–91.
T. Bylander, “Estimating generalization error on two-class datasets using out-of-bag esti-
mates”, Machine Learning, vol. 48, no. 1-3, pp. 287–297, 2002.
C. Cabral et M. Silveira, “Classification of Alzheimer’s disease from FDG-PET images using
favourite class ensembles.” Conference proceedings : Annual International Conference of the
IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and
Biology Society. Annual Conference, vol. 2013, pp. 2477–2480, 2013.
CaliSun, “What is the role of the Somatosensory Association Cortex.” 2013. En ligne :
https://www.memrise.com/user/CaliSun/mems/created/page=7
F. Carbonell, A. P. Zijdenbos, A. Charil, M. Grand’Maison, et B. J. Bedell, “Optimal
Target Region for Subject Classification on the Basis of Amyloid PET Images.” Journal
of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 56, no. 9, pp.
1351–8, 2015. En ligne : http://www.ncbi.nlm.nih.gov/pubmed/26135108
A. Chaddad, C. Desrosiers, et M. Toews, “LOCAL DISCRIMINATIVE CHARACTERI-
ZATION OF MRI FOR ALZHEIMER ’ S DISEASE´”, Isbi, pp. 1–5, 2016.
83
J. M. Chalovich et E. Eisenberg, “Apolipoprotein E and Alzheimer disease : risk, mecha-
nisms, and therapy.” Biophysical Chemistry, vol. 257, no. 5, pp. 2432–2437, 2005.
P. Chetsadaporn, M. Kolber, P. Ramchandra, M. Moghbel, S. Houshmand, M. Schöll, H. Bai,
T. J. Werner, A. Alavi, et C. Buchpiguel, “Multimodality Imaging Approach in Alzheimer
disease, Part I : Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magneti-
zation Transfer Imaging.” Dementia & Neuropsychologia, vol. 9, no. 4, pp. 318–329, 2015.
N. Chumchob et K. Chen, “A robust affine image registration method.” International Jour-
nal of Numerical Analysis and Modeling, vol. 6, no. 2, pp. 311–334, 2009.
M. Chupin, A. Hammers, R. Liu, O. Colliot, et al., “Automatic segmentation of the hippo-
campus and the amygdala driven by hybrid constraints : method and validation.” Neuroi-
mage, vol. 46, no. 3, pp. 749–761, 2009.
D. L. Collins, a. P. Zijdenbos, V. Kollokian, J. G. Sled, N. J. Kabani, C. J. Holmes, et a. C.
Evans, “Design and construction of a realistic digital brain phantom.” IEEE transactions
on medical imaging, vol. 17, no. 3, pp. 463–468, 1998.
C. Cortes et V. Vapnik, “Support-Vector Networks.” Machine Learning, vol. 20, no. 3, pp.
273–297, 1995.
L. Crews et E. Masliah, “Molecular mechanisms of neurodegeneration in Alzheimer ’ s
disease.” HMG Advance Access, vol. 19, no. 1, pp. 12–20, 2010.
G. Cybenko, “Approximation by superpositions of a sigmoidal function.” Mathematics of
Control, Signals and Systems, vol. 2, p. 303–314, 1989.
P. Dayan et L. F. Abbott, “Theoretical Neuroscience : Computational and Mathematical
Modeling of Neural Systems.” MIT press, Computational Neuroscience, p. 480, 2001.
S. De Santi, M. J. De Leon, H. Rusinek, A. Convit, C. Y. Tarshish, A. Roche, W. H. Tsui,
E. Kandil, M. Boppana, K. Daisley, G. J. Wang, D. Schlyer, et J. Fowler, “Hippocampal
formation glucose metabolism and volume losses in MCI and AD”, Neurobiology of Aging,
vol. 22, no. 4, pp. 529–539, 2001.
R. S. Desikan, H. J. Cabral, C. P. Hess, W. P. Dillon, C. M. Glastonbury, M. W. Weiner,
N. J. Schmansky, D. N. Greve, D. H. Salat, R. L. Buckner, et al., “Automated MRI measures
identify individuals with mild cognitive impairment and Alzheimer’s disease.” Brain, p.
awp123, 2009.
84
I. Despotovic, B. Goossens, et W. Philips, “MRI Segmentation of the Human Brain : Chal-
lenges , Methods , and Applications.” Computational and Mathematical Methods in Medi-
cine, vol. 2015, p. 23.
M. M. Dessouky et T. E. Taha, “Selecting and Extracting Effective Features for Automated
Diagnosis of Alzheimer ’ s Disease.” International Journal of Computer Applications, vol. 81,
no. 4, pp. 17–28, 2013.
T. G. Dietterich, “Experimental comparison of three methods for constructing ensembles
of decision trees : bagging, boosting, and randomization.” Machine Learning, vol. 40, no. 2,
pp. 139–157, 2000. En ligne : http://en.scientificcommons.org/426370985Cnuuid/
7906280C-AEF8-405A-9A94-6BAA1DDAED1E
C. V. Dolph, M. D. Samad, et K. M. Iftekharuddin, “Classification of Alzheimer’s disease
using structural MRI.” Proc MICCAI workshop challenge on computer-aided diagnosis of
dementia based on structural MRI data, pp. 31–37, 2014.
S. Duchesne, A. Caroli, C. Geroldi, C. Barillot, G. B. Frisoni, et D. L. Collins, “MRI-
based automated computer classification of probable AD versus normal controls”, IEEE
Transactions on Medical Imaging, vol. 27, no. 4, pp. 509–520, 2008.
R. Duda, P. Hart, et D. Stork, “Pattern Classification.” New York : John Wiley, Section,
p. 680, 2001.
A. S. El-Baz, R. Acharya U, A. F. Laine, et J. S. Suri, Multi Modality State-of-the-Art
Medical Image Segmentation and Registration Methodologies - Volume II. NewYork, USA, :
Springer., 2015.
A. Elnakib, G. Gimel’farb, J. S. Suri, et A. S. El-Baz, Multi Modality State-of-the-Art
Medical Image Segmentation and Registration Methodologies - Volume II. NewYork, USA, :
Springer., 2015, ch. 1. Medical Image Segmentation : A Brief Survey., pp. 1689–1699.
B. Fischl, D. H. Salat, E. Busa, M. Albert, M. Dieterich, C. Haselgrove, A. Van Der Kouwe,
R. Killiany, D. Kennedy, S. Klaveness, et al., “Whole brain segmentation : automated labe-
ling of neuroanatomical structures in the human brain.” Neuron, vol. 33, no. 3, pp. 341–355,
2002.
B. Fischl, D. H. Salat, E. Busa, M. Albert, M. Dieterich, C. Haselgrove, A. van der
Kouwe, R. Killiany, D. Kennedy, S. Klaveness, A. Montillo, N. Makris, B. Rosen,
Dale, et M. Anders, “Whole Brain Segmentation : Neurotechnique Automated
85
Labeling of NeuroanatomicalStructures in the Human Brain.” Neuron, vol. 33, no. 3,
pp. 341–355, 2002. En ligne : http://eutils.ncbi.nlm.nih.gov/entrez/eutils/
elink.fcgi?dbfrom=pubmed&id=11832223&retmode=ref&cmd=prlinks5Cnpapers2:
//publication/uuid/23BE8334-219B-4E46-AE68-C9D02B8AC109
Food and Drug Administration, “Update - New Fludeoxyglucose F 18 Injection PET
Drug Approved in Less than 6 Months.” 2014. En ligne : http://www.fda.gov/Drugs/
DevelopmentApprovalProcess/Manufacturing/ucm182642.htm
N. L. Foster, J. L. Heidebrink, C. M. Clark, W. J. Jagust, S. E. Arnold, N. R. Barbas, C. S.
DeCarli, R. Scott Turner, R. A. Koeppe, R. Higdon, et S. Minoshima, “FDG-PET improves
accuracy in distinguishing frontotemporal dementia and Alzheimer’s disease.” Brain, vol.
130, no. 10, pp. 2616–2635, 2007.
N. C. Fox, P. A. Freeborough, et M. N. Rossor, “Visualisation and quantification of rates
of atrophy in Alzheimer’s disease.” Lancet, vol. 348, no. 9020, pp. 94–97, 1996.
G. B. Frisoni, N. C. Fox, C. R. Jack, P. Scheltens, et P. M. Thomp-
son, “The clinical use of structural MRI in Alzheimer disease.” Na-
ture Reviews Neurol., vol. 6, no. 2, pp. 67–77, 2010. En ligne : http:
//www.nature.com/nrneurol/journal/v6/n2/abs/nrneurol.2009.215.html5Cnhttp:
//discovery.ucl.ac.uk/144642/5Cnhttp://dx.doi.org/10.1038/nrneurol.2009.215
K. J. Friston, J. Ashburner, C. D. Frith, J.-B. Poline, J. D. Heather, et R. S. J.
Frackowiak, “Spatial registration and normalization of images.” Human Brain Mapping,
vol. 3, no. 3, pp. 165–189, 1995. En ligne : http://onlinelibrary.wiley.com/doi/10.
1002/hbm.460030303/abstract5Cnhttp://doi.wiley.com/10.1002/hbm.460030303
L. Fu, L. Liu, J. Zhang, B. Xu, Y. Fan, et J. Tian, “Comparison of dual-biomarker PIB-PET
and dual-tracer PET in AD diagnosis.” European Radiology, vol. 24, no. 11, pp. 2800–2809,
2014.
S. Furber et S. Temple, “Neural systems engineering.” Journal of the Royal Society, Interface
/ the Royal Society, vol. 4, no. 13, pp. 193–206, 2007.
F. H. Gage, “Structural plasticity of the adult brain.” Dialogues in Clinical Neuroscience,
vol. 6, no. 2, pp. 135–141, 2004.
K. J. Gorgolewski, G. Varoquaux, G. Rivera, Y. Schwartz, V. V. Sochat, S. S. Ghosh,
C. Maumet, T. E. Nichols, J. B. Poline, T. Yarkoni, D. S. Margulies, et R. A. Poldrack,
86
“NeuroVault.org : A repository for sharing unthresholded statistical maps, parcellations,
and atlases of the human brain.” NeuroImage, vol. 124, no. April, pp. 1242–1244, 2016.
K. R. Gray, R. Wolz, R. A. Heckemann, P. Aljabar, A. Hammers, et D. Rueckert,
“Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer’s
disease.” NeuroImage, vol. 60, no. 1, pp. 221–229, 2012. En ligne : http:
//dx.doi.org/10.1016/j.neuroimage.2011.12.071
K. R. Gray, P. Aljabar, R. A. Heckemann, A. Hammers, et D. Rueckert, “Random
forest-based similarity measures for multi-modal classification of Alzheimer’s disease.”
NeuroImage, vol. 65, pp. 167–175, 2013. En ligne : http://dx.doi.org/10.1016/j.
neuroimage.2012.09.065
C. Grova, A. Biraben, J. M. Scarabin, P. Jannin, I. Buvat, H. Benali, et B. Gibaud, “A me-
thodology to validate MRI/SPECT registration methods using realistic simulated SPECT
data.” Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial
Intelligence and Lecture Notes in Bioinformatics), vol. 2208, pp. 275–282, 2001.
G. Guo, “Support Vector Machines Applications.” Y. Ma and G. Guo (eds.),
Support Vector Machines Applications, Springer., pp. 269–302, 2014. En ligne :
http://link.springer.com/10.1007/978-3-319-02300-7
I. Guyon et A. Elisseeff, “Feature Extraction, Foundations and Applications : An
introduction to feature extraction”, Studies in Fuzziness and Soft Computing, vol. 207, pp.
1–25, 2006. En ligne : http://eprints.pascal-network.org/archive/00002475/
C. Habeck, N. L. Foster, R. Perneczky, A. Kurz, P. Alexopoulos, R. A. Koeppe, A. Drzezga,
et Y. Stern, “Multivariate and univariate neuroimaging biomarkers of Alzheimer’s disease.”
NeuroImage, vol. 40, no. 4, pp. 1503–1515, 2008.
A. Hammers, R. Allom, M. J. Koepp, S. L. Free, R. Myers, L. Lemieux, T. N. Mitchell,
D. J. Brooks, et J. S. Duncan, “Three-dimensional maximum probability atlas of the human
brain, with particular reference to the temporal lobe.” Human Brain Mapping, vol. 19, no. 4,
pp. 224–247, 2003.
R. A. Heckemann, J. V. Hajnal, P. Aljabar, D. Rueckert, et A. Hammers, “Automatic ana-
tomical brain MRI segmentation combining label propagation and decision fusion.” NeuroI-
mage, vol. 33, no. 1, pp. 115–126, 2006.
87
A. Heyman, W. Wilkinson, J. Stafford, M. Helms, A. Sigmon, et T. Weinberg, “Alzheimer’s
disease : a study of epidemiological aspects.” Ann Neurol, no. 15, p. 335–41, 1984.
C. Hinrichs, V. Singh, L. Mukherjee, G. Xu, M. K. Chung, et S. C. Johnson,
“Spatially augmented LPboosting for AD classification with evaluations on the
ADNI dataset.” NeuroImage, vol. 48, no. 1, pp. 138–149, 2009. En ligne :
http://dx.doi.org/10.1016/j.neuroimage.2009.05.056
M. Hoffman, “Picture of the Brain, Human Anatomy.” 2014. En ligne : http:
//www.webmd.com/brain/picture-of-the-brain#1
K. Hornik, M. Stinchcombe, et H. White, “Multilayer feedforward networks are universal
approximators”, Neural Netw., vol. 2, no. 5, pp. 359–366, 1989.
K. Hornik, “Approximation capabilities of multilayer feedforward networks”, Neural Net-
works, vol. 4, no. 2, pp. 251–257, 1991.
R. Howlett et L. Jain, Radial Basis Function Networks 2 New Advances in Design. New
York, : Springer-Verlag, 2001, vol. 67.
http ://www.edoctoronline.com, “2016 Alzheimer’s Disease Facts and Figures,Report.”
2016. En ligne : http://www.edoctoronline.com/medical-atlas.asp?c=4&id=21701
X. Hua, S. Lee, I. Yanovsky, A. D. Leow, Y.-y. Chou, A. J. Ho, J. Harvey, J. Kornak,
N. Schuff, G. E. Alexander, et M. W. Weiner, “Optimizing power to track brain degeneration
in Alzheimer’s disease and mild cognitive impairment with tensor-based morphometry : An
ADNI study of 515 subjects.” NIH Public Access.
L. Ibanez, W. Schroeder, L. Ng, et J. Cates, “The ITK software guide.” 2005.
K. Ishii, T. Soma, A. K. Kono, K. Sofue, N. Miyamoto, T. Yoshikawa, E. Mori, et K. Murase,
“Comparison of regional brain volume and glucose metabolism between patients with mild
dementia with lewy bodies and those with mild Alzheimer’s disease”, J Nucl Med, vol. 48,
no. 5, pp. 704–711, 2007.
C. R. Jack, M. M. Shiung, J. L. Gunter, P. C. O’Brien, S. D. Weigand, D. S. Knopman,
B. F. Boeve, R. J. Ivnik, G. E. Smith, R. H. Cha, E. G. Tangalos, et R. C. Petersen,
“Comparison of different MRI brain atrophy rate measures with clinical disease progression
in AD.” Neurology, vol. 62, no. 4, pp. 591–600, 2004.
88
W. J. Jagust, “ADNI PET Core Report 2010.” Alzheimer’s Dementia, vol. 6, no. 3, pp.
221–229, 2010.
R. Jahn, “How neurons talk to each other.” 2016. En ligne : https://www.mpg.de/
10743509/how-neurons-talk-to-each-other
Japan Association of Remote Sensing., “Image Processing - Classification.” pp. 208–225,
1996.
M. Jenkinson et S. Smith, “A global optimisation method for robust affine registration of
brain images.” Medical Image Analysis, vol. 5, no. 2, pp. 143–156, 2001.
M. Jenkinson, P. Bannister, M. Brady, et S. Smith, “Improved optimization for the robust
and accurate linear registration and motion correction of brain images.” NeuroImage, vol. 17,
no. 2, pp. 825–841, 2002.
K. A. Johnson, N. C. Fox, R. A. Sperling, et W. E. Klunk, “Brain imaging in Alzheimer
disease.” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 4, pp. 1–23, 2012.
S. Joshi, D. Shenoy, V. S. G.G., P. Rrashmi, K. Venugopal, et L. Patnaik,
“Classification of Alzheimer’s Disease and Parkinson’s Disease by Using Machine
Learning and Neural Network Methods.” 2010 Second International Conference
on Machine Learning and Computing, pp. 218–222, 2010. En ligne : http:
//ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=5460738
R. N. Kalaria, G. E. Maestre, R. Arizaga, R. P. Friedland, D. Galasko, K. Hall, J. A.
Luchsinger, A. Ogunniyi, E. K. Perry, F. Potocnik, M. Prince, R. Stewart, A. Wimo, Z. X.
Zhang, et P. Antuono, “Alzheimer’s disease and vascular dementia in developing countries :
prevalence, management, and risk factors.” The Lancet Neurology, vol. 7, no. 9, pp. 812–826,
2008.
H. Kalini, “Atlas-based image segmentation : A Survey.” Neuroscience, pp. 1–7, 2004.
R. Katzman, “Education and the prevalence of dementia and Alzheimer’s disease.” Neuro-
logy, no. 43, p. 13–20, 1993.
T. Kawachi, K. Ishii, S. Sakamoto, M. Sasaki, T. Mori, F. Yamashita, H. Matsuda, et
E. Mori, “Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very
mild Alzheimer’s disease”, European Journal of Nuclear Medicine and Molecular Imaging,
vol. 33, no. 7, pp. 801–809, 2006.
89
S. S. Keerthi et C.-J. Lin, “Asymptotic behaviors of support vector machines with
Gaussian kernel.” Neural computation, vol. 15, no. 7, pp. 1667–89, 2003. En ligne :
http://www.ncbi.nlm.nih.gov/pubmed/12816571
S. J. Kiebel, J. Ashburner, J. B. Poline, et K. J. Friston, “MRI and PET coregistration-
a cross validation of statistical parametric mapping and automated image registration.”
NeuroImage, vol. 5, no. 4 Pt 1, pp. 271–279, 1997.
Y. Y. Kim, H. J. Shin, M. J. Kim, et M. J. Lee, “Comparison of effective radiation doses from
X-ray, CT, and PET/ CT in pediatric patients with neuroblastoma using a dose monitoring
program”, Diagnostic and Interventional Radiology, vol. 22, no. 4, pp. 390–394, 2016.
J. S. Kippenhan, W. W. Barker, S. Pascal, J. Nagel, et R. Duara, “Evaluation of a neural-
network classifier for PET scans of normal and Alzheimer’s disease subjects.” Journal of
Nuclear Medicine, vol. 33, no. 8, pp. 1459–1467, 1992.
R. Kirwan, “Brain.” 2016. En ligne : http://www.infocomcanada.com/CMPI/Program%
20Guide/brain.htm
S. Klein, M. Staring, K. Murphy, M. A. Viergever, et J. P. W. Pluim, “Elastix : A toolbox
for intensity-based medical image registration.” IEEE Transactions on Medical Imaging,
vol. 29, no. 1, pp. 196–205, 2010.
S. Klöppel, C. M. Stonnington, C. Chu, B. Draganski, I. Scahill, J. D. Rohrer, N. C. Fox,
C. R. J. Jr, J. Ashburner, et R. S. J. Frackowiak, “UKPMC Funders Group Automatic
classification of MR scans in Alzheimer ’ s disease”, Brain, vol. 131, no. Pt 3, pp. 681–689,
2008.
S. B. Kotsiantis, “Supervised machine learning : a review of classification techniques.” In-
formatica (03505596), vol. 31, no. 3, 2007.
J. Lancaster, L. Rainey, J. Summerlin, et C. Freitas, “Automated labeling of
the human brain : a preliminary report on the development and evaluation
of a {. . . }.” Human Brain Mapping, vol. 242, pp. 238–242, 1997. En ligne :
http://www3.interscience.wiley.com/journal/56443/abstract
J. L. Lancaster, L. H. Rainey, J. L. Summerlin, C. S. Freitas, P. T. Fox, A. C. Evans, A. W.
Toga, et J. C. Mazziotta, “Automated labeling of the human brain : A preliminary report on
the development and evaluation of a forward-transform method.” Human Brain Mapping,
vol. 5, no. 4, pp. 238–242, 1997.
90
J. L. Lancaster, M. G. Woldorff, L. M. Parsons, M. Liotti, C. S. Freitas, L. Rainey, P. V.
Kochunov, D. Nickerson, S. A. Mikiten, et P. T. Fox, “Automated Talairach Atlas labels for
functional brain mapping.” Human Brain Mapping, vol. 10, no. 3, pp. 120–131, 2000.
P. E. Lee, G. R. Hsiung, D. Seitz, S. S. Gill, et P. a. Rochon, “Cholinesterase inhibitors”,
BC Medical Journal, vol. 53, no. 8, pp. 404–408, 2011.
L. Lemieux, A. Hammers, T. Mackinnon, et R. S. N. Liu, “Automatic segmentation of the
brain and intracranial cerebrospinal fluid in T1-weighted volume MRI scans of the head,
and its application to serial cerebral and intracranial volumetry.” Magnetic Resonance in
Medicine, vol. 49, no. 5, pp. 872–884, 2003.
D. Lenzi, L. Serra, R. Perri, P. Pantano, G. L. Lenzi, E. Paulesu, C. Caltagirone,
M. Bozzali, et E. Macaluso, “Single domain amnestic MCI : A multiple cognitive domains
fMRI investigation.” Neurobiology of Aging, vol. 32, no. 9, pp. 1542–1557, 2011. En ligne :
http://dx.doi.org/10.1016/j.neurobiolaging.2009.09.006
A. Liaw et M. Wiener, “Classification and Regression by Random Forest.” R news, vol. 2,
no. December, pp. 18–22, 2002.
J. Liu, M. Li, W. Lan, F.-X. Wu, Y. Pan, et J. Wang, “Classification of
Alzheimer’s Disease Using Whole Brain Hierarchical Network.” IEEE/ACM transactions
on computational biology and bioinformatics, vol. 14, no. 8, pp. 1–10, 2016. En ligne :
http://www.ncbi.nlm.nih.gov/pubmed/27925595
Y. Liu, L. Zhu, K. Plössl, S. R. Choi, H. Qiao, X. Sun, S. Li, Z. Zha, et H. F. Kung,
“Optimization of automated radiosynthesis of [18F]AV-45 : A new PET imaging agent for
Alzheimer’s disease.” Nuclear Medicine and Biology, vol. 37, no. 8, pp. 917–925, 2010.
H. Lodish, A. Berk, S. L. Zipursky, P. Matsudaira, D. Baltimore, et J. Darnell, “Molecular
Cell Biology.” 2000. En ligne : https://www.ncbi.nlm.nih.gov/books/NBK21475/
S. Love, “Neuropathological investigation of dementia : a guide for neurologists.”
J Neurol Neurosurg Psychiatry, vol. 76, pp. v8–14, 2005. En ligne : http:
//dx.doi.org/10.1136/jnnp.2005.080754
J. A. Luchsinger, M.-X. Tang, Y. Stern, S. Shea, et R. Mayeux, “Diabetes Mellitus
and Risk of Alzheimer’s Disease and Dementia with Stroke in a Multiethnic Cohort.”
American Journal of Epidemiology, vol. 154, no. 7, p. 635, 2001. En ligne :
http://dx.doi.org/10.1093/aje/154.7.635
91
R. Maani, Y. H. Yang, et S. Kalra, “Voxel-based texture analysis of the brain”, PLoS ONE,
vol. 10, no. 3, pp. 1–19, 2015.
P. J. Markiewicz, J. C. Matthews, J. Declerck, et K. Herholz, “Robustness of multivariate
image analysis assessed by resampling techniques and applied to FDG-PET scans of patients
with Alzheimer’s disease.” pp. 472–485, 2009.
I. Matsunari, M. Samuraki, W.-P. Chen, D. Yanase, N. Takeda, K. Ono, M. Yoshita, H. Mat-
suda, M. Yamada, et S. Kinuya, “Comparison of 18F-FDG PET and optimized voxel-based
morphometry for detection of Alzheimer’s disease : aging effect on diagnostic performance.”
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 48, no. 12,
pp. 1961–1970, 2007.
J. Maus, “PET-schema.png.” 2003. En ligne : https://commons.wikimedia.org/wiki/
File:PET-schema.png
Mayo Clinic Staff, “Mild cognitive impairment.” 2017. En ligne : http://www.mayoclinic.
org/diseases-conditions/mild-cognitive-impairment/home/ovc-20206082
G. M. McKhann, D. S. Knopman, H. Chertkow, B. T. Hyman, C. R. Jack, C. H. Kawas,
W. E. Klunk, W. J. Koroshetz, J. J. Manly, R. Mayeux, R. C. Mohs, J. C. Morris,
M. N. Rossor, P. Scheltens, M. C. Carrillo, B. Thies, S. Weintraub, et C. H. Phelps,
“The diagnosis of dementia due to Alzheimer’s disease : Recommendations from the
National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines
for Alzheimer’s disease.” Alzheimer’s and Dementia, vol. 7, no. 3, pp. 263–269, 2011.
En ligne : http://dx.doi.org/10.1016/j.jalz.2011.03.005
K. MILLER, Z. TAYLOR, et W. L. NOWINSKI, “Towards Computing Brain Deformations
for Diagnosis, Prognosis and Neurosurgical Simulation”, Journal of Mechanics in Medicine
and Biology, vol. 05, no. 01, pp. 105–121, 2005.
S. Miller, E. Fenstermacher, J. Bates, D. Blacker, et R. A. Sperling, “Hippocampal activation
in adults with mild cognitive impairment predicts subsequent cogntive decline.” J Neurol
Neurosurg Psychiatry, vol. 79, no. 6, pp. 630–635, 2009.
J. B. O. Mitchell, “Machine learning methods in chemoinformatics.” Wiley Interdisciplinary
Reviews : Computational Molecular Science, vol. 4, no. October, pp. n/a–n/a, 2014.
En ligne : http://doi.wiley.com/10.1002/wcms.1183
J.-P. Morin, C. Desrosiers, et L. Duong, “Atlas-based segmentation of brain magnetic
92
resonance imaging using random walks”, 2012 IEEE Computer Society Conference on
Computer Vision and Pattern Recognition Workshops, pp. 44–49, 2012. En ligne :
http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6239246
L. Mosconi, S. Sorbi, M. J. de Leon, Y. Li, B. Nacmias, P. S. Myoung, W. Tsui, A. Gi-
nestroni, V. Bessi, M. Fayyazz, P. Caffarra, et A. Pupi, “Hypometabolism exceeds atrophy
in presymptomatic early-onset familial Alzheimer’s disease.” Journal of nuclear medicine,
vol. 47, no. 11, pp. 1778–1786, 2006.
L. Mucke, “Neuroscience : Alzheimer’s disease.” Nature, vol. 461, no. 7266, pp. 895–7,
2009. En ligne : http://dx.doi.org/10.1038/461895a
Neurodegenerative Diseases Research, “Neurodegenerative diseases.” 2014. En ligne :
http://www.neurodegenerationresearch.eu/about/what/
F. P. Oliveira et J. M. R. Tavares, “Medical image registration : A review.”
Computer Methods in Biomechanics and Biomedical Engineering, vol. 17, no. 2,
pp. 73–93, 2014. En ligne : http://www.ncbi.nlm.nih.gov/pubmed/224353555Cnhttp:
//www.tandfonline.com/doi/abs/10.1080/10255842.2012.670855
Orthopaedics, “What is Magnetic Resonance Imaging.” 2017. En ligne : http:
//www.orthopaedics.com.sg/treatments/magnetic-resonance-imaging-mri
B. R. Ott, R. A. Cohen, A. Gongvatana, C. Ozioma, C. E. Johanson, E. G. Stopa, et
J. E. Donahue, “Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer’s
disease.” Alzheimers Dis, vol. 20, no. 2, pp. 647–657, 2011.
F. Pedersen, M. Bergstrom, E. Bengtsson, et E. Maripuu, “Principal component
analysis of dynamic PET and gamma camera images : a methodology to visualize
the signals in the presence of large noise.” 1993 IEEE Conference Record Nuclear
Science Symposium and Medical Imaging Conference, pp. 1734–1738, 1993. En ligne :
http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=373589
D. P. Pelvig, H. Pakkenberg, A. K. Stark, et B. Pakkenberg, “Neocortical glial cell numbers
in human brains.” Neurobiology of Aging, vol. 29, no. 11, pp. 1754–1762, 2008.
R. C. Petersen, J. C. Stevens, M. Ganguli, E. G. Tangalos, J. L. Cummings, et S. T.
Dekosky, “Practice parameter : Early detection of dementia : Mild Cognitive Impairment
(an evidence-based review).” Neurology, vol. 56, pp. 1133–1142, 2001.
93
D. L. Pham, C. Xu, et J. L. Prince, “Current methods in medical image segmentation.”
Biomedical Engineering, no. 2, pp. 315–37, 2000.
M. J. Pontecorvo et M. A. Mintun, “PET amyloid imaging as a tool for early diagnosis and
identifying patients at risk for progression to Alzheimer’s disease.” Alzheimer’s Research &
Therapy, vol. 3, no. 2, p. 11, 2011.
A. Pop, “Principal components analysis (PCA).” Computers & Geosciences, pp. 2–6, 1993.
En ligne : http://www.sciencedirect.com/science/article/pii/009830049390090R
S. Przedborski, M. Vila, et V. Jackson-lewis, “Neurodegeneration : What is it and where
are we ?” J. Clin. Invest., vol. 111, no. 1, pp. 3–10, 2003.
S. Pushpa, P. Vinod, et C. Maple, “Creating a forest of binary search trees for a multi-
processor system.” PARELEC 2006 - Proceedings : International Symposium on Parallel
Computing in Electrical Engineering, pp. 290–294, 2006.
A. Rao, Y. Lee, A. Gass, et A. Monsch, “Classification of Alzheimer’s Disease from structural
MRI using sparse logistic regression with optional spatial regularization.” Proceedings of the
Annual International Conference of the IEEE Engineering in Medicine and Biology Society,
EMBS, no. 3, pp. 4499–4502, 2011.
D. B. Reisberg, “What Are the 7 Stages of Alzheimer’s Disease ?” 2016. En ligne :
http://www.alzheimers.net/stages-of-alzheimers-disease/
E. Richard, B. A. Schmand, P. Eikelenboom, et W. A. Van Gool, “MRI and cerebrospinal
fluid biomarkers for predicting progression to Alzheimer’s disease in patients with mild
cognitive impairment : A diagnostic accuracy study.” BMJ open, vol. 3, no. 6, pp.
1–8, 2013. En ligne : http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=
3686215{&}tool=pmcentrez{&}rendertype=abstract
M. D. Richard et R. P. Lippmann, “Neural network classifiers estimate Bayesian a posteriori
probabilities.” Neural computation, vol. 3, no. 4, pp. 461–483, 1991.
E. D. Roberson et L. Mucke, “100 Years and Counting : Prospecs for Defeating Alzheimer’s
Disease.” Science, vol. 314, no. 5800, pp. 781–784, 2013.
F. Rodrigues et M. Silveira, “Longitudinal FDG-PET features for the classification of Alz-
heimer’s disease.” 2014 36th Annual International Conference of the IEEE Engineering in
Medicine and Biology Society, EMBC 2014, pp. 1941–1944, 2014.
94
R. Rojas, Neural Networks : A Systematic Introduction. New York, NY, USA : Springer-
Verlag New York, Inc., 1996.
G. Román et B. Pascual, “Contribution of Neuroimaging to the Diagnosis of Alzheimer’s
Disease and Vascular Dementia.” Archives of Medical Research, vol. 43, no. 8, pp. 671–676,
2012.
L. Saint-Aubert, F. Nemmi, P. Péran, E. J. Barbeau, P. Payoux, F. Chollet, et J. Pariente,
“Comparison between PET template-based method and MRI-based method for cortical
quantification of florbetapir (AV-45) uptake in vivo.” European Journal of Nuclear Medicine
and Molecular Imaging, vol. 41, no. 5, pp. 836–843, 2014.
L. Saint-Aubert, E. J. Barbeau, P. Péran, F. Nemmi, C. Vervueren, H. Mirabel,
P. Payoux, A. Hitzel, F. Bonneville, R. Gramada, M. Tafani, C. Vincent, M. Puel,
S. Dechaumont, F. Chollet, et J. Pariente, “Cortical florbetapir-PET amyloid load in
prodromal Alzheimer’s disease patients.” EJNMMI research, vol. 3, no. 1, p. 43, 2013.
En ligne : http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3733998&
tool=pmcentrez&rendertype=abstract
D. Salas-Gonzalez, J. M. Górriz, J. Ramírez, I. A. Illán, M. López, F. Segovia,
R. Chaves, P. Padilla, et C. G. Puntonet, “Feature selection using factor analysis for
Alzheimer’s diagnosis using 18F-FDG PET images.” Medical physics, vol. 37, no. 11, pp.
6084–95, 2010. En ligne : http://www.pubmedcentral.nih.gov/articlerender.fcgi?
artid=2994934{&}tool=pmcentrez{&}rendertype=abstract
E. Salmon, “Différentes facettes de la maladie de type Alzheimer”, Revue médicale de Liège,
vol. 63, no. 5, pp. 299–302, 2008.
A. Serrano-Pozo, M. P. Frosch, E. Masliah, et B. T. Hyman, “Neuropathological alterations
in Alzheimer disease.” Cold Spring Harbor perspectives in medicine, vol. 1, no. 1, pp. 1–23,
2011.
M. Silveira et J. Marques, “Boosting Alzheimer Disease Diagnosis using PET Images.” Pro-
ceedings of the 2010 20th IEEE International Conference on Pattern Recognition (ICPR),
pp. 2556–2559, 2010.
D. H. Silverman, G. W. Small, C. Y. Chang, C. S. Lu, M. A. Kung De Aburto, W. Chen,
J. Czernin, S. I. Rapoport, P. Pietrini, G. E. Alexander, M. B. Schapiro, W. J. Jagust,
J. M. Hoffman, K. A. Welsh-Bohmer, A. Alavi, C. M. Clark, E. Salmon, M. J. De Leon,
R. Mielke, J. L. Cummings, A. P. Kowell, S. S. Gambhir, C. K. Hoh, et M. E. Phelps,
95
“Positron emission tomography in evaluation of dementia : Regional brain metabolism
and long-term outcome.” JAMA, vol. 286, no. 17, pp. 2120–2127, 2001. En ligne :
http://dx.doi.org/10.1001/jama.286.17.2120
D. Silverman, PET in the Evaluation of Alzheimer’s Disease and Related Disorders., 1er éd.
New York : Springer Science and Business Media, 2009.
N. Smailagic, M. Vacante, C. Hyde, S. Martin, O. Ukoumunne, et C. Sachpekidis,
“18F-FDG PET for the early diagnosis of Alzheimer’s disease dementia and other
dementias in people with mild cognitive impairment (MCI).” Cochrane Database of
Systematic Reviews, no. 1, 2015. En ligne : http://onlinelibrary.wiley.com/doi/10.
1002/14651858.CD010632.pub2/abstract
S. M. Smith, M. Jenkinson, M. W.Woolrich, C. F. Beckmann, T. E. J. Behrens, H. Johansen-
Berg, P. R. Bannister, M. De Luca, I. Drobnjak, D. E. Flitney, R. K. Niazy, J. Saunders,
J. Vickers, Y. Zhang, N. De Stefano, J. M. Brady, et P. M. Matthews, “Advances in func-
tional and structural MR image analysis and implementation as FSL.” NeuroImage, vol. 23,
no. SUPPL. 1, pp. 208–219, 2004.
J. Stoeckel et G. Fung, “SVM Feature Selection for Classification of SPECT
Images of Alzheimer’s Disease Using Spatial Information.” Fifth IEEE International
Conference on Data Mining (ICDM’05), vol. 11, no. 2, pp. 410–417, 2007. En ligne :
http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=1565706
K. Strimbu et J. a. Tavel, “What are Biomarkers ?” Current Opinion in HIV and AIDS
(LWW), vol. 5, no. 6, pp. 463–466, 2011.
E. Stühler et D. Merhof, “Principal Component Analysis Applied to SPECT and PET
Data of Dementia Patients–A Review.” Principal Component Analysis : Multidisciplinary
applications, 2012. En ligne : http://nozdr.ru/data/media/biblioteka/kolxo3/
M_Mathematics/MV_Probability/MVsa_Statisticsandapplications/SanguansatP.
(ed.)Principalcomponentanalysis-multidisciplinaryapplications(InTech,2012)
(ISBN9789535101291)(O)(212s)_MVsa_.pdf#page=179
H.-I. Suk et D. Shen, “Deep learning-based feature representation for AD/MCI classifica-
tion.” dans International Conference on MICCAI. Springer, 2013, pp. 583–590.
P. M. Thompson, K. M. Hayashi, G. I. De Zubicaray, A. L. Janke, S. E. Rose, J. Semple,
M. S. Hong, D. H. Herman, D. Gravano, D. M. Doddrell, et A. W. Toga, “Mapping hip-
96
pocampal and ventricular change in Alzheimer disease.” NeuroImage, vol. 22, no. 4, pp.
1754–1766, 2004.
L. Tilley, K. Morgan, et N. Kalsheker, “Genetic risk factors in Alzheimer’s disease.” Journal
of Clinical Pathology, vol. 51, no. 6, pp. 293–304, 1998.
M. Toews, W. Wells, L. Collinsc, et T. Arbeld, “Feature-Based Morphometry : Discovering
Group-related Anatomical Patterns”, Neuroimage, vol. 49, no. 3, pp. 2318–2327, 2010.
T. Tong, K. Gray, Q. Gao, L. Chen, et D. Rueckert, “Multi-modal classification of
Alzheimer’s disease using nonlinear graph fusion.” Pattern Recognition, vol. 63, no.
September 2016, pp. 171–181, 2017. En ligne : http://dx.doi.org/10.1016/j.patcog.
2016.10.009
S. L. Tyas, J. Manfreda, L. A. Strain, et P. R. Montgomery, “Risk factors for
Alzheimer’s disease : a population-based, longitudinal study in Manitoba, Canada.”
International journal of epidemiology, vol. 30, no. 3, pp. 590–7, 2001. En ligne :
http://www.ncbi.nlm.nih.gov/pubmed/11416089
N. Tzourio-Mazoyer, B. Landeau, D. Papathanassiou, F. Crivello, O. Etard, N. Delcroix,
B. Mazoyer, et M. Joliot, “Automated anatomical labeling of activations in SPM using a
macroscopic anatomical parcellation of the MNI MRI single-subject brain.” NeuroImage,
vol. 15, no. 1, pp. 273–289, 2002.
L. A. Van de Pol, E. S. C. Korf, W. M. Van der Flier, H. R. Brashear, N. C.
Fox, F. Barkhof, et P. Scheltens, “Magnetic resonance imaging predictors of cognition
in mild cognitive impairment.” Archives of Neurology, vol. 64, no. 7, pp. 1023–1028,
2007. En ligne : http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=
2007-11296-006&lang=de&site=ehost-live&scope=site
W. F. Velicer, “Determining the number of components from the matrix of partial correla-
tions”, Psychometrika, vol. 41, no. 3, pp. 321–327, 1976.
P. Vemuri, H. J. Wiste, S. D. Weigand, D. S. Knopman, J. Q. Trojanowski, L. M. Shaw,
M. A. Bernstein, P. S. Aisen, M. Weiner, R. C. Petersen, et C. R. Jack, “Serial MRI and
CSF biomarkers in normal aging, MCI, and AD.” Neurology, vol. 75, no. 2, pp. 143–151,
2010.
P. Vemuri et C. Jack, “Role of structural MRI in Alzheimer’s disease.” Alzheimer’s Research
& Therapy, vol. 2, no. 4, p. 23, 2010. En ligne : http://alzres.com/content/2/4/23
97
A. G. Vlassenko, T. L. S. Benzinger, et J. C. Morris, “PET amyloid-beta imaging in
preclinical Alzheimer’s disease.” Biochimica et Biophysica Acta - Molecular Basis of
Disease, vol. 1822, no. 3, pp. 370–379, 2012. En ligne : http://dx.doi.org/10.1016/j.
bbadis.2011.11.005
C. Wachinger, M. Toews, G. Langs, W. Wells IIIi, et P. Golland, “Keypoint Transfer Seg-
mentation”, Information Processing in Medical Imaging, vol. 9123, pp. 233–245, 2015.
K. B. Walhovd, A. M. Fjell, J. Brewer, L. K. McEvoy, C. Fennema-Notestine, D. J. Hagler,
R. G. Jennings, D. Karow, A. Dale, et T. A. D. N. Initiative, “Combining MRI, PET and
CSF biomarkers in diagnosis and prognosis of Alzheimer’s disease.” American Journal of
Neuroradiology, vol. 31, no. 2, p. 347, 2010.
C. Watson, M. Kirkcaldie, et G. Paxinos, The Brain : An Introduction to Functional Neu-
roanatomy. Elsevier Science Publishing Co Inc, 2010.
M. P. Wattjes, “Structural MRI.” International Psychogeriatrics, vol. 23, no. S2, p. S13–S24,
2011.
M. Weiner et Z. Khachaturian, “The Use of MRI and PET for Clinical Diagnosis of Dementia
and Investigation of Cognitive Impairment : A Consensus Report.” Alzheimer’s Association,
Chicago, IL, no. 1, pp. 1–15, 2005. En ligne : http://www.alz.co.il/pdf/603333.pdf
E. Westman, A. Simmons, J. S. Muehlboeck, P. Mecocci, B. Vellas, M. Tsolaki, I. Klos-
zewska, H. Soininen, M. W. Weiner, S. Lovestone, C. Spenger, et L. O. Wahlund, “Add-
NeuroMed and ADNI : Similar patterns of Alzheimer’s atrophy and automated MRI classi-
fication accuracy in Europe and North America.” NeuroImage, vol. 58, no. 3, pp. 818–828,
2011.
R. Wolz, V. Julkunen, J. Koikkalainen, E. Niskanen, D. P. Zhang, D. Rueckert, H. Soininen,
et J. Lötjönen, “Multi-method analysis of MRI images in early diagnostics of Alzheimer’s
disease.” PLoS ONE, vol. 6, no. 10, pp. 1–9, 2011.
R. P. Woods, S. T. Grafton, C. J. Holmes, S. R. Cherry, et J. C. Mazziotta, “Automated
Image Registration : I. General methods and intrasubject, intramodality validation.” Journal
of computer assisted tomography, vol. 22, no. February 1998, pp. 139–152, 1998.
L. Xu, X. Wu, K. Chen, et L. Yao, “Multi-modality sparse representation-based
classification for Alzheimer’s disease and mild cognitive impairment.” Computer Methods
98
and Programs in Biomedicine, vol. 122, no. 2, pp. 182–190, 2015. En ligne :
http://dx.doi.org/10.1016/j.cmpb.2015.08.004
D. Zhang et D. Shen, “Predicting future clinical changes of MCI patients using longitudinal
and multimodal biomarkers”, PLoS ONE, vol. 7, no. 3, 2012.
D. Zhang, Y. Wang, L. Zhou, H. Yuan, et D. Shen, “Multimodal classification of
Alzheimer’s disease and mild cognitive impairment.” NeuroImage, vol. 55, no. 3, pp.
856–867, 2011. En ligne : http://dx.doi.org/10.1016/j.neuroimage.2011.01.008
D. Zhang, Y. Wang, L. Zhou, H. Yuan, D. Shen, et al., “Multimodal classification of Alz-
heimer’s disease and mild cognitive impairment.” Neuroimage, vol. 55, no. 3, pp. 856–867,
2011.
S. Zhang, N. Smailagic, C. Hyde, N.-S. Ah, Y. Takwoingi, R. Mcshane, et J. Feng, “11C-PIB-
PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people
with mild cognitive impairment ( MCI ) ( Review ).” Cochrane Database of Systematic
Reviews, no. 7, pp. 10–12, 2014.
B. Zitová et J. Flusser, “Image registration methods : A survey.” Image and Vision Com-
puting, vol. 21, no. 11, pp. 977–1000, 2003.
